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Development as a new Paradigm for Improved Tendon Healing: A
Characterization of Neonatal Tendon Development, Healing During Development
and An investigation into Differential Parameters During Accelerated Healing
Abstract
During neonatal development, tendons undergo a well orchestrated process whereby extensive structural
and compositional changes occur in synchrony to produce a normal tissue. Conversely, during the repair
response to injury, structural and compositional changes occur, but in this case, a mechanically inferior
tendon is produced. An injured tendon that is mechanically inferior has compromised function and
reruptures after treatment are commonly observed clinically. As a result, the process of development has
been postulated as a potential paradigm through which improved adult tissue healing may occur. First,
the role of CD44 in healing was examined through a patellar tendon injury in a CD44 knockout mouse. A
beneficial environment post injury was shown to lead to improved function in the CD44 knockout tendons.
Second, type XIV collagen was examined in tendons during development and maturity through Col14a1-/-,
Col14+/- and Col14+/+ flexor digitorum longus tendons. A lack of type XIV collagen during development
was associated with reduced mechanical parameters but had no effect in mature tendons. Third,
compositional, structural and mechanical properties were quantitatively characterized during multiple
stages of neonatal Achilles tendon development in a mouse. Mechanical parameters, collagen content,
fibril diameter average and standard deviation all increased with age. Biglycan expression decreased with
age while decorin and angular deviation did not change. Fourth, compositional, structural and mechanical
parameters were quantified after injury during two different stages of development, early and late. An
accelerated healing process was demonstrated during early development over late development. Lastly,
regression analysis was used to determine which compositional and structural parameters predicted
mechanical parameters during early and late development and healing. Applying these differentially
regulated parameters to new treatments may help improve healing in adult tendons. Importantly, this
dissertation was conducted in a mouse model which is allows for future mechanistic studies due to the
availability of genetically modified mice and commercially available assays. Over all, this dissertation
introduces development as a new paradigm through which to study improved function during healing and
potential new therapeutic treatments.
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ABSTRACT
DEVELOPMENT AS A NEW PARADIGM FOR IMPROVED TENDON HEALING: A
CHARACTERIZATION OF NEONATAL TENDON DEVELOPMENT, HEALING DURING
DEVELOPMENT AND AN INVESTIGATION INTO DIFFERENTIAL PARAMETERS DURING
ACCELERATED HEALING
Heather L. Ansorge
Louis J. Soslowsky, Ph.D.
During neonatal development, tendons undergo a well orchestrated process whereby extensive
structural and compositional changes occur in synchrony to produce a normal tissue. Conversely,
during the repair response to injury, structural and compositional changes occur, but in this case,
a mechanically inferior tendon is produced. An injured tendon that is mechanically inferior has
compromised function and reruptures after treatment are commonly observed clinically. As a
result, the process of development has been postulated as a potential paradigm through which
improved adult tissue healing may occur. First, the role of CD44 in healing was examined
through a patellar tendon injury in a CD44 knockout mouse. A beneficial environment post injury
was shown to lead to improved function in the CD44 knockout tendons. Second, type XIV
collagen was examined in tendons during development and maturity through Col14a1-/-, Col14+/and Col14+/+ flexor digitorum longus tendons. A lack of type XIV collagen during development
was associated with reduced mechanical parameters but had no effect in mature tendons. Third,
compositional, structural and mechanical properties were quantitatively characterized during
multiple stages of neonatal Achilles tendon development in a mouse. Mechanical parameters,
collagen content, fibril diameter average and standard deviation all increased with age. Biglycan
expression decreased with age while decorin and angular deviation did not change. Fourth,
compositional, structural and mechanical parameters were quantified after injury during two
different stages of development, early and late. An accelerated healing process was
demonstrated during early development over late development. Lastly, regression analysis was
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used to determine which compositional and structural parameters predicted mechanical
parameters during early and late development and healing. Applying these differentially regulated
parameters to new treatments may help improve healing in adult tendons. Importantly, this
dissertation was conducted in a mouse model which is allows for future mechanistic studies due
to the availability of genetically modified mice and commercially available assays. Over all, this
dissertation introduces development as a new paradigm through which to study improved function
during healing and potential new therapeutic treatments.
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Chapter 1: Introduction

1.1 Significance
1.1.1 Prevalence of Tendon Injuries in the US
Tendon injuries affect a large number of individuals and account for enormous associated
costs [1, 2]. These injuries account for 45% of the almost 33 million musculoskeletal injuries that
occur in the United States each year[3]. The work place is a large source of these injuries. In
1996, approximately 44% of all injuries and illness that resulted in days away from work were
sprains, strains and tears [4]. However, soft tissue injuries are also extremely common outside
the work place. Between the years 1991 and 1998, the number of sports related injuries in
people 35-54 years of age increased 33% [5]. It was estimated that from the approximately 1
million sports related injuries in 1998, the cost to the nation was more than $18.7 billion[5]. The
number of tendon injuries will continue to increase in our aging and active population[6]. Tendon
injuries that are especially common, requiring surgical repair, include the shoulder's rotator cuff
tendons (51,000 per year), the Achilles tendon (44,000 per year), and the patellar tendon (42,000
per year) [7] [8]. Tendon injuries are of particular concern because they heal slowly and rarely
regain normal function. Surgery [9], rehabilitation [10], drugs [11] and tendon grafts [7] have all
been employed to improve healing. However, despite surgical advances, adhesion formation,
reruptures and decreased function are still common problems.

1.1.2 Scar Formation
Adult tendons heal through a reparative process [12, 13] and undergo a set of
coordinated responses that include inflammation, extracellular matrix production and remodeling
of the tissue [14] . During these processes, cellular and extracellular matrix components are
quickly deposited by fibroblasts to fill the defect and restore function; however, the quality and the
structure of the scar tissue are both altered from native uninjured tendon. While in some cases
this scar does return some function to the tendon, it is still mechanically impaired. For instance,
scar tissue from the tendon proper can attach to the tendon sheath preventing normal sliding of
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the tendon through the sheath. Reduced quality of tissue results in tendon reruptures and is of
prominent concern. Therefore, it is imperative that new strategies are developed to quickly return
tendon to normal function post-injury.

1.1.3 Healing Parameters throughout Development
Unlike adult reparative healing, fetal tissue is well known to heal through a regenerative
process [15]. While first demonstrated in skin, fetal healing also occurs in tendon [16, 17]. In
general, fetal wound healing occurs at a fast rate and without scar formation [18]. The
mechanism behind fetal healing is still unknown, but it is believed that the regenerative response
is a property of the tissue and not the environment [17]. Some candidates with differential
expression or roles during fetal healing versus adult healing include the presence or absence of
cytokines, relative amounts and organization of extracellular matrix components and mechanical
stresses on the tissue. While fetal healing is an excellent model for scarless healing, it is possible
extensive differences, including load and inflammation, between fetal and adult healing may have
prevented major breakthroughs in improving adult healing. It has been hypothesized that healing
parameters change from the fetal stage, through development and into adulthood. For example,
neonatal developmental tendons may heal through scar formation but regain normal structure
and function faster than adult tendons. Few studies have been able to test this hypothesis due to
the small size and fragile nature of developing tendons. One study, on the healing of subfailure
ligament injury in immature and mature rat, showed that a 21 day old rat regained 95% of its
strength by 7 days post injury whereas an 8 month old rat only regained 81% at 14 weeks [19].
Understanding which parameters contribute most to improved healing will allow the identification
of key factors to examine when developing new therapies for adult healing. The hope of this
dissertation is to develop new therapeutic strategies to improve the outcome of tendon injuries
through basic science investigations into the mechanisms involved in development and injury at
different stages of neonatal development.
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1.2 Background
1.2.1 Tendon Composition and Structure
Tendon is a highly organized soft
connective tissue composed mainly of parallel
collagen fiber bundles surrounded by extracellular
matrix and tendon fibroblasts (Figure 1.1). The
fiber bundle’s main constituent is type I collagen
whereas the matrix that surrounds the fibers is

Figure 1.1: Example of a normal tendon
with aligned fibers stained with hemotoxylin
and eosin.

composed mainly of water, minor collagens,
proteoglycans, and glycosaminoglycans (GAGs).
Figure 1.2:
Hierarchical
structure of tendons
from collagen
molecule through the
fascicle. Inset
demonstrates a
hypothesized
interaction of
proteoglycans with
the collagen fibrils
(Derwin, 1998).

Water represents 60-80% of the wet weight of tendon while type I collagen represents
approximately 65-80% of the dry weight. Proteoglycans, such as decorin and biglycan, are
approximately 1-5% of the dry weight [20, 21]. Minor collagens, such as type XII and type XIV
collagens, are present in varying, yet small, amounts throughout tendon development and
maturation [22-24].
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The development of tendon’s hierarchical structure is a complex process consisting of
fibrillogenesis and higher order organization. Fibrillogenesis alone consists of three distinct
phases [25-27] and each step is independently regulated by specific fibril-associated
macromolecules including proteoglycans and minor collagens. First, immature type I collagen
molecules assemble extracellularly to form immature fibril intermediates. Next, during linear fibril
growth, pre-formed fibril intermediates assemble end-to-end to form longer fibril consistent with
mature, mechanically functional fibrils. Lastly, in lateral fibril growth, the fibrils associate laterally
to generate larger diameter fibrils. As tendons mature, this lateral association of fibrils creates a
wide range of fibril diameter sizes [2, 27-29]. For example, a fibril range from 40 to 400nm is
seen in a three month old mouse[27]. The fully formed fibrils are then organized into fibers which
are primarily parallel and aligned with the long axis of the tendon (Figure 1.2). These fibers,
along with the spindle-shaped tendon fibroblasts, are organized into fascicles. Lastly, sheaths
called endotenon bind fascicles together to form

tendon which are in

turn surrounded by epitenon. The formation of this
hierarchy is a highly regulated, multistep process on

Gastocnemius Muscle

which the mechanical integrity and function of tendon
is dependent.
Achilles Tendon

1.2.2 Tendon Mechanics
Tendon is primarily a uniaxial tissue which
transfers load from muscle to bone and stabilizes the

Calcaneous

joint (Figure 1.3). Whereas the primary function of
collagen in tendon is to withstand tensile strength,
the non-collagenous components are thought to

Figure 1.3: Achilles tendon shown
connecting the calcaneous to the
gastrocnemius
muscle.
(Photo:
http://www.eorthopod.com)

serve mainly as resistance to compressive forces.
Tendons have the highest tensile strength of any connective tissue in the body, a characteristic
that is likely due to the high collagen content of the tendon fibers and their densely packed,
parallel alignment along the direction of force. For example, direct in vivo measurements of
4

forces during various activities revealed loading in the Achilles tendon as high as 9 kN during
running in humans, which is up to 12.5 times body weight [30].
In vivo, tendons most often experience uniaxial tensile forces. Mechanically testing a
tendon ex vivo in similar conditions produces a nonlinear curve. Stress-strain curves can be
calculated from load-displacement uniaxial tensile

Ramp to Failure

testing and the cross-sectional area of the tendon

σ

(Figure 1.4). There are three distinct regions of
the tendon stress-strain curve produced during
tensile testing [31]. Initially the curve is

Toe Linear Yield and
Region Region Failure

ε

Figure 1.4: Typical stress vs strain curve
from a constant ramp to failure tensile
test of tendon. The toe, linear, yield and
failure regions are indicated.

characterized by a low modulus (toe) region at low
strains. The toe region is thought to be a result of
the gradual recruitment and uncrimping of fibers
as the tendon is elongated. During this period
there is extensive deformation with little increase

in load. After the toe region, the stress-strain curve is characterized by a high modulus (linear)
region during which the tendon demonstrates linear elastic behavior. It is believed that at these
strains all of the fibers are engaged and bear load. The yield point, where the modulus gradually
decreases, is thought to be the point where collagen fibers begin to break, slide past each other
and eventually fail.
Structural properties, which do not account for differences in size and structure, can be
obtained from the load-displacement curve. Toe region properties are calculated from a bilinear
fit where the inflection point is identified. Subsequently the toe region stiffness is calculated as
the slope of the curve up to the inflection point and the load and deformation can be determined
at the inflection point. Parameters obtained from the linear region include the maximum load (the
highest load reached) and stiffness (the slope of the curve in the linear region). These structural
parameters describe the behavior of the tendon as a whole. On the other hand, material
properties are intrinsic measures of the quality of the tissue substance. Material properties
including, toe region modulus, inflection point stress and strain, maximum stress and linear region
5

modulus, can be calculated in a similar fashion as the structural properties but from the stressstrain curve.
Tendons possess time and history
dependant properties that can be observed

σ

Stress Relaxation

through stress relaxation (Figure 1.5) and
creep mechanical tests. Stress relaxation
tests involve stretching the tendon to a

t

constant length (strain) and allowing the stress
to vary over time. Subsequently, percent

Figure 1.5: Representative schematic for a
tendon during a stress-relaxation test.

relaxation can be calculated from peak stress,
the (highest stress after initial strain) and equilibrium stress (the stress reached after relaxation
has occurred). A creep test involves subjecting tissue to a constant force and allowing the length
to vary with time. Viscoelastic parameters are dependant on time and rate of loading of the
tendon. Proteoglycans and water, along with the inherent viscoelasticity of the collagen itself, are
thought to be primarily responsible for viscoelastic behavior [32, 33]. Structural, material and
viscoelastic parameters characterize the functional behavior of tendons; however, one instance
when all these parameters are markedly changed from normal mature tendon values is after
tendon injury.

1.2.3 Reparative Tendon Healing
Adult tendons heal through a reparative process [12, 13] and undergo a set of
coordinated responses that include inflammation, extracellular matrix production and remodeling
of the tissue [14] . During the inflammatory phase, accumulating leukocytes perform extensive
phagocytosis of necrotic tissue and release pro-inflammatory cytokines [34]. Subsequent to
fibroblast proliferation, increased extracellular matrix production then alters the composition of the
tendon from its uninjured state. For example, biglycan levels increase and decorin levels
decrease [35, 36], the cellular receptor CD44 is highly expressed[16] and type XIV collagen is
upregulated [37]. At this stage, not only is the composition altered but also the structure. For
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instance, the fibril diameter size distribution is narrowed and consists mainly of small diameter
fibrils [38-40]. Extracellular matrix is also laid down in a disorganized fashion, altering the parallel
alignment of the fibers[41]. During remodeling, the final stage, collagen fibrils begin to coalesce
laterally and fibers reorganize along the long axis of the tendon. However, even after remodeling,
the overall result of reparative healing is a fibrotic scar with structure, composition and
mechanical properties that are inferior to normal tendon.
Tendon properties improve over time after injury, but they rarely return to normal levels
[42, 43]. For example, the repair tissue in the patellar tendon 1.5 months post-injury only
achieved 20% of normal maximum stress and at 6 months was still only 22% of normal [43].
Similarly, 21 months after a central third defect the patellar tendon only regained 34% of the
uninjured ultimate stress [44]. Numerous studies have tried to improve the reparative healing
response through the application of cytokines and growth factors, mechanical stimulation or
deprivation and gene therapy to name a few. While some studies demonstrate improved
mechanical properties of one treatment versus another, even in the best cases, mechanical
properties remain only a fraction of native tissue. Therefore, it is imperative that new strategies
are developed that promote an efficient return to normal function post-injury.

1.2.4 Current Strategies for Tendon Repair
As previously stated, tendon injuries are still a major area of scientific study due the
inability of most tendons to fully heal on their own. Clinical management of tendon injury currently
follows two basic routes: conservative (rehabilitation, rest and pain relief) or surgical. However,
treatment choices between and within each of these disciplines can be complicated. For
example, in the biceps tendon, nonoperative treatments (rest, activity modification, ice, nonsteroidal anti-inflammatories, immobilization) are employed for older patients while younger
patients receive acute repair[45]. Many factors affect outcome including the specific tendon
injured (flexor, intrasynovial, extrasynovial, other), age of the patient and the type of injury
(chronic, acute), not to mention obesity, diabetes and other health complications[46]. The most
conventional surgical treatment, suturing the torn tendon back to itself or to bone, is commonly
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used to repair rotator cuff tears. However, despite a greater understanding of tendon healing and
advances in surgical treatment, rotator cuff failure after surgery remains common[47]. Reruptures
have been correlated with tear size, tear chronicity, and patient satisfaction[48]. Tendon grafts
are an alternative to tissue repair and are commonly used; however, they can insight
inflammatory reactions and can also mechanically fail [49]. It is clear that despite recent surgical
and rehabilitative advances extensive improvement in the treatment of injured tendon is still
necessary.
New methods to help advance tendon healing are being explored to improve upon
current clinical outcomes. Specific cytokines play a role in wound healing include transforming
growth factor-beta, platelet-derived growth factor, basic fibroblast growth factor and interleukin-1
beta [50] (Table 1.1). While many in vivo animal studies observed promising results for cytokine
application[14], there are still many complications to be overcome before wide clinical application.
For instance, not all cytokines have a monotonic effect. One study found that bFGF promoted the
Table 1.1: Example of several key growth factors and cytokines
involved in tendon healing.

Cytokine Function
Stimulates angiogensis, cellular migration and
bFGF
proliferatoin
BMP-12 Stimulates cellular differentiation
IL1β
Intiaties multiple pro-inflammatory cascades
IL-10 Anti-inflammatory
Influences extracellular matrix remodeling and
PDGFB
DNA synthesis
Plays a role in the initial inflammatory response
TGFβ1
and throught to increase fibrosis
Involved in inflammation and is increased in
TGFβ3
scarless healing
VEGF Plays a role in angiogensis
formation of repair tissue; however, while a high dose was not detrimental, it delayed later
maturation of the tissue [51]. Even when appropriate doses are determined in animal models it is
difficult to scale these doses for clinical application. Animal studies have also shown that growth
factors work well in combination, but again, the appropriate ratios and concentrations are difficult
to determine clinically. Clinical application of a single growth factor has been successful in
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orthopaedic tissues but can be accompanied by unforeseen complications.. Therefore, while
promising, the application of cytokines and growth factors still pose many clinical concerns.
One solution to the issues posed by cytokine application is the use of autologous growth
factors, particularly those obtained through platelet-rich plasma (PRP). PRP is being widely used
clinically for both surgical and non-surgical treatments in sports orthopaedics. Platelets contain
many biologically active factors, including proteins responsible for haemostasis, synthesis of new
connective tissue and revascularisation [52]. It is thought that PRP can stimulate a physiological
release of growth factors to jumpstart healing in chronic injuries, or speed up an acute injury
repair process [53-55]. However, few studies have shown a direct effect from PRP on soft tissue
healing and very few randomized controlled trials have been performed. Even fewer trials are
adequately powered, use appropriate outcome measures or have decent follow-ups[56]. In
general, the results of treating tendon injuries with PRP are unknown.
An alternative method for the delivery of specific growth factors or cytokines is gene
therapy. Genes can be transfected into cells ex vivo or in vivo through retro-viruses, and thereby
increase the expression of a protein or suppress protein synthesis in targeted cells. With this
technology, it might be possible to deliver multiple genes of specific cytokines to cells, and to

Figure 1.6: Maximum stress after injury in tendons injected with either saline, empty vector or IL-10
vector. The asterisk (*) indicates a significant difference (p<0.05) and the pound sign (#) denotes a trend
(p<0..1) when comparing between treatment groups within a postinjury time point. (RIcchetti, 2008).

regulate the extent and timing of their expression. Adenoviral-mediated gene transfer has been
successfully used in numerous soft tissue wound healing animal models [57]. Similarly, Richetti
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et al demonstrated successful gene transfer of IL-10 into healing adult murine patellar tendon
using a lentiviral vector[58] and showed improved mechanics relative to controls (Figure 1.6).
While viruses can be amplified easily, they can also elicit an immune response. The use of viral
vectors also places constraints upon the size of the gene being transferred, and can require that
the target cells be actively dividing which posses a complication with tendon fibroblasts. While
gene therapy is a promising new area, there are still many complicated issues that need to be
unraveled before it is widely used.
Tendon grafts, in conjunction with cell based therapies, are also being used to improve
tendon healing. Autologous cells are removed, expanded in vitro, possibly treated and placed
back in vivo with a carrier device (graft). This consists of removing autologous cells, expanding
them in culture, possibly treating them in vitro, and placing them back in vivo with a carrier device.
Potential cell sources include mesenchymal stem cells (MSCs) or cells from the native tissue,
tendon fibroblasts. Numerous in vitro studies have been done to improve cell/graft constructs
prior to implantation. Some of the methods include application of growth factors and mechanical
stimulation[59, 60]. These methods have been shown to stimulate extracellular matrix
production, cell proliferation and improved mechanical properties. In vivo studies showed that
implantation of MSCs into injured rabbit Achilles tendons significantly improved their structural
properties [61, 62]. Despite these advances cell based therapies have their limitations.
Specifically, using autologous cells requires two surgeries with the possibility of donor site
morbidity. In addition, cell/graft constructs have yet to recapitulate the mechanical strength of
native tissue and could possibly rupture after implantation.
One can easily see from the previous paragraphs that while great advances have been
made in the field of tendon healing, there is still significant room for improvement. By gaining a
greater understanding of the natural development of tendons and their mechanical strength,
these processes may be recapitulated during healing.

1.2.6 Regenerative Tendon Healing
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Extensive experimental evidence suggests that early and mid-gestation fetal tissue
responds to injury in a fundamentally different way than adult tissue. While first observed in skin,
regenerative healing also occurs in fetal tendon [16] (Figure 1.7). Identifying key factors in fetal
healing has been previously used as a strategy with which to improve adult healing. One main

Figure 1.7: Adult and fetal tendon response to healing. H&E stained tendon: 1)
adult normal, 2) adult wounded showing significant fiber disruption, 3) fetal normal,
4) fetal wounded with completely reconstituted collagen architecture (Beredjiklian,
2003).
difference between fetal and adult healing is that fetal healing occurs with almost no inflammatory
response and anti-inflammatory cytokines are elevated. Some authors believe that this differential
response plays a key role in scarless healing; therefore, numerous studies were conducted that
decreased inflammation in adult tissue. For example, hyaluronic acid (HA) is a
glycosaminoglycan that is abundant in tendons and is associated with embryogenesis, and
healing [63-65]. It is believed that high molecular weight HA is anti-inflammatory while low
molecular weight in pro-inflammatory. During adult tendon healing, CD44 (a cellular receptor for
hyaluronic acid, HA) and HA levels were both elevated [17, 34]. However, during scarless
11

regenerative fetal healing, CD44 expression is down regulated [17] (Figure 1.8) and HA levels
surpass those of healing adult tendons [15, 66]. Studies attempting to recreate regenerative
wound environments have demonstrated that increased levels of HA are indeed beneficial,
possibly through an anti-inflammatory pathway [67, 68]. Therefore, since HA is degraded
primarily through CD44, strategies to decrease CD44 expression or activation may reduce scar
formation
The regenerative response of fetal tendon offers a model for the study of scarless healing
mechanisms. Current investigations however have yet to produce profound effects on adult
healing. However, it is interesting to note that while fetal wounds looked healed histologically,
they still had significantly decreased mechanical parameters post injury [16]. This could be one
reason why current investigations using knowledge gained from fetal studies have yet to produce
profound effects on adult healing. Additional limitations of the fetal healing model system are the

Figure 1.8: CD44 expression in adult and fetal healing. CD44 increased markedly in the
wounded adult tendons but only slightly or not at all in the fetal (black indicates wound, brown
represents immunostaining). (A) Adult, original magnification 100; (B) 1 week fetal, original
magnification 200 (Beredjiklian 2003).
numerous and drastic differences between fetal and adult healing. Specifically, fetal healing
occurs in a relatively unloaded environment which could be the cause of reduced mechanics
despite histological healing. A lack of inflammatory response in fetal healing also presents an
issue when trying to apply fetal healing mechanisms to adult healing. Therefore, while fetal
healing may be an appropriate paradigm for studying reduction in scar, it is not an ideal model for
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improved function and mechanical strength. A new model system that employs improved healing
but also incorporates improved function needs to be explored.

1.2.7 Structure-Function Relationships
It has long been hypothesized that the structure and composition of tendons are a result
of the specific function tendons perform. Previous studies have provided insight into the complex
interplay of a tendon’s constituents which is critical to formalizing structure-function relationships
[29, 69-71]. Importantly, some studies have performed statistical correlations between structure
or composition and mechanics. For example, age-related declines in tissue strength have been
positively correlated with a
decrease in fibril diameter
distribution and size. Similarly,
collagen fibril cross-sectional area
fraction explained more than half
of the changes in mechanical
properties of mature to aged
tendons through linear regression
[72] (Figure 1.9). Interestingly,
the addition of data from younger

Figure 1.9: Linear regression plots for strength
versus collagen cross sectional area fraction. Solid
line is data from adult mice only (R2=0.61), dashed
line includes data from Robinson et al of 3wk old
mice (R2=0.69) (Goh, 2008).

tendons to this study improved the
regression model, thereby supporting the need for further structure-function analyses of younger,
developing tendons.
While many studies have demonstrated that fibril diameter size is correlated with tendon
mechanics in normal tendons, similar relationships have not been shown in healing tendons. A
study in the healing MCL of rabbits demonstrated that while the injured ligament increased in
mechanical strength to 2/3 the control tendon at 40 weeks, the mean fibril diameter remained
smaller than controls and did not increase over the same time period [73]. An extended study in
the same model showed that the mean fibril diameter did not change up to 104 weeks post injury;
13

however, it was noted that there was an increased proportion of very small fibrils along with large
fibrils, creating an increased spread in fibril diameter size [42]. This indicates that fibril diameter
spread may be a more appropriate collagen fibril parameter to correlate with mechanics than
mean fibril diameter size.
These studies begin to distinguish the relationships between structure, composition and
mechanics; however several limitations should be noted. First, few studies used quantitative
correlations. Second, few studies have systematically quantified tissue structure, composition
and mechanical properties simultaneously. Further investigation into these relationships,
specifically during development and healing could identify key factors necessary for the
production of functional tendon.

1.2.8 Tendon Development
Tendon development is initiated
in utero and continues through neonatal
development until maturity. Numerous
studies have investigated the
composition and structure of tendon
throughout growth and have found them
intimately connected. The development
of tendon’s hierarchical structure
through fibrillogenesis is a multistep
process with at least three phases [2527] (Figure 1.10). First, collagen
molecules assemble extracellularly to
form immature fibril intermediates.
Next, during linear fibril growth, fibril
intermediates assemble end-to-end.

Figure 1.10: Tendon fibrillogenesis. (A) Molecular
assembly of type I collagen generates the fibril
intermediate. (B) In the linear growth step, the
intermediates in (A) grow by end-to-end growth to
generate longer fibrils. (C) In the lateral growth
step, there is a lateral association and growth of
the developing fibrils (Zhang, 2005).
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Lastly, in lateral fi bril growth, the fibrils associate laterally to generate larger diameter fibrils.
Each step of fibrillogenesis is independently regulated by specific fibril-associated
macromolecules, including minor collagens, type XII and XIV, and the proteoglycans, biglycan
and decorin. Type XIV collagen is believed to play a role in linear growth of the fibrils. Biglycan
is believed to promote fibril diameter growth, where as decorin is believed to control lateral fusion
of the fibrils and increase fibril stability. During early development, biglycan and type XIV
collagen are highly expressed while decorin is relatively low; however, as growth progresses
biglycan and type XIV collagen are down regulated and decorin is upregulated [2, 74-76]. Due to
their role in fibrillogenesis, it has been hypothesized that their temporal expression during
development plays a crucial role in the mechanical formation of tendons. In support of this, in
vivo studies of decorin and biglycan deficient mice showed unregulated lateral growth, structurally
abnormal tendon fibrillogenesis and altered mechanics [77, 78]. Therefore, it has been
hypothesized that type XIV collagen, biglycan and decorin not only play a role in the structure of
tendons but also in the function.
Another parameter that changes throughout development is the distribution of fibril

Figure 1.11: Collagen fibril structure during development in mouse tendons. Transmission
electron micrographs of transverse sections from mouse flexor tendons and the diameter
distributions at each developmental stage from normal mice (a-d). Bar 300nm (Ezura, 2000).
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diameter sizes [28, 71, 79, 80] (Figure 1.11). Early in development, the distribution is narrow,
consisting of mainly small diameter fibrils. As growth progresses, the distribution increases as
fibrils coalesce to form larger diameters while some remain unaltered. Often this change begins
at the onset of locomotion; therefore, it has been hypothesized that the large diameter fibrils have
higher tensile stress than small diameter fibrils [29, 71]. The small size and fragile nature of
neonatal tendons has made it difficult to obtain mechanical data to test this hypothesis during
development when the largest changes in fibril diameter are occuring. However, one study
showed a rapid increase in ligament mechanical strength throughout development but the
youngest age studied was only 1.5 months old in a r at [81]. An additional study done in chick
tendons examined composition, structure and mechanics from post-fertilization through hatchling
[82] (Figure #). While this model does provide mechanical data of tendon development, the chick
is not the ideal model system due to lack of genetically modified animals and available assays.
An ideal model system would allow for the detailed study of the mechanisms behind structural,
compositional and mechanical changes during
development.
As previously mentioned tendons
undergo drastic compositional and structural
changes during both development and healing.
Many of these changes parallel each other. In
both development and healing collagen content
increases and the fibril diameters increase.
Minor matrix molecules, like Collagen XIV and
biglycan, are present during development and
healing but are very sparse in mature

Figure 1.12: Mechanical changes during
chick development from prehatchling day 43
to 2 day old hatchling. These stress strain
curves demonstrate an increase in
mechanical strength during development
(McBride, 1988).

tendon[83]. However, there are also
differences in these two events. In particular,
during development decorin is initially low and
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increases with age, and biglycan is initially high and decreases [2]. Alternatively healing, both
decorin and biglycan are elevated and most notably, biglycan maintains higher levels for an
extended period of time. The most striking difference, despite the numerous similarities, is that
during development a mechanically functional tendon is formed whereas during healing a tendon
with inferior mechanics results. Therefore, there must be inherent difference between
development and healing. It has been postulated that development could serve as a paradigm
through which improved adult healing may occur. By comparing and contrasting neonatal
development and healing, key parameters can be identified through which adult healing can be
improved.

1.3 Specific Aims and Hypotheses
The overall aim of this bioengineering study is to investigate parameters that affect
tendon mechanics within neonatal development and healing. The overall objective is to use
neonatal development as a paradigm through which to study healing, specifically by studying
compositional and structural parameters during healing and neonatal development and relate
them to the mechanical strength of the tendon. The specific aims and hypotheses are as follows:
Specific Aim 1: To investigate the effect of CD44 in the healing of the adult patellar tendon.
Hypothesis 1: CD44 knockout mice will have decreased material properties and increased
organization of the healing patellar tendon.
This hypothesis is based on previous studies that showed a delay in skin wound closure
in the CD44 knockout mouse [84] CD44 was chosen to be investigated in tendon healing based
on previous studies that demonstrated a lack of CD44 in scarless healing. To assess the healing
parameters of tendon in the CD44 knockout mouse a mouse patellar tendon injury model will be
used.
Specific Aim 2: To determine the functional role(s) of type XIV collagen in the development of
tissue-specific mechanical properties.
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Hypothesis 2a: The significant role type XIV collagen plays in the regulation of fibrillogenesis
would lead to alterations in the mechanics of developing Col14a1 null tendons but not mature null
tendons.
Hypothesis 2b: Prolonged presence of type XIV collagen in skin versus tendon would lead to
altered mechanics in Col14a1 null mature skin but not mature null tendon.
This hypothesis is based on previous work that demonstrates the role of type XIV
collagen in linear fibril growth and in regulating lateral fibril fusion. A knockout mouse model,
Col14a1-/-, along with the heterozygote, Col14a1-/+ and wildtype counterparts will be employed.
The flexor digitorum longus tendon was chosen to be investigated during neonatal development
and in maturity. In addition, skin mechanics will be investigated in mature animals to determine
the tissue specific role of type XIV collagen.
Specific Aim 3: To characterize the structure, composition and biomechanics of the developing
tendon.
Hypothesis 3a: The collagen fiber alignment of the developing tendon will not change during
development. The collagen content and fibril diameter spread will increase throughout
development.
Hypothesis 3b: Biglycan will decrease and decorin will increase throughout development.
Hypothesis 3c: The maximum stress and modulus of the developing tendon will decrease
during early development and then increase, whereas the percent relaxation will increase and
then remain constant.
These hypotheses are based on previous compositional and structural studies in the
mouse and one previous mechanical study conducted in the chick. An Achilles tendon mouse
model of neonatal development will be used to create a quantitative model that can make use of
numerous genetically modified mice and commercially available assays. The availability of these
tools will allow for study of the specific mechanisms involved during development.
Specific Aim 4: To determine the differential affect of developmental age on the healing
response. Specifically, characterize the structure, composition and biomechanics of the healing
tendon at two stages of development.
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Hypothesis 4a: Maximum stress, modulus and decorin levels will be significantly higher in early
developmental injury when compared to late developmental injury (injured tendon normalized by
contralateral uninjured tendon).
Hypothesis 4b: Collagen content, fibril diameter spread and percent relaxation will be
significantly higher at late stages of healing in early developmental injury when compared to late
developmental injury (injured tendon normalized by contralateral uninjured tendon).
Hypothesis 4c: Collagen content, angular deviation and biglycan levels will significantly increase
over time in late developmental injury (injured tendon normalized by contralateral uninjured
tendon).
Hypothesis 4d: When normalized, maximum stress, modulus and percent relaxation will
significantly increase over time in early development injury but will remain low in late development
injury.
These hypotheses are based on previous studies of tendon healing. The mouse model
of neonatal tendon development created in specific aim 3 will be used to determine two distinct
stages of tendon development through which to study healing. A full thickness, partial width
injury will be created in one Achilles tendon of each neonatal mouse while the controlateral leg
will serve as the uninjured control.
Specific Aim 5: To determine the differential roles of structure and composition on
biomechanical properties during development and healing using a predictive statistical
model based on experimentally measured inputs.
Hypothesis 5a: Collagen content will be a significant predictor in all groups for all mechanical
parameters.
Hypothesis 5b: Fibril diameter spread will be a significant predictor for maximum stress and
modulus in late development and late stages of healing; however, it will be a stronger predictor in
injury during early development than in injury during late development.
Hypothesis 5c: Biglycan and decorin will both be significant predictors of maximum stress and
modulus; however biglycan will predict decreased mechanics and decorin will predict increased
mechanics.
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Previous studies have attempted to determine which compositional and structural
parameters are involved in the development of mechanical strength with limited success. This
aim will use the data collected in specific aim 4 and implement it in a linear, backwards stepwise
regression model. This study will lend significant insight into the structure-function relationships
in tendons. Key factors identified in this study will provide design parameters for both new
therapeutic treatments and tissue engineered constructs.

1.4 Chapter Overviews
This thesis consists of 7 chapters and an Appendix. Chapter 1 is an introduction and
provides the necessary framework for the studies described in the subsequent chapters. This
includes a summary of basic tendon composition, structure and mechanics. In addition, the
typical response of adult tendon to injury along with current strategies for treatment is included. It
also provides background on the processes that are currently known to occur during
development, both fetal and neonatal, that serve as a foundation for the work that follows.
Chapter 2 addresses Aim 1 of this dissertation by evaluating the effect of an absence of
the cellular receptor CD44 on adult tendon healing. To accomplish this a CD44 knockout mouse
was used along with a mouse patellar tendon injury model to evaluate healing at multiple time
points post injury. CD44 was investigated in this study due to its lack of expression in scarless
fetal healing but high expression in adult tendon healing. Tendon mechanics, structure and gene
expression of specific cytokines and growth factors were examined.
Type XIV collagen has been shown to be highly expressed during neonatal development
but not in mature tendons. Chapter 3 addresses Aim 2 by evaluating the affect of an absence of
type XIV collagen on skin mechanics and neonatal and mature tendon mechanics. This was
accomplished by utilizing the Col14a1-/-. Col14a1-/+ and wildtype mice at 7 and 60 days old.
Background on type XIV collagen and the Col14a-/- mouse is provided in Chapter 3. Due to the
small size and fragile nature of neonatal tendons they have not previously been mechanically
evaluated. Details on the development of a new method to mechanically test these tendons are
also provided in Chapter 3.
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The establishment of a method to mechanically test neonatal tendons led directly to the
characterization of the mechanical, compositional and structural parameters during neonatal
tendon development as described in Chapter 4 (Aim 3). Of particular importance was developing
a quantitative method to measure all parameters investigated. In addition, a mouse model was
chosen due to the availability of genetically modified mice and commercially available assays.
After the establishment of basic knowledge of normal development, the specific mechanisms of
mechanical development can be ascertained through these available tools.
Chapter 4 clearly described specific stages of development in the neonatal mouse
Achilles tendon. It has been previously hypothesized that composition and structure play a
significant role in healing. Therefore, Chapter 5 (Aim 4) evaluates the differential affect of healing
at two distinct stages of development. A full thickness, partial width (~50%) injury without need
for suture repair was created in the neonatal mouse Achilles tendon with a biopsy punch that
created a full thickness, partial width (~50%) injury without need for suture repair. Only one
Achilles tendon per neonatal mouse was injured so the uninjured controlateral leg could serve as
an internal control.
Rigorous statistical tests have previously been used to determine which parameters play
a significant role in tendon mechanics. The data from Chapter 5 was used in a backwards
stepwise regression in Chapter 6 (Aim 5) to determine which compositional and structural
parameters had a significant effect on neonatal development and healing. The ability to use
rigorous statistical methods in this manor was the motivation behind developing quantitative
assays in Aims 3 and 4. Finally, Chapter 7 draws overall conclusions from the studies described
in Chapters 2-6 and discusses potential future directions in which this research might advance.
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Chapter 2: CD44 deficiency improves healing tendon mechanics and increases matrix and
cytokine expression in a mouse patellar tendon injury model

2.1. Introduction
2.1.1 Significance
Tendon injuries affect a large number of individuals and account for enormous associated
costs[1]. The number of tendon injuries will continue to increase as our population continues to
age and remain active. A complex cascade of events occurs during healing which results in a
fibrotic scar. Scar tissue is characterized by altered structure and composition and decreased
tendon function. Despite advances in surgical techniques and postoperative rehabilitation
protocols, adhesion formation[2], reruptures and decreased function due to scaring are still
common problems; therefore, decreasing the formation of the fibrotic scar may lead to improved
healing properties.

2.1.2 CD44 and Hyaluronic Acid
CD44, a polymorphic type I
transmembrane glycoprotein, is a key
mediator during fibrotic healing (Figure 2.1).
CD44 is involved in cell-cell and cell-matrix
interactions, leukocyte homing and activation,
cellular migration, extracellular matrix
assembly and cytokine binding and
activation[3, 4]. However, its main role is
mediating the uptake and clearance of
hyaluronic acid (HA)[5]. HA is a high
molecular-weight (HMW)
glycosaminoglycan that is abundant in

Figure 2.1: Schematic of the cellular receptor
CD44 (Photo: http://www.cancertherapy.org/CT2A/html/25.%20Coradini%20et
%20al,%20201-21%20copy.html).
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soft connective tissue[6]. Degradation and turnover of hyaluronic acid is associated with multiple
processes including embryogenesis[7], healing [7, 8], and inflammation[3]. However, HMW-HA
and LMW-HA have differential roles. LMW-HA has demonstrated numerous proinflammatory
effects[8], where as HMW-HA blocks proinflammatory effects[9-11]. Therefore, in some
environments increased levels of HMW-HA are beneficial but LMW-HA is detrimental.
The increased presence of CD44 and LMW-HA in the adult wound environment plays a
role in inflammation and cellular activities [12, 13]. For example, HA suppresses the expression of
IL-1B [14]and PDGF-BB induced cellular migration[15]. The CD44-mediated clearing of LMW-HA
is thought to contribute to the resolution of the inflammatory response. These data suggest that
CD44 plays a crucial role during inflammation and healing during adult healing. Unlike adult
wounds, fetal wounds are known to heal through a regenerative process characterized by
decreased inflammation, early deposition of extracellular matrix and lack of scar [13, 17, 18].
During regenerative fetal healing, CD44 expression is down regulated [13] and HA levels surpass
those of healing adult tendons [19, 20]. Studies attempting to recreate regenerative wound
environments have demonstrated that increased levels of HA are indeed beneficial[16] [17] in
animal models, but similar results clinically have been unsuccessful[18]. Therefore, since HA is
degraded primarily through CD44, strategies to decrease CD44 expression or activation may
reduce scar formation.
One strategy to decrease the interaction between CD44 and HA is the use of anti-CD44
blocking antibodies. Multiple antibodies have been employed with different modes of action,
including CD44 receptor blocking and receptor shedding [22-25]. In vivo studies have shown
decreased migration of cells [19, 20]and decreased tissue damage[21]. These studies have
demonstrated a role of CD44 in inflammatory disease; however interpretation of the results
warrant some caution due to poor understanding of the exact action of the antibodies.
A CD44 knockout mouse was created to study the effects of a complete absence of CD44 [26,
27]. These mice had decreased macrophage recruitment and decreased expression of
proinflammatory cytokines at the site of lung injury[22]. When examining inflammatory disease,
CD44 knockout mice had greater HA accumulation when compared to their wild type
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counterparts[23]; however, increased signaling through RHAMM, another HA receptor, may have
exacerbated inflammation in this disease model[24]. Lastly, the absence of CD44 in skin wounds
delayed early wound closure[25]. These studies collectively demonstrate that CD44 plays a
crucial role in wound healing and inflammation; however, to date, the role of CD44 in tendon
healing has not been evaluated.

2.1.3 Objective and Hypotheses
The purpose of this study was to investigate the effect of CD44 in the healing of the
patellar tendon. We hypothesize that CD44 knockout mice[26] will have decreased material
properties and increased organization of the healing patellar tendon. In addition, we hypothesize
that proinflammatory cytokines will be down regulated and extracellular matrix proteins will be up
regulated during early stages of
healing.

2.2 Methods
2.2.1 Specimens
This study was
approved by the University of
Pennsylvania IACUC. Forty-two
male mice from both C57Bl/6
wild type (WT) and CD44

knockout (KO) in a C57Bl/6
background were included in
this study. Thirty two mice from
each group underwent surgery

Figure 2.2: Photos that depict the partial transection created
in the mouse patellar tendon. A plastic coated backing is
placed underneath the tendon (Fig. 1(1)), and a circular
biopsy punch is used to create a full thickness partial
transection (Fig. 1(2)). A distinct and reproducible injury is
left (Figs. 1(3) and (4)).

at 12 weeks of age using an established tendon injury model in our laboratory as previously
described[27] (Figure 2.2). Briefly, mice were prepared under normal sterile conditions and both
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hind limbs were shaved. Following a skin incision, two cuts parallel to the tendon were made in
the retinaculum on each side, and a plastic coated blade was then placed underneath the patellar
tendon. With the coated blade serving as support, a 0.75mm diameter biopsy punch (Shoney
Scientific, Waukesha, WI) was used to create a full thickness partial transection in the patellar
tendon (Figure 2.2). Marginal fibers were left intact, circumventing the need for suture repair. An
injury was created in both legs. Skin wounds were closed with suture and the mice were allowed
to resume normal cage activity until they were sacrificed at 1 day (n=4), 3 days (n=4), 7 days
(n=4), 3 weeks (n=10), and 6 weeks (n=10) post surgery. An additional ten mice per genotype
were sacrificed without injury to serve as controls.

2.2.2 Biomechanical Analysis
To determine the mechanical properties of the healing patellar tendon, one patellar
tendon from each of twenty-six mice of each genotype was used. Ten mice were sacrificed at
both 3 and 6 weeks post injury while six uninjured mice
were sacrificed to serve as controls. As described
previously[27], the patellar tendons were dissected and
cleaned, leaving only the patella, patellar tendon, and tibia
as one unit. Tendon width and thickness were then
quantified, and cross-sectional area was measured using
a custom built device consisting of LVDTs, a CCD laser,
and translation stages[28]. Each tendon was dumbbell
stamped to remove the uninjured fibers on either side of
the injury. The cross-sectional area was then measured

Figure 2.3: Example of the set up
for tensile testing of mouse patella
tendon.

again for material property calculations. Stain lines were placed 1mm apart in the midsubstance
to track strain optically. The tibia was then embedded in polymethylmethacrylate in a customdesigned fixture. The patella was held in place with a custom-designed cone-shaped fixture
(Figure 2.3). Each tendon specimen underwent the following protocol while immersed in a 37oC
saline bath—preloaded to 0.02 N, preconditioned for 10 cycles from 0.02 to 0.04N at a rate of
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0.1%/s (0.003 mm/s), and held for 300 s. Immediately following, a stress relaxation experiment
was performed by elongating the tendon to a strain of 5% (0.15 mm) at a rate of 5%/s (0.15
mm/s), followed by a relaxation for 600s. The tendon was returned to pre-stress relaxation
elongation (-0.15mm) for 60s and finally, a ramp to failure was applied at a rate of 0.1%/s (0.003
mm/s). Local tissue strain was measured optically as described previously[29]. From these tests,
maximum stress and failure strain were determined, modulus was calculated using linear
regression from the near-linear region of the stress–strain curve and strain energy density was
calculated as the area under the stress-strain curve until failure. Failure strain was defined as the
strain at the point of maximum stress.

2.2.3 Histological Analysis
To determine the organization of the healing patellar tendon, the contralateral legs used
in the biomechanical analysis were evaluated using a quantitative polarized light microscopy
method as described previously[30]. Briefly, the hind limb was disarticulated, the skin dissected
off, and processed with standard histological techniques. 7 µm sagittal sections were cut parallel
to the tendon fibers, stained with hematoxylin and eosin, and analyzed using a quantitative
polarized light microscopy method. Using circular statistics (Oriana, Kovach Computing Services,
Wales, UK), the angular deviation, a measure of collagen fiber orientation, was determined.

2.2.4 Gene Expression
To determine the expression of matrix components and cytokines (Table 2.1), one
patellar tendon from each of sixteen mice of each genotype was used. Four mice were sacrificed
at each of 1, 3 and 7 days post injury while four uninjured mice were sacrificed to serve as
controls. Individual patellar tendons were mechanically homogenized with a mortar and pestle
under liquid nitrogen and RNase-free conditions. RNA was extracted using the TRIZOL isolation
system (Invitrogen, Carlsbad, CA) and RNeasy Mini Kit (Qiagene Inc., Valencia, CA) as
described by the manufacturers. cDNA was produced by reverse transcription-polymerase chain
reaction (RT-PCR) from 100 ng of total RNA using the Superscript first-strand synthesis system
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for RT-PCR as described by the manufacturer (Invitrogen). 1 µL aliquots of the cDNA were

Table 2.1: Brief description of the growth factors and matrix components
examined

Cytokine

Function

bFGF

Cytokine that stimulates angiogenesis, cellular
migration and proliferation

IL1β

Cytokine that initiates multiple proinflammatory
cascades

PDGFB

Cytokine that influences extracellular matrix
remodeling and DNA synthesis

TGFβ1

Cytokine that plays a role in the initial
inflammatory response and thought to increase
fibrosis

TGFβ3

Cytokine involved in inflammation and is
increased in scarless healing

COL1A2

Fibrillar collagen that is the main component of
tendon

COL3A1

Fibrillar collagen involved in development and
healing

DEC

Proteoglycan that regulates lateral fusion of fibrils

BIG

Proteoglycan that promotes fibril diameter growth

HAS2

Main synthase of hyaluronic acid

GAPDH

Housekeeping gene

amplified by real time quantitative polymerase chain reaction (Q-PCR) in a 25 µL reaction volume
in a ABI Prism 7300 Sequence Detection System (Perkin-Elmer; Applied Biosystems, Warrington,
UK) with a SYBR Green PCR Master Mix (Applied Biosystems). Mouse specific primers were
used for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), collagen type I (COL1A2),
collagen type III (COL3A1), decorin (DEC), biglycan (BIG), hyaluronan synthase 2 (HAS2),
interleukin-1 beta (IL1βtransforming growth factor beta 1 (TGFβ1), transforming growth factor
beta 3 (TGFβ3), platelet derived growth factor B (PDGFB) and basic fibroblast growth factor
(bFGF) (Table 2.2). Each replicate was performed in triplicate. CT values will be determined for
each gene during the linear phase of the CT verses amplification plots. The relative quantity and
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range of mRNA for each gene of interest was computed using the comparative 2-∆∆CT method
(ABI; Sequence Detection System User Bulletin #2) relative first to GAPDH within each specimen
and then to the uninjured tendons within each genotype.

2.2.5 Statistical Analysis
Prior to initiating the study, a power analysis was performed to ensure sufficient power for
the experiments proposed (80% power, with p<0.05). All material, structural and organizational
parameters were statistically analyzed by 2-way ANOVA across time post injury and genotype.
Gene

Forward Primer

Reverse Primer

BP

bFGF

AGCGACCCACACGTCAAACT

CGTCCATCTTCCTTCATAGCAA

103

BIG

CCTTCCGCTGCGTTACTGA

GCAACCACTGCCTCTACTTCTTATAA

68

COL1A2

AGGCTGACACGAACTGAGGT

ATGCACATCAATGTGGAGGA

137

COL3A1

CCCTGGTCCACAAGGATTACA

CTCCAGGTGCACCAGAATCA

142

DEC

GCTGCGGAAATCCGACTTC

TTGCCGCCCAGTTCTATGAC

139

GAPDH

CTCGTCCCGRAGACAAAATGG

GTGACCAGGCGCCCAATA

66

HAS2

CATTCCCAGAGG ACC GCT TAT

AAGACCCTATGGTTGGAGGTGTT

166

IL1β

TTGACGGACCCCAAAAGATG

TGGACAGCCCAGGTCAAAG

54

PDGFB

CGCCTGCAAGTGTGAGACAAT

CGAATGGTCACCCGAGCTT

104

TGFβ1

TCGACATGGAGCTGGTGAAA

GAGCCTTAGTTTGGACAGGATCTG

70

TGFβ3

GTCCTCAGTGGAGAAAAATGGAA

TTGGGCACCCGCAAGA

65

Table 2.2: Q-PCR Primers: Forward and Reverse Primers and the Base Pair (BP) Length of the
Amplicon Used in Q-PCR
An LSD post-hoc test was used to evaluate differences across time and between genotypes.
Statistical significance was set at p ≤0.05; and a trend was defined at p ≤ 0.1.

2.3 Results
2.3.1 Biomechanical Analysis
There were no differences among groups based on gross inspection at any time point
post surgery. In addition, no significant difference in cross-sectional area was found across
genotype in the uninjured tendons (Figure 2.4). However, the cross-sectional area of the CD44
knockout tendons was significantly reduced at 3 (p = 0.008) and 6 weeks (p = 0.05) post injury
when compared to wild type. Similarly, no significant differences across genotype were seen in
maximum stress, failure strain or strain energy density in the uninjured tendons (Figure 2.5);
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however, the maximum stress in the knockout animals was significantly greater than in the wild
type at 3 (p = 0.003) and 6 (p = 0.02) weeks post injury. The strain energy density was also
significantly increased at 3 (p = 0.02) and 6 (p = 0.03) weeks post injury. The knockout animals
demonstrated a trend toward increased failure strain at both 3 (p = 0.1) and 6 (p = 0.09) weeks
post injury. No differences across genotype were observed for modulus. See Appendix # for

Cross-sectional Area (mm2)

complete data set.

0.8
WT
KO

*

0.6

2.3.2 Histological Analysis

*

Qualitative observations
of hematoxylin and eosin stained
sections showed no differences

0.4

across genotype at any time
0.2

point. Injured tendons in both
genotypes and at both time

0.0
Uninjured

3 weeks

6 weeks

Weeks Post Injury

Figure 2.4: Cross-sectional area was significantly reduced
in knockouts (KO) compared to wild-types (WT) at both 3
and 6 weeks postinjury.

points post injury had increased
cellularity and an obvious injury
site when compared to uninjured
tendons. No difference in

angular deviation between CD44 knockout and wild type tendons was seen at any time point
when comparing across genotype. When examining across time, in contrast to comparing
knockout to wild type, angular deviation showed an appreciable difference. The wild type tendons
remained disorganized up to 6 weeks post injury; however, the knockout tendons approached
uninjured values at 6 weeks post injury (Figure 2.6). Figure 2.7 is representative images from
each time point post injury and uninjured samples to qualitatively demonstrate changes observed.
2.3.3 Gene Expression
The relative quantity of TGFβ3, bFGF and DCN was increased at least two fold at 1, 3
and 7 days post injury in the CD44 knockout when compared to wild type (Figure 2.7). Similarly,
the relative expression of COL3A1 and PDGFB was increased at least two fold at 1 and 3 days
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WT
KO

300
225
150
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Uninjured

3 weeks

0

6 weeks

Weeks Post Injury

Uninjured

Weeks Post Injury

Figure 2.5: Maximum stress and strain energy density were significantly increased in
knockouts (KO) compared to wild-type (WT) at both 3 and 6 weeks postinjury. Similarly,
knockout animals demonstrated a trend toward greater failure strain compared to wild-type.
No significant changes were seen across genotype in modulus. *:p < 0.05; #:p < 0.1.

post injury. Relative expression was also increased at least two fold for BGN at 1 day post injury
and for TGFβ1 at 3 days post injury in the CD44 knockout. HAS2 was initially decreased at 1 day
post injury in knockout animals but by 3 days was increased to at least 2 fold. There were no
appreciable differences in COL1A2 and IL1β.
2.4 Discussion
2.4.1 Interpretation of Results
This study demonstrated that the absence of CD44 led to improved healing in a patellar
tendon injury. Alternative to our hypothesis, the material properties of the healing CD44 knockout
patellar tendon were superior when compared to wild type tendons at both 3 and 6 weeks post
injury. It was initially hypothesized that CD44 knockout mice would have decreased material
properties based on delayed wound healing in skin[25]. However, in the current study, it was
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demonstrated that extracellular matrix components were upregulated while some of the
proinflammatory cytokines showed little change. The gene expression data indicates that matrix
components and cytokines that are beneficial to superior healing were up regulated in CD44
knockout tendons. These findings

25

*

studies that showed improved
healing through decreased
inflammation and an accumulation
of HA in the absence of CD44[28,

Angular Deviation (o)

are in agreement with previous
20

*

15

*

10
5

29]. Therefore, the current study
0

demonstrated that the absence of

Uninjured 3wks
Wild Type

CD44 in tendon healing leads to
improved material properties and
reduced cross-sectional area

6wks

Uninjured 3wks 6wks
Knockout

Figure 2.6: Appreciable differences were seen in
angular deviation in the knockout (KO) tendons across
time. While the wild-type (WT) tendons remained
disorganized, the KO tendons approached uninjured
values at 6 weeks post injury. *:p < 0.05; #:p < 0.1.

through superior extracellular
matrix expression.
CD44 and HA are important mediators in healing and numerous studies have shown
beneficial effects from decreased CD44 expression and elevated levels of HA. It has previously
been shown, by our laboratory and others, that this environment occurs naturally during fetal
wound healing [13, 20]. Unlike reparative healing in adult tissue, fetal tissue is well known to heal
through a scarless regenerative process [20, 36]. It is believed that recapitulating a regenerative
environment during adult healing will reduce adhesion formation and the rate of reruptures[13]. In
the current study HAS2 expression, the main HA synthase, was elevated in concurrence with a
previous CD44 knockout study[22]. Interestingly, in an a prior in vitro study, HA-treated cells
stimulated type III collagen and TGFβ3 expression[31], both of which are indicative of
regenerative healing. TGFβ1, which is indicative of fibrotic healing, was also increased by HA;
however, this effect was no longer present when cells were pretreated with CD44 silencing RNA.
Similarly, the previous study also showed an increase in type I collagen expression only when low
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Figure 2.7: Representative histological images for each genotype and time point. Injury is clear
in both genotype at 3 and 6 weeks post injury; however, in the knockout tendons the fibers are
more aligned.
molecular weight HA was added but not with high molecular weight or native HA. Conversely,
type III collagen expression was increased with all three forms of HA. Even more importantly is
that the increased type I expression by low molecular weight HA was reversed with the
application of CD44 silencing RNA. Therefore, in agreement with the previous study, in the
current study increased HAS2, an increased expression of TGFβ3 and type III collagen with only
a mild up regulation in TGFβ1 and no changes in type I collagen were demonstrated. These
factors combined indicate that the absence of CD44 created an environment that is conducive to
regenerative healing.
The absence of CD44 in this study altered the expression of multiple extracellular matrix
components and cytokines. The effects of cytokines and matrix components on cells are
interdependent. Cytokines stimulate extracellular matrix production; however, the interaction
between extracellular matrix molecules and cellular receptors, like CD44, lead to the upregulation
of certain cytokines. For example, administration of bFGF to injured tendon increased expression
of type III collagen[32]. Similarly, application of TGFβ3 to skin wounds reduced scar
formation[33]. Conversely, decorin is closely
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Figure 2.8: Gene expression in a patellar tendon injury in wildtype (WT) and CD44
knockout (KO) represented as relative quantity fold changes (2- ) with error bars
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related to both collagen metabolism and TGFβ activity [34]. Similar results were demonstrated in
the current study, indicating that these synergistic effects helped create an improved tendon
healing environment.
Previous studies showed that CD44 was over expressed in fibrotic healing[35] yet had
decreased expression in scarless healing. This suggests that CD44 is detrimental to healing and
subsequently led to methods that decreased CD44 expression or activation. One strategy was
the application of anti-CD44 blocking antibodies in a healing environment. Blocking antibodies
decreased cellular migration[19] and tissue damage[21], but interpretation of these results
warrant some caution due to poor understanding of the exact function of the antibodies. Studies
have also previously been conducted in the CD44 knockout mouse model. While most CD44
knockout studies examined inflammatory disease[30], one group demonstrated a delay in skin
wound closure at 1 and 3 days post injury which recovered by 7 days[25]. Unlike the previous
study, in the current study tendon injury was examined through multiple parameters of healing at
both early and late stages of healing. While healing was not directly measured during early
stages, improved extracellular matrix gene expression was demonstrated. An improved
environment early in healing resulted in improved material properties during late stages.
Therefore, the current study offers a more complete understanding of how the absence of CD44
affects wound healing at both early and late stages of healing.
There is currently extensive knowledge on the role of CD44 during fetal development and
healing and during adult healing. However, little information is available about the role of CD44 in
neonatal development and healing. During neonatal development, structural and compositional
changes occur that are similar to those seen during adult healing; however, unlike adult healing a
functional tendon results. An advantage to studying neonatal development verses fetal
development is that environmental and mechanical factor are more similar between neonates and
adults; therefore the influence of other factors can more easily be elucidated in neonates than in
fetal tissue. It is known from the current study that a lack of CD44 in adult healing improves
tendon function. In addition, that neonatal tendons express more HA than adult tendons and
therefore can hypothesize that neonatal healing would show superior healing over adult healing is
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also known. By examining first, the role of CD44 and HA in normal neonatal tendon development
and second, the effect of an absence of CD44 in neonatal development and healing, a greater
understanding of CD44 and HA can be obtained. Future studies will include developing a mouse
model of tendon development and developmental healing which includes mechanical analysis.
Then the CD44 knockout mouse can be used to determine the mechanisms behind CD44’s role
in development, healing and mechanical strength.

2.4.2 Limitations
This study has several limitations. First, mRNA expression may not completely mirror the
protein levels since there is post-transcriptional regulation of protein synthesis. Nevertheless, our
findings are consistent with those reported by other investigators. Second, only male mice were
examined in this study. It was recently demonstrated that collagen synthesis in human females is
significantly less than in males[36]; therefore, the results of this study may not be translatable to
female mice. However, since there was no change in type I collagen expression, the overall
conclusions are likely still applicable to both sexes. Third, all the uninjured control tendons were
harvested at 12 weeks of age, even though they were compared to injured mice as up to 18
weeks of age. Somerville et al [37]demonstrated that most material and mechanical properties of
cortical bone had reached their maximum value around 3 months of age. Therefore, it is unlikely
that an additional 6 weeks would have significantly affected results on the material properties of
the tendons due to growth. Fourth, as with all knockout studies, there is a possibility of
compensation by other molecules. The most likely candidate is RHAMM, another HA receptor.
Expression of RHAMM was not increased in the CD44 knockout under normal or arthritic
conditions in a previous study [30]. However, prolonged RHAMM signaling was seen and could
be attributed to the accumulation of HA. Finally, the inflammatory response or RHAMM
expression and signaling was not directly examined. Nevertheless, expression of IL1β, a main
down stream effecter of RHAMM, was not increased in this study; therefore, it is unlikely that
RHAMM signaling increased in this study.
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2.4.3 Summary
In summary, it was demonstrated that the absence of CD44 in a mouse patellar tendon
injury creates an environment that is conducive to regenerative healing through altered gene
expression, resulting in superior material properties and reduced cross-sectional area. It was
also shown that cytokines and matrix molecules that are characteristic of regenerative healing are
elevated in the CD44 knockout animals during healing. The application of these and similar
cytokines to improve tendon healing is commonly studied; however, varying concentrations and
time courses of application make the results difficult to interpret and implement in a clinical
setting. In this study, it was demonstrated that the elimination of CD44 during wound healing
gave rise to beneficial changes in cytokines and extracellular matrix gene expression. Therefore,
by altering the activities of this single cellular receptor, multiple advantageous downstream effects
are initiated that lead to superior tendon healing. This study indicates that limiting the role of
CD44 may improve healing parameters in adult tendon injury.
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Chapter 3: Temporal and tissue specific dysfunction in the absence of type XIV collagen :
in a mouse model

3.1 Introduction
3.1.1 Tendon Development and Fibril Associated Macromolecules
Connective tissues, such as tendons and skin, have tissue-specific structure and
function. The collagen fibril is the major structural element in these tissues and is assembled from
fibril-forming collagens, specifically types I, II, III, V and XI[1]. The development of the
extracellular matrix is dependent on the organization of fibrils into higher ordered structures, e.g.,
fibers and lamellae. The assembly of collagen fibrils is a multi-step process that is highly
regulated. Specific developmental periods are associated with distinct stages in collagen fibril
assembly and growth[2, 3]. Early development is a pregrowth phase that is characterized by
short, small-diameter fibril intermediates. Sequentially, an end to end linear growth occurs
followed by lateral growth of the preformed intermediates. Each step is independently regulated
by specific fibril-associated macromolecules. These molecules associate with fibrils and modify
fibrillar properties. There are two major groups of fibril-associated molecules. The first group is
the small leucine-rich repeat proteoglycans and glycoproteins, which includes decorin, biglycan,
lumican and fibromodulin. Previous studies found that these proteoglycans associate with
collagen fibrils and regulate lateral growth during tendon development[4]. A deficiency of these
macromolecules in vivo resulted in unregulated lateral growth and therefore structurally abnormal
tendon fibrillogenesis[5-7]. The second group of fibril-associated molecules is the fibril-associated
collagen with interrupted triple helices (FACIT). Members of this group include type IX, XII, XIV,
XVI, XIX, XX, XXI, XXII and XXVI collagen[8]. The focus of the current work, type XIV collagen, is
present in developing tendon[9, 10] and is localized to the surface of tendon fibrils[11, 12].

3.1.2. Type XIV collagen
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a

b

c
Figure 3.1: Model of type XIV collagen in fibril assembly. (a): Type XIV collagen has
multiple functional domains. These domains interact with different components of the
extracellular matrix (ECM). (b): Type XIV is localized periodically to the surface of the
striated collagen fibrils. (c): Fibrillogenesis can be divided into distinct phases beginning
with the formation of short, immature fibril segments, then a period of linear growth,
followed by a rapid lateral growth characterized by an increase in fibril diameter and
length (Young, 2000).
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Type XIV collagen decorates the surface of collagen fibrils and its large non-collagenous
domain (NC3) projects into the inter-fibrillar space (Figure 3.1a)[11, 12]. This domain has been
implicated in the regulation of fibril packing[13, 14] and these interactions would be expected to
inhibit lateral fibril growth; therefore, decreased expression of type XIV collagen would be
associated with the beginning of lateral fibril growth (Figure 3.1c). The controlled replacement of
type XIV collagen with other fibril-associated molecules such as type XII collagen or leucine-rich
proteoglycans would allow continued regulation of the growth steps.
Studies of type XIV collagen in chicken[12, 15], bovine [15] and human [16] tissues
showed that type XIV collagen is prevalent in skin, tendon, cornea and articular cartilage. In
addition, type XIV collagen is often found specifically in areas of high mechanical stress[10, 17,
18]. Localization to these areas indicates that collagen XIV may affect the mechanical properties
of a tissue. Evidence in support of this is that type XIV collagen plays a role in corneal stromal
compaction[19] and promotes
collagen gel contraction in
vitro [18]. In addition, in vivo
studies of chicken tendon
during embryogenesis and
early post-hatching stages
showed that type XIV collagen
Figure 3.2: Type XIV collagen expression in normal
neonatal developing mouse tendons. Type XIV collagen
mRNA expression (between P4-P90) was analyzed by real
time quantitative RT-PCR (a) and semi-quantitative RT-PCR
(b). (c) Semi-quantitative immuno-blotting analysis. All results
demonstrate a clear decrease in type XIV collagen in
neonatal development.

expression is high during
development, but decreases
during tissue
maturation[12].

3.1.3 Type XIV Collagen in Neonatal Tendon Development
The regulatory role(s) of type XIV collagen in fibrillogenesis have been analyzed in
developing tendons. Expression of Col14a1 mRNA in mouse flexor digitorum longus (FDL)
tendons at post-natal days 4, 10, 30, and 90 (P4, P10, P30 and P90) were analyzed using semi50

quantitative and quantitative reverse transcription polymerase chain reaction (RT-PCR) [17].
Quantitative PCR demonstrated the highest amount of Col14a1 mRNA at P4 that then decreased
sharply between P4 and P10. A very low level of expression was reached by P30 and this was
maintained in the mature (P90) tendon (Figure 3.2a). Semi-quantitative PCR confirmed these
results (Figure 3.2b). Expression of type XIV collagen was also analyzed using immuno-blot
analyses. Protein immuno-blot results were consistent with the mRNA analyses (Figure 3.2c).
Tendons at P4 demonstrated the highest amount of type XIV collagen with a sharp reduction by
P10. Virtually no type XIV collagen was present in extracts from P30 and P90 tendons.
The temporal and spatial expression patterns of type XIV collagen in the tendon were
investigated utilizing immunofluorescence microscopy (Figure 3.3). These findings demonstrate
homogeneous type XIV collagen expression throughout the tendon at P4 and P10. However, by
P30 and maintained at P90, reactivity against type XIV collagen was undetectable. Consistent
with the immuno-blot and QPCR analyses, a reduction in type XIV collagen reactivity was
observed between P4 and P10. The temporal and spatial expression patterns indicate a role(s)
for type XIV collagen in regulation of the early stages in tendon fibrillogenesis.

3.1.3 Type XIV Collagen Knockout Mouse
Our collaborators created a Col14a1 knockout mouse in a C57BL/6 background and
confirmed its genotype by southern blot, semi-quantitative PCR, immunolocalization (Figure 3.4a)
and immunoblot (Figure 3.4b) in the skin [17]. These mice did not show any gross phenotypic
differences when compared to wild type counterparts. However, ultrastructural differences were
observed when examining the fibril diameters in the FDL tendon. At early stages of development
between 1 and 5 days old, tendon architecture was disorganized in the Col14a1-/- compared to
wild type tendons. This was seen as altered organization of fibrils into fibers with a disruption of
the associated fibroblast compartmentalization in the null tendons. This suggests a role for type
XIV collagen in mediating inter-fibrillar interactions involved in packing into fibers. Absence of
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Figure 3.3: Type XIV Collagen expression patterns in mouse tendon neonatal development.
Localization of type XIV collagen or type I collagen by immunofluorescence microscopy with
nuclear localization using DAPI (blue). There was a dramatic decrease in reactivity against
type XIV collagen between P10 and P30.
these interactions may also suggest a role in altered biomechanical properties. However, in the
mature type XIV collagen-deficient tendons, general fiber and fibroblast organization was
comparable to that observed in the wild type tendons.
The P4 null and wild type tendons both had a normal circular cross-sectional fibril profile.
However, the collagen fibrils in the null tendons were larger and less uniform in size than fibrils
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from wild-type tendons (Figure 3.5a). In addition, the P60 type XIV collagen-deficient tendons
contained fibrils with larger cross sectional profiles compared to fibrils from wild type controls.
The increase in fibril diameter seen at all stages of development, suggests that type XIV collagen
functions to regulate entry into the lateral fibril growth phase during development.
The fibril diameter distributions for both P4 and P60 tendons were also analyzed (Figure
3.5b). At P4 the fibril diameter distribution of wild type and Col14a1-/- tendons were both
unimodal, however

a. Immunoflourescence

there was a
broadening of the
distribution and
shift toward larger
diameter fibrils in
the Col14a1-/tendons. This
Figure 3.4: Absence of type XIV collagen in Col14a1 null mouse skin.
observation was

(a). Immunofluorecence staining of Col14a1 knockout mouse skin using

consistent with a

anti-type XIV collagen antibody was completely negative in Col14a1

premature entry

null mice skin. DAPI staining shows skin structure (blue nuclear). (b).
Western blotting of protein samples extracted from mouse skin showed

into the fibril

complete absence of type XIV collagen in Col14a1 null mice and

growth phase in

reduced synthesis in heterozygous mice.

tendon development. In contrast, at P60, the fibril diameter distributions in
both Col14a1-/- and wild type tendons were multimodal with a comparable range of diameters.
However, the fibrils in Col14a1-/- tendons had a prominent subpopulation of large diameter fibrils
in the 150-190nm range that was not present in the wild type tendons. This subpopulation is
consistent with the progression of fibril growth of the fibrils seen at P4 in the null tendons[12]

53

Figure 3.5: Altered collagen fibril formation in Col14a1-/- tendons. Transmission electron
micrographs of FDL tendon at P4 and P60 from (a) Col14a1+/+ and (b) Col14a1-/- mice.
In the Col14a1-/- tendon, there are fewer smaller fibrils and more fibrils of larger diameter
as compared to the wild type control. Bar = 100 nm. (c) Histograms representing fibril
diameter measurements of tendons at P4 and P60.
suggesting that type XIV collagen could stabilize immature fibrils, preventing lateral association
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and therefore, lateral growth in tendon. In addition, immature fibrils undergo significant linear
growth during the period where type XIV collagen expression is down regulated[3, 20]. Therefore,
while type XIV collagen may not play an active role during lateral growth, the current data indicate
that it regulates the fibril’s entry into the lateral growth phase.
Lastly, the expression of leucine rich proteoglycans and type XII collagen at P4 and P30
was determined to investigate the possibility of
compensation in the FDLs of null mouse at P4 and
P30 (Figure 3.6). Type XIV collagen, type XII
collagen, biglycan, decorin, lumican, and
fibromodulin protein expression were analyzed by
semi-quantitative immunoblot. Relative expression
levels of proteoglycans and type XII collagen
showed that the core protein expression in the wild
type compared with null mice was comparable for
all four proteoglycans and type XII collagen at both
developmental stages..Therefore, if any
biomechanical alterations are observed in
Col14a1-/- mice , these data would indicate a direct
relationship between the absence of type XIV
Figure 3.6: Proteoglycan expression in
the FDLs of Col14a1-/- tendon. (a) No
significant difference was found in
expression at either P4 or P30 for type
XII collagen, biglycan, decorin, lumican,
or fibromodulin.

collagen and the structural and functional changes
observed in the tendon.

3.1.4 Objective and Hypotheses
The purpose of this study was to determine the functional role(s) of type XIV collagen in
the development of tissue-specific mechanical properties. Mechanical analysis was conducted on
skin and at multiple stages of tendon growth, including neonatal development and maturity, to
elucidate the role(s) of type XIV collagen in regulation of mechanical properties. It was
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hypothesized that the significant role type XIV collagen plays in the regulation of fibrillogenesis
would lead to alterations in the mechanics of developing soft tissues.

3.2 Methods
3.2.1. Mechanical Analysis of Skin
For analyses of skin, samples were dissected at 60 days old (P60) from the back of 6
wild type and 7 Col14a1-/- littermates. The hair was shaved and two dumbbell-shaped skin
specimens per mouse, oriented normal to the sagittal plane, were prepared (Figure 3.7). The right
side of each sample was marked to ensure consistency of direction. Cross-sectional area of the
skin was calculated from measurements of the width and thickness[21]. Skin samples were glued
(cyanoacylate) to sand paper 10mm apart and stain lines were placed 5mm apart within the midsubstance to track strain optically[22]. Samples were clamped in custom test fixtures. Standard
mechanical testing protocols were used, including preload to 0.03N and loading to failure at
0.33mm/s (1.67%/s)[21]. Both skin samples for each mouse were tested and parameters were
averaged within each animal. For all tests, samples
were immersed in a 37ºC saline bath and tested with
an Instron 5543 (Instron Corp., Canton, MA).

Figure 3.7: Dumbbell stamped skin
sample. Skin samples were dumbbell
stamped for mechanical testing. Stain
lines were placed at 10mm for grip to
grip gauge length placement and 5mm
apart for optical strain measures.

Maximum stress was determined and modulus was
calculated using linear regression from the nearlinear region of the stress-strain curve.

3.2.2. Mechanical Analysis of Neonatal Developmental FDL Tendons
For analyses of P7 FDLs, 6 wild type, 13 Col14a-/- and 12 Col14a1+/- littermates were
utilized. Cross-sectional area of the P7 FDL was measured using a custom built device consisting
of LVDTs, a CCD laser, and translation stages. Briefly, the specimen was translated beneath the
laser while displacement data was simultaneously acquired in two directions from two LVDTs, as
well as thickness data from a CCD laser displacement sensor[23]. Due to their extremely small
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size and fragile nature, P7 mouse tendons have not been mechanically tested previously. Each
end of the P7 tendon was glued (cyanoacylate) to sand paper 4mm apart. Stain lines were placed
2mm apart within the mid-substance to track strain optically[22]. Tendons were placed in custom
grips and a
custom holding
fixture was
secured to the
grips (Figure 3.8).
Importantly, the
holding fixture
was designed to
ensure that the
tendons
remained
unloaded prior to
testing. The
tendons were

Figure 3.8: Custom designed fixture for P7 FDL mechanical
testing. The tendon (as shown with bold arrow) is secured in grips.
The holding fixture, which is attached to the clamps through pins,
ensures that the tendon is in a relaxed position until the fixture is
secured in the Instron.

preloaded to
0.005N and held for 5 minutes. The load was returned to 0N and held for 1 minute. The tendons
were then loaded at a constant ramp to failure at 0.004mm/s (0.1%/s). Both the right and the left
FDL were tested and parameters were averaged within each animal. Maximum load and stiffness
were determined, and maximum stress was calculated from the maximum load and crosssectional area, and modulus was calculated from the slope of the linear region.

3.2.3. Mechanical Analysis of Mature FDL Tendons
For analyses of P60 FDLs, 8 wild type, 12 Col14a1-/- and 8 Col14a1+/- littermates were
analyzed. Cross-sectional area of the P60 tendon was calculated from measurements of the
width and thickness as described previously [24]. P60 tendons were glued (cyanoacylate) to sand
57

paper 5mm apart and stain lines were placed 2.5mm apart within the mid-substance to track
strain optically[22]. Samples were clamped in custom test fixtures and standard mechanical
testing protocols were used including pre-conditioning, stress-relaxation and ramp to failure as
described[25]. Samples were immersed in a 37ºC PBS bath and tested with an Instron 5543
(Instron Corp., Canton, MA). Maximum load and stiffness were determined, and maximum stress
and modulus were calculated as

P60 Skin Mechanics
described above.

Cross-sectional Max Stress
Area (mm2)
(MPa)

1.5

3.2.4. Statistical Analyses
T-tests were performed
on skin cross-sectional area,
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maximum stress, and elastic
modulus across genotype
(significance at p≤0.05, trend at
p≤0.1). One way ANOVAs were
performed on tendon cross-

Figure 3.9: Skin mechanics in P60 wildtype and null
mice. No significant differences were found in the
cross-sectional area of the P60 skin. The maximum
stress was significantly decreased in the skin of the
col14 a1 null mice compared to that of wild-type.
Additionally, the modulus showed a trend toward lower
modulus when compared to wild type mice. *:p<0.05; #:
p<0.1.

sectional area, maximum load, maximum stress, stiffness, and elastic modulus comparing across
genotype within each age group (significance at p≤0.05, trend at p≤0.1).

3.3 Results
3.3.1. Skin Biomechanics
To ascertain the functional consequences of a type XIV collagen-deficient dermis, skin
from wild type and Col14a1-/- mice was subjected to biomechanical analyses. No significant
difference was seen in the cross-sectional area (Figure 3.9). However, significant alterations were
present in biomechanical properties associated with the type XIV collagen-deficient skin at P60.
The maximum stress was significantly decreased (p = 0.05) in the skin of the Col14a1-/- mice
compared to that of wild type controls. Additionally, the deficient mice showed a trend toward
decreased modulus when compared to wild type mice (p = 0.07).
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3.3.2. Tendon Biomechanics
Biomechanical studies of wild type, Col14a1+/- and Col14a1-/- tendons were conducted
for developing (P7) and mature (P60) tendons. Cross-sectional area as well as maximum load,
maximum stress, stiffness and modulus were measured. At both developmental stages the crosssectional areas were comparable in all genotypes (Figure 3.10). The develo ping Col14a1-/tendons (P7) demonstrated a significant reduction in maximum load (p = 0.005), stiffness
(p<0.001) and modulus (p=0.008) when compared to wild type tendons (Figure 3.11a). In
addition, FDLs from the developing Col14a1-/- mice showed significantly decreased maximum

Cross-sectional Area (mm2)
0.020

P7

0.100

0.015

0.075

0.010

0.050

0.005

0.025

0

(+/+) (+/-) (-/-)

0

P60

(+/+) (+/-) (-/-)

Figure 3.10: FDL cross-sectional area at P7 and P60.
No significant
differences were observed in cross-sectional area at P7 or P60 between
wildtype, heterozygotes or null FDLs at either stage of development.

load (p=0.02) and a trend towards decreased maximum stress (p=0.09) and stiffness (p=0.06)
when compared to the heterozygote mice. FDLs from heterozygous mice had significantly
decreased stiffness (p=0.02) compared with wild type mice. In contrast, the mature tendons
demonstrated no significant differences between the wild type, Col14a1+/- or Col14a1-/- tendons
(Figure 3.11b).

3.4 Discussion
3.4.1 Interpretation of Results
The assembly and final properties of the collagenous fibrillar matrix are not only
dependent on the main constituents of the fibrils, but also fibril associated molecules that
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participate in fibrillogenesis. In this study, type XIV collagen played a significant role in the
biomechanics of the neonatal developing mouse FDL tendon. Maximum load, stiffness and
modulus were all significantly reduced when comparing the Col14a1-/- with wild type tendons.
However, by P60 the differences seen at P7 were absent. Interestingly, there were no
differences seen in the cross-sectional area of any genotypes at either age. Therefore the
decrease in mechanics is not due simply to a decrease in type I collagen but most likely due to
the changes in structure of the collagen fibrils/fibers or the matrix that surrounds the fibers.
These results support the hypothesis that type XIV collagen plays a significant role in
fibrillogenesis during neonatal development.
Type XIV collagen has previously been implicated in playing a role in soft tissue
mechanics[10, 16, 20]. It was shown to aid in the compaction of collagen gels in vitro[18] and is
up-regulated during the compaction stage of the corneal stroma[19]. A previous study examined
type XIV collagen expression in chick tendon and demonstrated high expression during prehatchling phases of development but almost no expression post-hatchling [12]. Interestingly,
chick tendons have a marked increase in strength during the period when type XIV collagen
expression was decreasing [26]. It is also interesting to note that the heterozygote FDL tendons
had mechanical properties intermediate to those of the wild type and null tendons. This implies
that type XIV collagen has a dose dependent effect on the mechanics of neonatal developing
tendon. The current study, along with others, indicates that type XIV collagen
has a significant role in establishing the mechanical properties in developing tendons.
In the current study mechanical differences were not seen in mature null tendons but the
mechanics in the mature Col14a1-/- skin were inferior to wild type skin. Most notably, the null skin
aand a reduced maximum stress and modulus. Regional and temporal differences of the
presence of type XIV collagen in skin and tendon could help explain the tissue-specific
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Figure 3.11: FDL mechanics at P7 and P60. (a) The P7 FDL deficient tendons demonstrated
a significant reduction in maximum load, stiffness and modulus when compared to wild type
tendons. In addition, FDLs from the developing deficient mice showed significantly decreased
maximum load and a trend towards decreased maximum stress and stiffness when compared
to the heterozygote mice. FDLs from heterozygote mice also had significantly decreased
stiffness when compared to wild type mice. (b): In contrast, the mature tendons demonstrated
no significant differences between the control, deficient or heterozygote tendons. *:p<0.05; #:
p<0.1
differences observed in the null mouse[16]. Type XIV collagen was highly expressed early in
mouse FDL development. Furthermore, type XIV collagen expression rapidly decreases as the
tendon matures becoming virtually absent by P30. On the other hand, skin from P60 wild type
mice still contained type XIV collagen, even though it was greatly reduced from neonatal
development. These findings are consistent with previous studies that demonstrated expression
of type XIV collagen is maintained longer in skin than in tendon [16].
While skin and tendon are both connective tissues consisting mainly of collagen fibrils
organized as fibers, they have important differences. Most notably, the skin has a decreased
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fibril content compared to the tendons and the collagen fibers are loosely packed, small and nonaligned. In contrast, tendons are composed of densely packed, large and well aligned fibers.
Another important feature of connective tissues is the type of stresses they see in vivo. The skin
experiences multi-axial stresses whereas the tendon sees mainly tensile stresses. Each of these
tissues gives a unique view into how these components work together in a functioning tissue.
Therefore, while the basic fundamentals of fibrillogenesis are the same in these two tissues, it is
not surprising that we see a differential effect of the absence of type XIV collagen.
After tendon injury, many structural and compositional changes occur including a
decrease in fibril diameter and an increase in type XIV collagen (Figure 3.12, unpublished data

Figure 3.12: Type XIV collagen expression after tendon injury. The panel on the
left is a normal P90 tendon and the one on the right is a tendon 1 week post injury,
both were stained with anti-col14a1 antibody. No type XIV is present in the
uninjured tendon whereas protein expression is visible one week post injury.
from Dr. Birk). Type XIV collagen has been hypothesized to play a role in the linear growth of
fibrils, but not the lateral growth [12]. After injury, fibril diameters are markedly decreased and
uniform unlike normal mature fibril diameters [27]. Therefore, the increased expression of type
XIV collagen could play a role in the fibrillogenesis and linear growth of fibrils during repair. In
addition, its expression could prevent the lateral growth of collagen fibrils during injury [28]
helping to explain the extended presence of small diameter fibrils. Except for these few
observations, the specific role of type XIV collagen during tendon healing is unknown.
Understanding the role of type XIV collagen during healing would lend great insight into the
mechanism of tendon healing and mechanics. Future studies will include investigating type XIV
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collagen during injury and injury in the absence of type XIV collagen. In addition, the
mechanisms behind mechanical development and growth can be elucidated by examining
healing at distinct stages of neonatal development with and without the presence of type XIV
collagen.

3.4.2 Limitations
It was first proposed that fibril diameter parameters may predict mechanics by Parry et al
in a large, multiple species study[29]. Several groups, including ours, have since examined the
relationship between mechanics and fibril parameters including: mean fibril diameter size, fibril
cross-sectional area fraction and fibril distribution variation[30-32]. While some of these studies
have found significant correlations between fibril parameters and mechanics, they were usually
accompanied by a low correlation coefficient. A low correlation coefficient indicates that there are
other parameters that also play a significant role in tendon mechanics. For example, Robinson et
al. demonstrated that proteoglycans and fibril area fraction were both significant predictors of
mechanical parameters[32]. Therefore, while there are differences in fibril diameter distribution in
both the P4 and P60 tendons, it is very likely that at P60 another parameter, such as
proteoglycan or collagen content, is significantly affecting the mechanics.
Discrepancy between neonatal and mature tendons could be attributed to compensation
by other molecules in the mature null tendon or could simply mean type XIV collagen plays a
more significant role in mechanical development. Four proteoglycans, decorin, biglycan, lumican,
fibromodulin, and type XII collagen are the main candidates for compensation. Types XIV and XII
collagen are closely related members of the FACIT collagen class [8]. Type XII collagen is more
widely expressed throughout development, maturation and aging in most connective tissues [1,
33, 34]. It is possible that type XII collagen replaces type XIV collagen, both structurally and
functionally at later stages of tendon development. Therefore, compensation in the null mouse is
possible, however, compensation by type XII collagen was not observed in the developing
tendon. The four proteoglycans have previously been shown to play multiple roles during
fibrillogenesis, making them candidates for compensation. These proteoglycans were also not
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shown to be upregulated in the current study; therefore, it can be hypothesized that the
discrepancy seen between neonatal development and maturity in the Col14a1-/- tendon is due to
type XIV collagen. Work on other closely related fibril-associated molecules, the leucine-rich
proteoglycans, supports this suggestion. Both decorin/biglycan and fibromodulin/lumican have
been shown to be important regulators of collagen structure and mechanical function[5, 6, 35,
36]. However due to high similarity of these proteoglycans, they may share redundant function(s).
For example, in the fibromodulin-deficient mouse, lumican was increased[7] and in the decorin
deficient mouse, biglycan was increased [37]. Therefore, compensation occurs only when the
proteoglycan expressed throughout development, maturation and aging was deleted, i.e. decorin
or fibromodulin. If a similar interaction between types XII and XIV collagen exists, then a
compensation with up-regulation of type XIV collagen in the absence of type XII collagen would
be predicted and not the reverse. Future analyses of type XII collagen-null and compound type
XII/XIV collagen null mouse lines will provide insight into this and other possible interactions.
3.4.3 Summary
Overall, the data suggests a tissue-specific role of type XIV collagen in the structurefunction relationship of connective tissues. Differences in fibril and fiber architecture in
developing tendon, but not mature tendon may account for mechanical differences. Interestingly,
mechanical differences are seen in mature skin that could be due to longer temporal expression
of type XIV collagen in the skin as compared to the tendon.
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Chapter 4: Mechanical, Compositional and Structural Properties of the Neonatal Mouse
Achilles Tendon

4.1 Introduction
4.1.1 Significance
During neonatal development, tendons undergo a well orchestrated process whereby
extensive structural and compositional changes occur in synchrony to produce a normal tissue [1,
2]. Conversely, during the repair response to injury, structural and compositional changes occur,
but in this case, a mechanically inferior tendon is produced. Tendon injuries affect large numbers
of individuals and account for enormous associated costs. While the development of new
surgical techniques and postoperative rehabilitation protocols have led to improved results,
postsurgical scarring and restoration of the normal tendon mechanics following injury remain
problematic in tendon repair. An injured tendon that is mechanically inferior has compromised
function and reruptures after treatment are commonly observed clinically. As a result, the
process of development has been postulated as a potential paradigm through which improved
adult tissue healing may occur. Of particular importance is a thorough understanding of the
progression of mechanical strength and function during development. In depth knowledge of the
changes and processes during development could lead to new therapeutic treatments to improve
functional outcomes in adult tendon healing.

4.1.2 Tendon Development
Whereas embryonic growth has been thoroughly examined, less quantitative information
is available on changes in tendon mechanics, structure and composition during neonatal growth.
It is however well established that type I collagen is the most abundant constituent in tendon
during development and collagen content increases throughout development into maturity [3, 4].
The collagen hierarchy is established through fibrillogenesis, a multistep process that is
independently regulated by specific fibril-associated macromolecules, two of which include the
proteoglycans biglycan and decorin. Biglycan is believed to promote fibril diameter growth, where
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as decorin is believed to control lateral fusion of the fibrils and increase fibril stability. During
early development, biglycan is highly expressed while decorin is relatively low; however, as
growth progresses biglycan is down regulated and decorin is up regulated [5-8]. It has been
hypothesized that the temporal expression during development plays a crucial role in the
mechanical development of tendons. In support of this, in vivo studies of decorin and biglycan
deficient mice showed unregulated lateral growth, structurally abnormal tendon fibrillogenesis and
altered mechanics [9, 10].
Similarly, due to the preponderance of collagen and its hierarchical organization, many
have hypothesized that collagen is the main effecter of mechanical strength in tendon. Initially
during development, collagen fibril diameters are small and have a narrow distribution. As
tendons mature, the fibril diameter increases, as does the fibril diameter distribution [1, 2, 11]. It
is during this shift in collagen fibril diameter size and distribution that tendons gain significant
mechanical strength[12]. Collagen fibril diameter average has often been used to determine the
extent of mechanical contribution of collagen fibrils but has not always been a significant predictor
for mechanical parameters[13-15]. Therefore, other tendon parameters must also be affecting the
mechanical strength.

4.1.3 Animal Model
Neonatal development is characterized by a multitude of compositional, structural and
mechanical changes, including the ones outlined above and more. While there is currently a
basic knowledge of compositional and structural changes, there is sparse information on the
mechanical development of neonatal tendons. Previous studies have examined tendon
development in the mouse, rat, rabbit, chick and horse. Each of these animal models presents its
own set of benefits and deterrents when choosing an appropriate animal model to study tendon
development. The rabbit and horse’s larger size make tendons easy to be mechanically
manipulated, but handling the neonates is difficult and housing for these animals is expensive;
therefore only small sample sizes are feasible. The chick is beneficial because different stages of
growth, including pre-hatchling through hatchling, can be easily examined. One study did
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mechanically test post-fertilization, and hatchling chick tendons along with fibril diameter and
collagen content[12]. However, healing cannot be easily examined in prehatchling chick tendons.
Rats are easy to handle and house but there are limited commercial assays and few genetically
modified rats available to study specific mechanisms. Mice on the other hand, are easy to
handle, associated with low husbandry costs, and have similar tendon anatomy to humans. The
wide range of genetically modified mice and commercially available assays allow for rigorous
mechanistic studies to be conducted in mice. Due to the fragile nature and small size of neonatal
tendons most studies that have examined neonatal development have not mechanically tested
the youngest specimen[10], or simply started the study at later stages of development, when the
tendons are larger and easier to handle [4, 16]. . However, compositional and structural studies
have demonstrated that the most significant changes occur at very early stages of development,
including fetal and neonatal. In addition, it is during early neonatal growth that compositional and
structural changes are most similar to changes observed during healing. Therefore, the
establishment of a mouse model of tendon development that includes quantitative measures for
composition, structure and mechanics will be an enormously useful tool to determine the specific
mechanisms of tendon development.
The current study will use the mouse Achilles tendon (AT) as a model of tendon
development. The mouse was chosen due to the reasons outlined above. The Achilles tendon
was chosen due to homologous anatomy to the human Achilles tendon, manageable size during
development and accessibility for surgical injury (discussed in Chapter 5).

4.1.4 Objective and Hypotheses
The purpose of this study is to develop a quantitative model of neonatal development in the
mouse Achilles tendon. Collagen content, biglycan and decorin expression, collagen fiber
alignment, collagen fibril parameters, and elastic and viscoelastic mechanical properties will be
quantified. It is hypothesized that tendon mechanical properties, fibril parameters, and collagen
content will increase throughout neonatal development. In addition, it is hypothesized that
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decorin and biglycan will be temporally regulated and the collagen fibers will be well aligned
throughout development.

4.2 Methods
4.2.1 Animals
This study was approved by the University of Pennsylvania IACUC. Neonatal mice in a
C57BL/6 background were bred in house. All litters were weaned at birth to 6 pups to reduce
variance from litter size [17]. Mice were weaned at 21 days old and sexes were separated at this
time. Both males and females were used in this study. AT were harvested from neonatal mice at
4, 7, 10, 14, 21 and 28 days old. Care was taken to ensure that AT from the same mouse or from
the same litter was not used in the same assay.

4.2.2 Mechanical Analysis
To determine the mechanical properties of the developing neonatal mouse AT, one AT
from each of forty-eight mice (8/age) was carefully dissected under a dissection microscope. The
tendons were cleaned of excess tissue leaving only the calcaneous. Tendon width and thickness
were then quantified, and cross-sectional area was measured using a custom built device
consisting of LVDTs, a CCD laser, and translation stages[18]. Stain lines were placed to
measure strain optically. Sand paper was then glued to the calcaneous and myotendinous end of
the AT. Grip to grip and stain line to stain line gauge lengths were as follows (grip:stain): 4 and 7
days old (2mm:1mm), 10 and 14 days old (3mm:1.5mm), 21 and 28 days old (4mm:2mm). While
gauge lengths varied with age due to increased AT size, the ratio of grip to stain line gauge length
remained constant. Due to the fragile nature of neonatal mouse AT, custom fixtures were
designed to ensure the AT was unharmed during test preparation. Custom designed grips were
placed in a grip-boat to eliminate unwanted motion of the grips while the tendon was being
secured in the grips (Figure 4.1A). Once the tendon was secured, a custom grip-holder was
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Figure 4.1: A: Custom designed grip-boat with grips and an AT tendon. B: Custom
designed grip-holder, indicated by the arrow, with a tendon loaded between the grips,
indicated with the circle. The grip-holder ensured that the tendon remained unloaded
during manipulation and mounting prior to testing.
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Figure 4.2: Example of the testing protocol for neonatal AT. Protocol includes a preload,
precycle, stress relaxation and constant ramp to failure.
attached to both grips (Figure 4.1B). Importantly, this fixture ensured that the tendons remain
unloaded during handling and mounting for mechanical testing (Instron 5543, Instron Corp.,
Canton, MA).

Each AT underwent the following protocol while immersed in a 37oC PBS bath—

preloaded to a nominal load, preconditioned for 10 cycles (0.005N-0.008N for 4 to 7 days old,
0.01N-0.02N for 10 to 17 days old, 0.02N-0.04N for 21 to 28 days old) at a rate of 0.1%/s, and
held for 300s. Immediately following, a stress relaxation experiment was performed by elongating
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the tendon to a strain of 5% at a rate of 5%/s, followed by a relaxation for 600s. The tendon was
returned to pre-stress relaxation elongation for 60s and finally, a ramp to failure was applied at a
rate of 0.1%/s (Figure 4.2). Local tissue strain was measured optically as described
previously[19]. From these tests, percent relaxation, toe region stiffness and modulus, the load,
stress and strain at the transition point from toe to linear regions (from a bilinear fit), and linear
region stiffness and modulus were determined.
A pilot study was conducted to ensure that the stress-relaxation test did not mechanically
injure the neonatal tendons. Eight neonatal mice at 7 days old were utilized. One AT was
mechanically tested through stress-relaxation at 5% strain followed by a ramp to failure while the
contralateral tendon underwent only ramp to failure. Elastic parameters maximum load, maximum
stress, stiffness and modulus were then compared with paired t-tests to determine if damage had
decreased the elastic parameters. No significant differences were seen between stress
relaxation plus ramp to failure versus just ramp to failure (Table 4.1). Therefore, the stressrelaxation ramp did not cause damage to the tendon and it is acceptable to conduct a stressrelaxation test followed by ramp to failure on neonatal Achilles tendons.
Table 4.1 : Comparison of elastic parameters in pilot study in 7 days old neonatal tendons (mean +/- st dev)
Elastic Parameter
MaxLoad
Max Stress
Stiffness
Modulus
(N)
(MPa)
(N/mm)
(MPa)
0.45 ± 0.12
Ramp to failure only
16.45 ± 5.33
6.63 ± 4.45
168.23 ± 89.68
Stress-relaxation plus ramp to failure
0.40 ± 0.07
17.59 ± 2.46
6.05 ± 4.21
167.91 ± 81.48
p value
0.3
0.1
0.3
0.5

4.2.3 Hydroxyproline Analysis
For analysis of total collagen content, a total of twenty-four AT (4/age) were cleanly
dissected and the length of tendon corresponding to the grip to grip gauge length was isolated.
Wet weights were obtained and subsequently AT were dried at 65°C for 24 hours. Dry weights
were then obtained, followed by tissue digestion in 5mg/mL proteinase K solution at 65°C for 18
hours. For hydrolysis, samples were sealed in glass vials with 6N HCL and heated to 110C for
16 hours. Upon completion of hydrolysis, samples were neutralized by evaporating off HCL in a
lyophilizer with NaOH and then resuspended in water. o-Hydroxy-proline (OHP), a measure of
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collagen content, was determined colorimetrically by reaction of the digest with pbenzaminoaldehyde and chloramine-T. OHP content was converted to total collagen content,
assuming hydroxyproline content is 14% of total collagen as previously reported[20].

4.2.4 Gene Expression
To determine the mRNA expression of the proteoglycans biglycan and decorin, one AT
from each of twenty-four mice (4/age) was used. The AT was cleanly dissected and the length of
tendon corresponding to the grip to grip gauge length was isolated. Individual AT were
mechanically homogenized with a mortar and pestle in RNase-free conditions. RNA was
extracted using the TRIZOL isolation system (Invitrogen, Carlsbad, CA) and RNeasy Mini Kit
(Qiagene Inc., Valencia, CA) as described by the manufacturers. cDNA was produced by reverse
transcription-polymerase chain reaction (RT-PCR) from 100ng of total RNA using the Superscript
first-strand synthesis system for RT-PCR as described by the manufacturer (Invitrogen). 1 µL
aliquots of the cDNA were amplified by real time quantitative polymerase chain reaction (Q-PCR)
in a 25 µL reaction volume in a ABI Prism 7300 Sequence Detection System (Perkin-Elmer;
Applied Biosystems, Warrington, UK) with a SYBR Green PCR Master Mix (Applied Biosystems).
Mouse specific primers were used for glyceraldehyde-3-phosphate dehydrogenase (GAPDH; F CTC GTC CCG TAG ACA AAA TGG; R - GTG ACC AGG CGC CCA ATA), decorin (DEC; F –
GCTGCGGAAATCCGACTTC; R - TTGCCGCCCAGTTCTATGAC), biglycan (BIG; F –
CCTTCCGCTGCGTTACTGA; R - GCAACCACTGCCTCTACTTCTTATAA). Each replicate was
performed in triplicate. The relative quantity of mRNA for each gene of interest was computed
-∆CT

using the comparative 2

method (ABI; Sequence Detection System User Bulletin #2) relative

to GAPDH. Statistics were performed on the ∆CT value as is commonly done [7].

4.2.5 Histological Analysis
To determine the organization of the developing AT, a total of 31 neonatal mice were
euthanized (4-7/age). AT were evaluated using a quantitative polarized light microscopy method
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as described previously[21]. Briefly, the hind limb was disarticulated, the skin dissected off, and
processed with standard histological techniques. During processing the foot was secured at a 90
degree angle to the tibia[22]. 7 µm sagittal sections were cut parallel to the tendon fibers and
analyzed using a quantitative polarized light microscopy method. Using circular statistics (Oriana,
Kovach Computing Services, Wales, UK), the angular deviation, a measure of collagen fiber
orientation, was determined.

4.2.6 Transmission Electron Microscopy
AT samples from twenty-four mice (4/age) were analyzed by transmission electron
microscopy as previously described[23]. Briefly, the AT was dissected out with the calcaneous
and muscle intact and fixed in 4% paraformaldehyde, 2.5% glutaraldehyde, 0.1 M sodium
cacodylate, pH 7.4, with 8.0 mM CaCl2, post-fixed with 1% osmium tetroxide. They were
dehydrated in an ethanol series, followed by propylene oxide. The tissue samples were infiltrated
and embedded in a mixture of EMbed 812, nadic methyl anhydride, dodecenyl succinic
anhydride, and DMP-30 (Electron Microscopy Sciences, Hatfield, PA). Thin sections (80 nm)
were cut using a Leica ultramicrotome and poststained with 2% aqueous uranyl acetate and 1%
phosphotungstic acid, pH 3.2. The AT were examined at 80 kV using a JEOL 1400 transmission
electron microscope equipped with an Orius widefield side mount CCD camera.

4.2.7 Fibril Diameter Distribution
For each age, 4 AT were analyzed. Micrographs (4/AT) from non-overlapping regions of
the central portion of the tendon were taken at 60,000x. Micrographs were randomly chosen in a
masked manner from the different ages and fibril diameters were measured using a RM
Biometrics-Bioquant Image Analysis System (Nashville, TN). A region from a single micrograph,
containing 27-214 fibrils/field, was measured. Frequency of different diameter fibrils was
analyzed in a total of 1514-2995 collagen fibrils/age. All fibrils in the region of interest were
measured; multiple regions of interest were used if necessary to collect at least 70 fibril diameter
measurements per micrograph. For each age, the total number of regions of interest and
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minimum and maximum fibril measurements per region are as follows [age/# ROI (min-max)]:
4/16 (146-233), 7/16 (108-168), 10/16 (111-152), 14/20 (52-126), 21/23 (43-127), 28/36 (27-54).
For each AT the average and the standard deviation of the fibril diameters were determined and
analyzed statistically.

4.2.8. mRNA Comparison to Protein Expression
To determine whether mRNA expression mirrored protein expression, 6 mice were used
for each age. Both tendons were dissected (12/age), rinsed in PBS, and one AT was pooled for
immunoblot analysis while the contralateral AT was pooled for mRNA analysis according to age.
For immunoblot analysis, AT were homogenized in 10-20 fold excess (weight/volume) of
extraction buffer (4M guanidine-HCL, 50nM sodium acetate, pH 5.8) with proteinase inhibitor
(Roche). Proteoglycans were extracted at 4 C for 48 h with stirring followed by clarification by
centrifugation. After dialysis against 150 mM Tris-HCl pH 7.3, 150 mM NaCl, the samples were
digested with chondroitinase ABC for 24 h at 37 C. Total protein content in the samples was
determined using a BCA Protein Assay Kit (Pierce). For semi-quantitative analysis of decorin and
biglycan in neonatal developing tendons, 6-12 ug of total protein from neonatal developing
tendons was loaded based on determination of optimal loading conditions. Immuno-blotting was
done as previously described [24]. Antibodies (from Dr. L. Fisher, NIH-NICDR) anti-decorin
(LF#113) and antibiglycan (LF#159) were both used at 1:200. Anti-actin antibodies (Millipore,
MAB1501) were used at 1:100. Donkey anti-rabbit and sheep anti-mouse IgG-horseradish
peroxidase-linked secondary antibodies (GE Healthcare were used as 1:2500 (NA934V) and
1:2000 (NA931V), respectively, with an ECL (Amersham) detection system.
For mRNA analysis, tendons underwent the same protocol outlined above with the same
primer sets and were analyzed for ∆CT relative to actin.

4.2.9 Statistical Analysis
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Each parameter was quantitatively measured and the mean +/- the standard deviation
was reported unless otherwise stated. A one-way ANOVA with Tukey’s post hoc was performed
across age for each measured parameter (significance set at p< 0.05, trend set at p<0.1).

4.3 Results
4.3.1 Animals
Extensive body weight growth was observed in neonatal mice between the ages of 4 and
28 days old (Figure 4.3). To determine if sex had an effect on the mechanical parameters
measured in this study, individual t-tests were conducted at each age when possible. Due to
random assignment of mice, there were not enough female mice at 10 days of age for statistical

Body Weights of C57BL6 Mice
Body Weight (g)

20

Female
Male

16
12
8
4
0
0

7

14
21
Age (days)

28

35

Figure 4.3: Growth curve of the body weights of C57BL/6 mice during
neonatal development.
analysis of a sex effect. Table 4.2 demonstrates that sex did not have an effect on the
mechanical parameters measured in this study, with one exception of males having a significantly
larger transitional stress than females at 21 days of age.
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Table 4.2: Mean +/- standard deviation and the significance for each mechanical parameter
Parameter
Age (days)
4
7
14
21
28

Percent Relaxation (%)
Stiffness (N/mm)
Female
Male
p-value
Female
Male
p-value
51.7 ± 3.2 48.3 ± 4.7
0.3
3.18 ± 1.65 1.83 ± 0.86
0.2
55.5 ± 6.0 59.2 ± 6.6
0.5
7.27 ± 2.75 3.54 ± 2.15
0.08
61.2 ± 5.3 59.4 ± 5.1
0.7
9.08 ± 2.14 11.52 ± 4.00
0.4
63.6 ± 5.4 62.0 ± 3.9
0.7
19.74 ± 8.38 22.22 ± 12.18
0.8
58.2 ± 5.4 63.5 ± 6.3
0.2
38.84 ± 19.56 61.85 ± 38.03
0.3

Parameter
Age (days)
4
7
21
28

Transitional Load (N)
Female
Male
p-value
0.04 ± 0.03 0.03 ± 0.02
0.6
0.04 ± 0.02 0.04 ± 0.03
0.8
0.1 ± 0.02 0.06 ± 0.08
0.2
0.31 ± 0.3 0.2 ± 0.08
0.3

Transitional Stress (MPa)
Female
Male
p-value
1.64 ± 1.50 1.27 ± 0.81
0.7
1.13 ± 0.82 1.76 ± 1.60
0.6
1.76 ± 0.60 0.47 ± 0.53
0.05
2.13 ± 1.63 0.76 ± 0.37
0.2

Modulus (MPa)
Female
Male
p-value
102.2 ± 40.5
72.0 ± 31.7
0.3
238.8 ± 70.8
114.6 ± 77.7
0.09
373.7 ± 267.5
408.5 ± 58.2
0.8
469.2 ± 195.9 408.7 ± 141.1
0.7
566.7 ± 237.4 521.2 ± 278.4
0.8
Toe Stiffness (N/mm)
Female
Male
0.58 ± 0.18
0.53 ± 0.23
0.63 ± 0.23
0.48 ± 0.26
2.4 ± 1.14
1.65 ± 1.51
7.5 ± 4.79
5.27 ± 3.34

p-value
0.8
0.4
0.5
0.5

Toe Modulus (MPa)
Female
Male
p-value
22.8 ± 10.3
26.1 ± 22.6
0.8
22.6 ± 10.0
15.2 ± 9.4
0.4
63.5 ± 44.1
27.8 ± 17.8
0.3
99.7 ± 52.5
45.0 ± 27.8
0.1

4.3.2 Mechanical Properties
There were obvious changes
with age, specifically in size, upon
dissection (Figure 4.4). As expected,
the cross-sectional area increased
significantly with age (Figure 4.5). 21
and 28 days old AT were significantly
larger than all other ages studied, and
28 days old AT were significantly larger
than 21 days old AT. Most mechanical
parameters increased throughout
development as demonstrated by load
vs displacement curves of the constant
ramp to failure for representative
Figure 4.4: Typical 4 days old (A) and 28 days old samples at each age (Figure 4.6).
(B) AT immediately after dissection. Obvious size
increases occur over the period of time Specifically, percent relaxation, a
investigated in this study.

viscoelastic property, was significantly
lower in 4 days old AT when compared to 14, 21 and 28 days old AT (Table 4.3). Significant
differences were seen in toe region parameters that were obtained from a bi-linear fit. The
transitional strain (strain at the inflection point in the stress-strain curve) was significantly higher in
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4 and 7 days old AT when compared to 21 and 28 days old AT. Transitional load (load at the
inflection point) was significantly higher at 28 days old than at all other ages except at 21 days
old. Interestingly, transitional stress showed no significance at any age. Toe stiffness and toe
modulus, parameters obtained from the slope of the toe region, also showed significant increase
with age. Toe stiffness was significantly higher at 28 days old than at all other ages. Toe
modulus was significantly higher in 28 days old AT than at 7 and 14 days old AT. Similarly, linear
stiffness and modulus, parameters obtained from the linear portion of the curve increased with
age (Figure 4.7). AT were significantly stiffer at 28 days old than at all other ages. Linear
modulus was significantly lower in 4 days old AT than at 10, 14, 21 and 28 days old AT and in 7
days old AT than at 21 and 28 days old AT.
neonatal
development
(mean
Table 4.3:
1: Mechanical,
Mechanical,
compositional
compositional
andand
organization
organization
parameters
parameters
throughout
throughout
neonatal
development
(mean±
(mean
stdev)
± stdev)
± Stdev)
Linear Collagen
Linear
Toe
Toe
Trans Trans
Trans
Percent
CrossStress Strain Stiffness Modulus Stiffness Modulus Content
Load
Relax
Age sectional
(%)
(MPa)
(N/mm)
(N/mm) (MPa)
(%)
(MPa)
(N)
(%)
(Days) Area (mm2)
0.015 ±
50.03 ± 0.036 ±
1.43 ± 7.29 ±
0.55 ±
24.6 ±
2.50 ±
87.12 ±
2.88 ±
4
0.003ab
4.14abc 0.023a
1.06
4.28ab
019a
17.2
1.42a
37.3abcd 1.04abc
0.021 ±
56.86 ± 0.038 ±
1.47 ± 7.73 ±
0.57 ±
19.4 ±
5.87 ± 192.19 ± 6.38 ±
7
abc
0.006ab
6.05
0.025a
1.14
4.78ab
0.24a
9.7a
3.06a
93.4ab
0.8
0.023 ±
56.26 ± 0.047 ±
1.71 ± 3.36 ±
1.26 ±
62.0 ±
6.67 ± 345.75 ± 10.85 ±
10
0.008ab
9.06
0.026a
0.72
1.45
1.14a
40.0
2.33a
150.4
1.81ab
0.041±
60.51 ± 0.035 ±
0.80 ± 4.32 ±
0.61 ±
21.7 ±
9.99 ± 386.75 ± 18.74 ±
14
0.010ab
4.92
0.026a
0.43
1.95
0.20a
10.1a
2.97a
205.4
2.92a
0.098 ±
62.58 ± 0.096 ±
1.12 ± 2.25 ±
2.03 ±
45.7 ±
21.15 ± 431.37 ± 27.17 ±
21
0.030a
4.22
0.065
0.87
1.39
1.27a
35.9
9.97a
152.7
7.09
0.166 ±
60.85 ± 0.237 ±
1.45 ± 1.91 ±
6.39 ±
72.3 ±
50.35 ± 544.00 ± 36.20 ±
28
0.049
5.82
0.199
1.32
0.93
4.01
48.7
30.58
240.8
9.76
a: significantly different from 28 days; b: significantly differ
ent from 21 days; c: significantly different from 14 day;
d: significantly different from 10 days. Significance set at p? 0.05.

Ang
Dev
( o)
9.0 ±
2.4
6.7 ±
3.5
6.0 ±
1.0
6.8 ±
1.5
6.2 ±
3.3
6.2 ±
1.0

4.3.3 Collagen Content
Throughout neonatal development collagen content increased as expected (Table 4.3).
Specifically, the percent of collagen (per dry weight) in AT was significantly larger 28 days old
than at 4, 7, 10 and 14 days old. 21 days old AT also had significantly higher collagen content
than at 4, 7 and 10 days old AT. Lastly, 14 days old AT had significantly more collagen than at 4
and 7 days old AT.

4.3.4 Proteoglycan mRNA Expression
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The relative quantity of biglycan decreased with age (Figure 4.8). 4 days old AT had
significantly higher biglycan content than all ages. 10 days old had significantly higher biglycan
than at 21 and 28 days old AT and 14 days old AT had significantly higher biglycan than at 28
days old. No significant differences were seen in decorin content between any of the ages
studied.

4.3.5 Comparison of mRNA Expression to Protein Expression
Protein and mRNA expression are presented in Figure 4.9. No error bars are
represented for western blot analysis due to lack of experimental replicates (error bars for RTqPCR represent replicates of a single
Cross-sectional Area (mm2)

experimental sample) and each bar

0.250

represents only one pooled sample. As

0.200

shown, there is a small range of expression

0.150

across age for both decorin and biglycan in

0.100

both mRNA and protein expression in this

0.050

pilot experiment. Unfortunately, due to the
0

4

7
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14
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28

small range of expression values and lack of

Age (days)

experimental replicates, no conclusive result

Figure 4.5: Increase in cross-sectional area
throughout neonatal development; increases
occurred at 21 and 28 days old. -: p<0.05.

can be stated.

4.3.6 Fiber Organization
No differences were shown in angular deviation between any of the neonatal ages
studied. Qualitative observation of the hemotoxylin and eosin stained sections of the AT at each
age confirmed that the fibers are well aligned throughout development (Figure 4.10).

4.3.7 Fibril Diameter Parameters
Ultrastructural analyses demonstrated circular fibril profiles. Fibril diameters were initially
small and uniform as demonstrated in the 4 days old AT (Figure 4.11; Figure 4.12). As the mice
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developed, fibril diameters increased and the distribution of the diameters became spread out.
By 28 days old the fibril distribution was extremely spread out and no one range of fibrils
dominated the whole population. These changes are demonstrated quantitatively by examining
the average, and standard deviation (StDev) of the fibril diameters throughout development
(Table 4.4). All measured parameters demonstrated a significant increase with age during
development. Specifically, both the average and standard deviation of the fibril diameters were
significantly larger in 28 days old AT when compared to all other ages, 21 days old AT were
significantly larger than 4, 7 and 10 days old AT and were significantly larger in 14 days old AT
than in 4 and 7 days old.

Figure 4.6: Representative load vs displacement curves from the constant ramp to failure for
each neonatal developmental age.

4.4 Discussion
4.4.1 Interpretation of Results
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The goal of this study was to quantify compositional, structural and mechanical changes
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Figure 4.7: Linear stiffness and modulus significantly increased with age in a neonatal AT
(error bar represents st dev). – : p< 0.05
during neonatal development in a mouse Achilles tendon. The results demonstrated an increase
in mechanical strength throughout development. These changes were accompanied by
increased collagen content, decreased biglycan content, increased fibril diameter average and
standard deviation and no changes to decorin content or fiber angle. Known alterations in tendon
composition and structure during development include increased fibril diameter means, area
fraction and distributions, increased collagen content, temporally regulated proteoglycan
content[5, 7, 9, 10] and other minor constituents[3, 27], and increased mechanical strength[4, 12,
28]. Previous studies have focused on the chick, rabbit, rat and horse due to either accessibility of
embryonic tendons or the larger size of fetal and neonatal tendons. In addition to what is
currently known, the present study provides fundamental, quantitative knowledge of the
development of neonatal tendons. In addition, this new neonatal mouse AT model allows for
study of the mechanisms behind not only compositional and structural parameters but also
mechanical development during neonatal growth due to the availability of genetically modified
mice and commercially available assays for mice.
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Figure 4.8: Relative expression of biglycan and decorin relative to GAPDH. Biglycan
decreased significantly throughout development while no significant differences were seen
in decorin mRNA expression. 1-way ANOVA was performed on dCT values, while 2-∆Ct is
represented graphically. – : p< 0.05
It is widely hypothesized that mechanical strength is created through a combination of the
compositional and structural elements present in tendon. Despite the extensive work done to
understand these interactions, there is still little knowledge about how composition and structure
affect mechanical strength during development. One exception is a study examining the
mechanical strength of metatarsal tendons in chicks from post-fertilization day 14 through 2 days
post hatchling [12]. Chick and mouse tendon development have previously been compared
based on extensive work

Western Blot Results

RT-qPCR Results

done in fibrillogenesis[7].
Briefly, intermediate fibril
assembly occurs at postfertilization day 14 and in
neonatal mice at 4 days
old, fibril growth begins at
post-fertilization day 17
and in 10 days old
neonatal mice while rapid
lateral growth into maturity

Figure 4.9: Western blot and mRNA expression for 7, 14 and
28 days old pooled AT. Both sets of data were normalized to
7 days old for easy comparison.
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begins in hatchlings and sometime between 10 days and 1 month old in mice. Increased
mechanical strength was demonstrated throughout all stages of both chick (previously
demonstrated) and mouse development (current study). In the current study all structural
parameters increased with age, as expected considering the large increase in cross-sectional
area during neonatal development. Similarly, most material parameters increased with age in
both the chick and the mouse. However, in the current study, the transitional stress showed no
increase with neonatal age even though changes were seen in transitional load. It appears that
the quality of tissue initially present during neonatal development is sufficient for stresses
experienced within the toe region through out development.
Interestingly, transitional strain in the neonatal mouse decreased after 7 days of age and
remained low whereas no change was demonstrated in the chick. Previous studies have shown
that by post-fertilization day 17, almost no fibril intermediates could be identified in the chick
tendon[29], only mature fibrils. Full length fibrils would translate forces initially to uncrimp the
collagen (toe region) and then along the length of the fibrils (linear region). In the mouse,
intermediate fibrils are still forming until about 10 days of age. Therefore, the toe region in 4 and 7
days old mouse AT may not be an effect of collagen uncrimping alone but also collagen fibril
sliding and shearing. Further mechanical and histological studies need to be done to confirm this
hypothesis. In addition, it should be noted that significant differences in mechanical testing were
employed in each study. Most notably, strain was measure optically in the current study versus
grip to grip strain in the chick tendon study. Optical strain is a better measure of the local strains
experienced by the tissue; therefore, the grip to grip strains reported in the previous study may
have masked changes in transitional strain.
The AT was chosen for this study due to the relatively large size during neonatal
development and ease of accessibility. In addition, the AT is surgically accessible allowing for the
introduction of a developmental injury model in the future. While some of the parameters studied
were previously defined during development, it is imperative that these parameters were defined
in the proposed model due to differences in species [2, 14], between strains [30] and between
specific tendons[31]. For instance, extensive fibril diameter measures have been examined in
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mouse flexor tendons [31]. General trends observed in the current study are similar but the
mouse flexor tendon has a larger fibril diameter mean and spread at all comparable ages. In
addition, the expression of decorin has previously been shown to decrease during neonatal
development and remain at a moderate level[10] while in the current study a moderate level of
decorin was seen throughout development. Aside from differences between tendons, it has
recently been shown that structural and compositional differences are present in the same
tendon, at the same age in mice with different genetic backgrounds [30]. Therefore, not only is it
important to clearly define quantitative parameters in a new model, but also to take into account
the tendon, the species and strain studied when comparing and contrasting with previous studies.
Adult tendons heal through a reparative process [32, 33] and undergo a set of
coordinated responses that include inflammation, extracellular matrix production and remodeling
of the tissue [34]. Subsequent to fibroblast proliferation, increased extracellular matrix production
alters the composition of the tendon from its uninjured state. Specifically, collagen production
increases during healing [35, 36] which is similar to increases seen during development. In
addition, during healing, biglycan levels increase [37] and decorin levels remain unaltered or

4 days old

7 days old

10 days old

14 days old

21 days old

28 days old

Figure 4.10: Representative examples of H&E stained sections of the AT at 4, 7, 10,
14, 21, and 28 days old. Fibers were well aligned throughout development.
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decrease[37]. These changes are similar to tendon development but levels of biglycan remain
elevated in healing for an extended period of time, unlike development. Not only is composition
altered during healing but also structure. For instance, the fibril diameter size distribution is
narrowed and consists mainly of small diameter fibrils [38-40], similar to what is seen during the
early stages of neonatal development. However, this population does not mature into a
population of large fibrils with a wide spread. Instead fibrils remain fairly small and unimodel for
an extended time post-injury. In addition, the extracellular matrix that is produced is disorganized
during healing, altering the parallel alignment of the fibers[41]. The parallel alignment does return
to an organized state throughout remodeling; however, this is in stark contrast to development
where fibers are aligned throughout. The current study starts to define the similarities and
differences between development and healing.
Recently researchers have attempted to improve adult tendon healing through the
application of cytokines and growth factors. However, applying current knowledge of cytokines
and growth factors in a clinical setting presents many complications including appropriate dosage,
time of administration, synergistic effects with other cytokines, and length of exposure. Therefore,
new strategies for improved healing need to be investigated. A neonatal development model not
only provides compositional and structural changes similar to those seen during adult healing, but
also provides a model of increased mechanical strength and function. By comparing and

0
30

60

90

120

150

0

180

0

30

14 days old

25
20
15
10
5
0

0

30

60

90

120

150

Fibril Diameter (nm)

60

90

120

150

180

10 days old

25
20
15
10
5
0
0

30

Fibril Diameter (nm)
Frequency (%)

Frequency (%)

Fibril Diameter (nm)

180

21 days old

25
20
15
10
5
0
0

30

60

90

120

150

Fibril Diameter (nm)

60

90

120

150

180

Fibril Diameter (nm)
Frequency (%)

0

7 days old

25
20
15
10
5

Frequency (%)

4 days old

25
20
15
10
5

Frequency (%)

Frequency (%)

contrasting parameters of neonatal development and adult healing differential effects can be

180

28 days old

25
20
15
10
5
0
0

30

60

90

120

150

180

Fibril Diameter (nm)

Figure 4.11: Frequency of fibril diameters demonstrated increased fibril diameters and fibril
diameter distributions through out mouse AT neonatal development.
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ascertained. Parameters that show a differential effect during development can be implemented
in new tissue engineered constructs. For instance, adding an element to a construct that
decreases the amount of biglycan present may improve healing. A treatment that promotes the
lateral fusion of the collagen fibrils during healing may help reestablish mechanical strength in the
healing process; thereby improving the functional outcome of adult tendon healing.

4.4.2 Limitations
The current study is not without limitations. For instance, the increase in collagen content
observed during healing and development usually has a larger percentage of type III collagen
than is observed in normal mature tendon. A relationship between type III collagen and small
diameter fibrils has previously been reported in the literature[3]. Type III collagen is present
during early development but disappears from the mid-substance of the tendon when the fibril
diameters start to increase; however, these changes occur before the youngest age examined in
this study [42]. Therefore, it can be assumed that the contribution of type III collagen to the total
collagen content measured in this study is insignificant.
The relative expression of biglycan and decorin were measured through mRNA
Figure 4.12:
Representative
micrographs for
each age
throughout
neonatal
development.
Fibril diameters
were circular
throughout
neonatal
development
and an obvious
increase in fibril
diameter size
occurred
throughout
development.
expression in this study. It would have been advantageous to measure the
actual protein content of these proteoglycans during development. The ability to collect
quantitative measures from individual tendons is necessary for rigorous statistical regression
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models. Therefore, this goal was used when selecting compositional and structural parameters
to measure. Unfortunately, protein measures could not be obtained for individual tendons due to
the small size of neonatal AT and limited quantity of biglycan and decorin in an individual tendon.
Specifically, a commercial biglycan ELISA kit is not currently available. While an ELISA for
human biglycan was developed by collaborators in our laboratory, it was not sensitive enough to
detect the small amount of biglycan present in neonatal tendons. An alternate approach would
have been to detect biglycan and decorin through western blot analysis. However, western blot
analysis is even less sensitive than ELISAs. Previous studies that detected these proteins
through western blot have pooled 6-12 neonatal tendons to obtain enough protein. In the current
study, a pilot study was conducted with pooled comparisons of mRNA and protein. Unfortunately,
the results of this study were inconclusive. Despite this, previous work in mouse neonatal tendon
development showed some similarities between mRNA and protein expression in the FDL [10].
In addition, a study in rabbit ligament demonstrated similar expression between decorin protein
and mRNA expression after injury [43].Therefore, given the restraints of the study design, tissue
size and data from previous studies, the relative expression of mRNA is likely a reasonable
predictor of the actual protein present and supports its use in this study.
While it is currently
Table 4.4: Average and standard deviation of fibril diameters
Age (days)
Average (nm)
StD ev (nm)
abc
abc
4
41.3 ± 5.9
9.87 ± 0.17
7

ab

13.80 ± 1.90

ab

50.1 ± 3.9
54.3 ± 2.4

ab
15.43 ± 0.54

14

a
70.5 ± 14.3

a
22.15 ± 6.77

a

a

28

83.1 ± 14.0
107.9 ± 8.8

differences at the ages examined,

ab

10
21

unknown if there are sex

25.99 ± 6.42
36.26 ± 6.08

a: significantly different from 28 days; b: significantly different
from 21 days; c: signi ficantly different than 14 days

previous studies showed little to no
effect of sex on tendon mechanics
and composition in one month old
mice or rats[4, 28, 44]. It is
important to note that effects due

to sex were seen at older ages, after the onset of puberty in some studies. While there is still a
possibility of sex differences even in pre-pubescent mice, we were unable to demonstrate any in
the mechanical parameters in the current study. Compositional and structural parameters were
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not evaluated for sex differences due to the low number of total specimens per group; however,
based on previous studies it is assumed that there is no effect due to sex.

4.4.3 Summary
In summary, quantitative compositional, structural and mechanical changes during
neonatal development of the mouse AT were demonstrated. Through this mouse model, the
mechanisms governing the development of mechanical strength can be rigorously studied with
genetically modified mice and commercially available assays. In addition, by comparing and
contrasting development and healing new therapies for adult tendon healing can be ascertained.
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Chapter 5: Recapitulation of the Achilles tendon mechanical properties during neonatal
development: a study of differential healing during two stages of development in a mouse
model

5.1 Introduction
5.1.1 Significance
Tendon injuries are a common occurrence and of particular concern because of scar
formation. Scar is created when adult tendons undergo a reparative process [1, 2] after injury
that includes inflammation, extracellular matrix production and remodeling of the tissue. During
these processes, extracellular matrix components are quickly deposited by fibroblasts to fill the
defect and restore function. The composition and the structure of the scar tissue are
consequently altered from normal tendon resulting in inferior mechanical properties. While in
some cases scar returns some function to the tendon over time, the tendon rarely regains its
original functionality or mechanical properties [3, 4]. Two common problems from this scar
include adhesion formation between the tendon and tendon sheath preventing normal sliding and
reduced mechanical properties that can result in reruptures.
Clinical advances have been made in tendon repair over the last two decades through
improved surgical techniques and postoperative rehabilitative protocols [5, 6]. Even with these
improvements, scarring and reruptures still remain a frequent occurrence. Alternatively,
knowledge of the biological processes during tendon repair has also significantly advanced.
From this knowledge, attempts have been made to improve tendon healing through cytokine
application, gene therapy, cell based therapies, and tendon grafts. While some of these studies
have been successful in animal models, a significant improvement in clinical tendon healing is still
needed. Most of the previous studies used normal, adult healing as a model because a thorough
understanding of the natural processes during scar formation is valuable; however, it may be
difficult to discover novel treatments when using reparative adult healing as a model. Therefore,
new in vivo models of superior tendon healing need to be explored so novel strategies that
quickly return tendon to normal function post-injury can be developed.
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5.1.2 Regenerative Healing
Unlike adult reparative healing, fetal tissue is well known to heal through a regenerative
process [7]. While first demonstrated in skin, fetal scarless healing also occurs in tendon and is
characterized by faster wound healing, lack of an inflammatory response and an absence of scar
tissue[5, 8, 9]. The mechanism responsible for fetal healing is still unknown, but it is believed that
the regenerative response is a property of the tissue and not the environment [9]. Extensive
investigations have been done on fetal healing in the hope of being able to recapitulate scarless
healing in adults. However, while fetal healing presents great promise, there are many
parameters that are different between adult and fetal healing, for instance, the mechanical
environment during healing and inflammation [9]. These differences can not easily be
recapitulated in adult tendon healing; therefore, a new model system needs to be developed to
investigate improved healing parameters.

5.1.3 Tendon Development and Healing
Developing tendons undergo a well orchestrated process whereby extensive structural
and compositional changes occur in synchrony to produce a functional tissue [10, 11].
Interestingly, many of these changes parallel structural and compositional changes that occur
during the repair response to injury. For instance, collagen content and the average fibril
diameters increase throughout both development and healing. In addition, biglycan is present
during early stages of development and healing but is very sparse in mature tendon [12].
However, there are also differences in development and healing. While biglycan is elevated in
early development and healing, expression rapidly decreases as development progresses but
remains elevated for an extended period during healing [13, 14]. In addition, during development,
the diameters of the collagen fibrils begin to spread out and have a large distribution while during
healing the diameters remain fairly uniform. The most striking difference, despite the numerous
similarities, is that during development, a mechanically functional tendon is formed whereas
during healing, a tendon with inferior mechanics results; therefore, it has been postulated that
development could serve as a paradigm through which improved adult healing may occur [15].
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It has been hypothesized that healing parameters change from the fetal stage, through
development and into adulthood [11]. For example, neonatal developing tendons may heal
through scar formation but regain normal structure and function faster than during adult healing.
Therefore, a neonatal development model of tendon healing may be beneficial to improve adult
healing. Few studies have been able to test this hypothesis due to the small size and fragile
nature of developing tendons. One study, on the healing of subfailure ligament injury in immature
and mature rat, showed that a 21 day old rat regained 95% of its strength by 7 days post injury
whereas an 8 month old rat only regained 81% at 14 weeks [16]. Therefore, greater
understanding of healing at different stages of neonatal development can provide guidance in the
development of new therapeutic strategies to improve the outcome of adult tendon healing.

5.1.4 Objective and Hypotheses
The objective of this study is to develop and quantitatively characterize a model of
neonatal healing at two stages of development in the mouse Achilles tendon (AT). A surgical
model will be developed and utilized to injure AT in neonatal mice at 7 and 21 days old. Mice will
be sacrificed at two time points post injury and collagen content, biglycan and decorin mRNA
expression, collagen fibril parameters, collagen organization, cell shape, cell number and elastic
and viscoelastic mechanical properties will be quantified. It is hypothesized that maximum stress,
modulus and decorin levels will be significantly higher in early developmental injury when
compared to late developmental injury (injured tendon normalized by contralateral uninjured
tendon). Collagen content, fibril diameter spread and percent relaxation will be significantly
higher at late stages of healing in early developmental injury when compared to late
developmental injury (injured tendon normalized by contralateral uninjured tendon). Collagen
content, collagen organization and biglycan levels will significantly increase over time in late
developmental injury (injured tendon normalized by contralateral uninjured tendon). Lastly, when
normalized, maximum stress, modulus and percent relaxation will significantly increase over time
in early development injury but will remain low in late development injury.
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5.2 Methods
5.2.1 Animals
This study was approved by the University of Pennsylvania IACUC. Neonatal mice in a
C57BL/6 background were bred in house. All litters were weaned at birth to 6 pups to reduce
variance from litter size [17]. Mice were weaned at 21 days old and sexes were separated at this
time. Both males and females were used in this study. Care was taken to ensure that mice from
the same litter were not used in the same assay.

5.2.2 Surgical Model
In preparation for the surgical procedure, 288 neonatal mice at 7 and 21 days old (144
mice /age) were anesthetized with a mixture of isofluorane (5%) and oxygen (0.6%). For the 21
days old mice, one hindlimb, chosen randomly, was shaved. During the surgical procedure,
anesthesia was delivered via a nose cone with a reduced level of isofluorane (1-2.5%) and 0.6%
oxygen. The neonatal mice were placed ventral side down and the foot of the randomly chosen
limb was dorsal flexed. A skin incision was made lateral to the AT to ensure the AT was not
accidentally injured. A plastic coated blade was then placed underneath the AT tendon and the
end was gripped with hemostats for additional support (Figure 5.1) With the coated blade serving
as support, a 0.3mm diameter biopsy punch (Shoney Scientific, Waukesha, WI) was used to
create a central full thickness, partial width (~50%), excisional injury in the AT, approximately
2mm proximal from the calcaneous. While no suture repair was performed on the AT, the skin
wound was closed with a single suture. The contralateral AT remained uninjured to serve as an
internal control of developmental changes. Mice were allowed to resume normal cage activity
until euthanized at 3 or 10 days post injury. Mice were euthanized by CO2 inhalation and cervical
dislocation to confirm death.
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Figure 5.1: Unilateral injuries were performed on neonatal mice. A rubber backing was
used for support as the biopsy punch created a partial width, full thickness injury in the
Achilles tendon.
5.2.3 Mechanical Analysis
To determine the mechanical properties of the developing neonatal mouse AT, both the
injured and uninjured controlateral AT from each of forty-eight mice (12 mice/group) were
carefully dissected out under a dissection scope. The tendons were cleaned of excess tissue
leaving only the calcaneous. Tendon width and thickness were then quantified, and crosssectional area was measured using a custom built device consisting of LVDTs, a CCD laser, and
translation stages[18]. Each tendon was dumbbell stamped to 0.3mm width of the central portion
with a custom built device to remove the uninjured fibers on either side of the central injury
(Figure 5.2). The cross-sectional area was measured again for material property calculations.
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Stain lines were placed to measure strain optically, 1.5 mm apart for 7 days old AT sacrificed at 3
and 10 days post injury and 2 mm apart for 21 days old AT sacrificed at 3 and 10 days post
injury. Sandpaper was then glued to the calcaneous and myotendinous end of the AT, 3 mm
apart for 7 days old AT sacrificed at 3 and 10 days post injury and 4 mm apart for 21 days old AT

Figure 5.2: Dumbbell stamping device. The stamp is affixed to the upper fixture and the
tendon rests on the platform. Linear bearings maintained constant vertical translation of the
stamping device to ensure appropriate placement of the stamp in the neonatal tendon.
.
sacrificed at 3 and 10 days post injury (Figure 5.3). While gauge lengths varied with age due to
increased AT size, the ratio of grip to stain line gauge length remained constant. Due to the
fragile nature of neonatal mouse AT, custom fixtures were designed to ensure the AT was
unharmed during test preparation, as shown in Chapter 4. Custom designed grips were placed in
a grip-boat to eliminate unwanted motion of the grips while the tendon was being secured in the
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grips. Once the tendon was secured, a custom grip-holder was attached to both grips.
Importantly, this fixture ensured that the
tendons remain unloaded during handling
and mounting for mechanical testing
(Instron 5543, Instron Corp., Canton, MA).
Each AT underwent the following
protocol while immersed in a 37oC PBS
bath—preloaded to a nominal load,
preconditioned for 10 cycles (0.01N-0.02N
for AT injured at 7 days old, 0.02N-0.04N
for AT injured at 21 days old) at a rate of
0.1%/s, and held for 300s. Immediately
following, a stress relaxation experiment
Figure 5.3: Representative sample of a
developmental Achilles tendon prepared for
mechanical testing, with the ends glued between
sandpaper and the stain lines in the midsubstance.

was performed by elongating the tendon
to a strain of 5% at a rate of 5%/s,
followed by a relaxation for 600s. The

tendon was returned to pre-stress relaxation elongation for 60s and finally, a ramp to failure was
applied at a rate of 0.1%/s. Local tissue strain was measured optically as described
previously[19]. From these tests, percent relaxation, linear region modulus and maximum stress
were determined. All parameters were then normalized within an individual mouse by dividing the
value from the injured AT by the value from the uninjured AT. This normalization was performed
to isolate changes in healing from changes in development. A value less than one is indicative of
a decrease in the mechanical property, a value higher than one is an increase in the mechanical
property and a value of 1 indicates no difference between injured and uninjured.
5.2.4 Hydroxyproline Analysis
For analysis of total collagen content both the injured and uninjured contralateral AT from
48 mice (12/group) were cleanly dissected and the length of tendon corresponding, to the grip to
grip gauge length, was isolated. Wet weights were obtained and subsequently AT were dried at
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65°C for 24 hours. Dry weights were then obtained, followed by tissue digestion in 5mg/mL
proteinase K solution at 65°C for 18 hours. For hydrolysis, samples were sealed in glass vials
with 6N HCL and heated to 110C for 16 hours. Upon completion of hydrolysis, samples were
neutralized by evaporating off HCL in a lyophilizer with NaOH and then resuspended in water. oHydroxy-proline (OHP), a measure of collagen content, was determined colorimetrically by
reaction of the digest with p-benzaminoaldehyde and chloramine-T. OHP content was converted
to total collagen content, assuming hydroxyproline content is 14% of total collagen as previously
reported[20]. Collagen content was normalized to the dry weight of the individual samples.
Collagen content/dry weight was then normalized within an individual mouse by dividing the value
from the injured AT by the value from the uninjured AT.

5.2.5 Gene Expression
To determine the expression of the proteoglycans biglycan and decorin, both the injured
and uninjured AT from each of forty-eight mice (12 mice/group) were used. The AT was cleanly
dissected and the length of tendon corresponding to the grip to grip gauge length was isolated.
Individual AT were mechanically homogenized with a mortar and pestle in RNase-free conditions.
RNA was extracted using the TRIZOL isolation system (Invitrogen, Carlsbad, CA) and RNeasy
Mini Kit (Qiagene Inc., Valencia, CA) as described by the manufacturers. cDNA was produced by
reverse transcription-polymerase chain reaction (RT-PCR) from 100ng of total RNA using the
Superscript first-strand synthesis system for RT-PCR as described by the manufacturer
(Invitrogen). 1 µL aliquots of the cDNA were amplified by real time quantitative polymerase chain
reaction (Q-PCR) in a 25 µL reaction volume in a ABI Prism 7300 Sequence Detection System
(Perkin-Elmer; Applied Biosystems, Warrington, UK) with a SYBR Green PCR Master Mix
(Applied Biosystems). Mouse specific primers were used for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH; F - CTC GTC CCG TAG ACA AAA TGG; R - GTG ACC AGG CGC
CCA ATA), decorin (DEC; F – GCTGCGGAAATCCGACTTC; R – TTGCCGCCCAGTT
CTATGAC), biglycan (BIG; F – CCTTCCGCTGCGTTACTGA; R – GCAACCACTGCCTCTAC
TTCTTATAA). Each sample was assayed in triplicate. The relative quantity of mRNA for each
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gene of interest was computed using a six-fold dilution standard curve. Biglycan and decorin were
normalized by the GAPDH value within the same tendon. All parameters were then normalized
within an individual mouse by dividing the value from the injured AT by the value from the
uninjured AT. Statistics were performed on the relative quantity as is standard [21].

5.2.6 Histological Analysis
To determine the organization of the AT, both the injured and uninjured contralateral AT
from each of forty-eight mice (12 mice/group) were evaluated histologically. Briefly, the hind limb
was disarticulated, the skin dissected off, and processed with standard histological techniques.
During processing, the foot was secured at a 90 degree angle to the tibia [22]. 7 µm sagittal
sections were cut parallel to the tendon and stained with hematoxylin-eosin. Sections were then
graded for cellularity, cell shape, and collagen fiber organization. This analysis was
accomplished in a semiquantitative manner by assigning a rank (1-4) to each of the observations
Table 5.1: Grades and ke y for each non-pa remeteric parameter m easured by 3 blind ed graders
Grade Cell Sha pe
Cell Number
Fiber Organization
1
Spindle
Few cells, spre ad out
Well aligned, straight, parallel fibers
2
Most cells are spindle
Few cells, multiple in a line
Majority of area is organized
3
Most cells are rounded
Many cells, with matrix seperating
Disorganized, with areas of aligned fibers
4
Rounded
Many cells with little matrix between
Greatly disorganized, no clear aligneme nt

where 1 represents low cellularity, spindle cell shape and organized fibers and 4 represents high
cellularity, rounded cell shape and disorganized collagen fibers (Table 5.1). The experimental
tendons were evaluated based on a series of standards with defined ranks for each variable at
each level to facilitate comparison and reliable grade assignment. This series included of both
uninjured and injured AT. The histologic analysis was performed independently by 3 graders
masked to specimen group on representative sections from each tendon. For each variable
examined, the median of the measures from the 3 graders for each sample was determined.
The overall median and interquartile range for both the injured and uninjured AT within each
group were then determined. Histologic parameters were not normalized due to the nonparametric nature of the measurements obtained. Statistical analysis was also not performed on
these parameters due to a non-normal distribution and non-parametric nature of the
measurements.
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5.2.7 Transmission Electron Microscopy
AT samples from both legs of forty-eight mice (12 mice/group) were analyzed by
transmission electron microscopy as previously described [23]. Briefly, the AT was dissected out
with the calcaneous and muscle intact and fixed in 4% paraformaldehyde, 2.5% glutaraldehyde,
0.1 M sodium cacodylate, pH 7.4, with 8.0 mM CaCl2, post-fixed with 1% osmium tetroxide. They
were dehydrated in an ethanol series, followed by propylene oxide. The tissue samples were
infiltrated and embedded in a mixture of EMbed 812, nadic methyl anhydride, dodecenyl succinic
anhydride, and DMP-30 (Electron Microscopy
Sciences, Hatfield, PA). Thin sections (80 nm)
were cut using a Leica ultramicrotome and poststained with 2% aqueous uranyl acetate and 1%
phosphotungstic acid, pH 3.2. The AT were
examined at 80 kV using a JEOL 1400
transmission electron microscope equipped with
an Orius widefield side mount CCD camera.

5.2.8 Fibril Diameter Distribution
For each of the 4 groups, 12 injured and
12 uninjured contralateral AT were analyzed.
Figure 5.4: Schematic of the
predetermined grid for TEM sampling.

Micrographs from non-overlapping regions of the
central portion of the tendon were taken at

60,000x. The injury was visually located in the micrograph and micrographs were obtained from
predetermined locations (Figure 5.4). Specifically, the central line of the injury was identified
then, within the injury, the predetermined grid was used as a guideline for sampling locations.
This configuration ensured that sampling was taken in the region of interest and that possible
variability within the injury would not bias the data. Four unique micrographs were sampled for
uninjured AT, six unique micrographs were sampled for injured samples. Fibril diameters were
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measured using a RM Biometrics-Bioquant Image Analysis System (Nashville, TN). All fibrils
within a region of interest in each micrograph were measured; multiple regions of interest were
used if necessary to collect at least 80 fibril diameter measurements per micrograph. For each
group, the total number of regions of interest and minimum and maximum fibril measurements
per region are as follows [age at injury/days post injury/(I)njured or (U)ninjured/# ROI (min-max)]:
7/3/U/40 (82-200), 7/3/I/65 (45-238), 7/10/U/85 (44-96), 7/10/I/79 (46-204), 21/3/U/100 (29-74),
21/3/I/152 (23-129), 21/10/U/110 (28-60), 21/10/I/148(15-98). For each AT the average and
standard deviation were determined and analyzed statistically. The standard deviation is used
here to represent the spread of the fibril diameter sizes. All parameters were then normalized
within an individual mouse by dividing the value from the injured AT by the value from the
uninjured AT.

5.2.9 Statistical Analysis
Each quantitative parameter was measured and normalized within each mouse by the
contralateral AT (injured/uninjured) as described. The mean +/- the standard deviation was
reported unless otherwise stated. A two-way ANOVA with Fisher’s LSD hoc was performed
across age at injury and days post injury for each quantitative parameter measured. Additionally,
3 and 10 days post injury data were paired at both 7 and 21 days old through a bootstrapping
technique to compare changes across post injury time. For both AT injured at 7 and 21 days old,
multiple (between 9 and 13, depending on sample size) random pairings were made between the
3 and 10 days post injury time points for all parameters (i.e., cross-sectional area, maximum
stress, modulus, percent relaxation, collagen content, decorin and biglycan content, fibril diameter
average, fibril diameter coefficient of variation, fibril diameter median and fibril diameter
interquartile range). The standard deviations for the resulting normalized data (3 days post injury
was subtracted from 10 days post injury) were calculated. The pairing that produced the median
result was chosen for comparison to provide the best pairing. Paired, normalized data was
analyzed using a one-tailed t-test. For all statistical tests, significance was set at p ≤ 0.05 and a
trend at p ≤ 0.1.
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5.3 Results
5.3.1 Pilot Studies
5.3.1a Ex vivo surgery pilot
A pilot study was conducted in 8 days old neonatal Achilles mice to confirm that collagen
fibers were being consistently severed during injury. Figure 5.5 demonstrates the tendon before

Rubber
backing

Tendon

0.3mm
biopsy
punch

Pre-injury

Creating injury

Figure 5.5: A pilot study was conducted in 8
days old AT to ensure the tendon fibers were
being cut. The top panels clearly show the
mode of injury with a rubber backing placed
under the tendon and a 0.3mm biopsy punch
utilized to create the injury. The panel at
right clearly shows cut fibers when the AT is
viewed under polarized light.

Injury
Cut Fibers

AT under polarized light
and after a biopsy punch was used to create a full thickness, 50% width injury in the middle of the
Achilles tendon. A distinct injury can be seen post-injury. In addition, when viewed under
polarized light, cut fibers are distinct and can be clearly seen providing support for the injury
method.

5.3.1b “Normal” contralateral pilot
A pilot study was conducted to determine if the uninjured contralateral tendon was altered
due to potential compensation due to the injured tendon’s limb after injury. To conduct this study,
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eight 7 days old tendons underwent unilateral injury (as described above) while four 7 days old
mice underwent no injury to either tendon. All mice were sacrificed at 17 days of age (10 days
post injury). All uninjured tendons were then mechanically tested (as described above).
Mechanical parameters from uninjured contralateral tendons in injured mice were compared to
both AT in uninjured mice through a one-tailed t-test. No differences were seen between the two
groups in any of the mechanical parameters. Therefore, the uninjured contralateral tendon in this
model can be considered normal.

Myotendinous junction

5.3.1c Pilot to determine “ruptured”

Tendon

No Tendon

parameters
A pilot study was conducted to
ensure that if a neonatal AT ruptured after
injury, in vivo, it could be easily identifiable
as if this was not possible, it would be
difficult to consistently address our study

Calcaneous

goals. Three mice at 7 days old under

Figure 5.6: An example of a neonatal limb with
a normal AT injury (left) and a fully ruptured AT
(right). The rough, “sunken in” appearance of
the area where the AT should be is indicative of
a fully ruptured AT. (The black near the AT in the
photos is India ink used to help identify the AT).

went surgery. Achilles tendons were
randomly assigned to undergo normal
surgery (as described above) followed by
both struts ruptured, one strut ruptured or

no struts ruptured. Two AT were included in each group. Mice were sacrificed at 10 days post
injury. Differences between fully ruptured AT were clear and distinct (Figure 5.6). Therefore, AT
ruptured in vivo in experimental mice would also be easily identifiable.

5.3.1 Animals
Extensive body weight growth was observed in neonatal mice between the ages of 10 and 31
days old (Figure 5.7). The surgical procedure did not appear to have a negative effect on normal
neonatal growth as determined by normal body weight increases in experimental mice. Upon
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dissection, AT injured at 7
20
20

Data from Ch 4

days old and euthanized at 3

Data from Ch 5

days post injury had large

Body Weight (g)

15
15

areas of scared tendon with
translucent tissue and non-

10
10

uniform cross-sectional areas.
By 10 days post injury, the

5

healing area had remodeled

-4

0
0

and regained a uniform cross3

10

17

24

31

Age (days)

Figure 5.7: Comparison of body weights between normal
development and injury during development demonstrating no
detrimental effects of the surgical method on developmental
growth.
Figure 5.7: Comparison of body weights between normal

sectional area but still
maintained a translucent
appearance that was

distinctly different than that of the uninjured contralateral AT (Figure 5.8). AT injured at 21 days
old and sacrificed at 3 days post injury had the white glistening appearance of an uninjured
tendon except for a very small area directly around the injury. This area had a distinct injury still
present and sometimes contained small amounts of scar tissue. By 10 days post injury, the area
around the injury had become translucent and increased in size.

Figure 5.8: Representative samples of AT after gross dissection for each age and time
point post injury. One unit = 1 mm.
5.3.2 Mechanical Properties
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In AT that were injured at 7 days old, the normalized cross-sectional area was
significantly decreased at 10 days post injury when compared to 3 days post injury (Figure 5.9).
Alternatively, AT injured at 21 days old showed a trend towards increased normalized crosssectional area at 10 days post injury when compared to 3 days post injury. When comparing
across days post injury, specifically 3 days post injury, the normalized AT injured at 7 days were
significantly larger compared to those injured at 21 days post injury.
For viscoelasticity, the only difference observed is a trend towards increased normalized
percent relaxation inthe AT injured at 21 days at 3 days post injury when compared to those
injured at 7 days post injury (Figure 5.10). When comparing across age at injury, the normalized
maximum stress and modulus

Cross-sectional area (mm 2/mm 2)
10

were significantly greater in

*

7 days old
21 days old

*

AT injured at 21 days old

8

when compared to those
6

injured at 7 days old at 3 days
post injury. However, at 10

#

4

days post injury, the AT
2

injured at 21 days old were
significantly weaker than

0
3

10
3
Days Post Injury

10

Figure 5.9: The cross-sectional area was increased during
early development but decreased by 10 days post injury.
During late developmental injury, little change was observed
at 3 days injury and an increase in cross-sectional area was
seen at 10 days post injury. The horizontal line at 1 indicates
no change from normal development. Error bars represent
standard deviation.

those injured at 7 days old.
When comparing across days
post injury, in the AT injured at
7 days old, the normalized
maximum stress and modulus

were significantly increased at 10 days post injury when compared to 3 days post injury. A
significant decrease in normalized modulus was observed in AT injured at 21 days old between 3
and 10 days post injury and a trend toward decreased maximum stress was observed.
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Bootstrapping techniques were utilized to pair 3 and 10 days post injury time points to
determine differences between time post injury in 7 days old animals and 21 days old mice. Mice
injured at 7 days old had a larger difference, between 3 and 10 days post injury than those at 21
days old. For the mechanical parameters percent relaxation, maximum stress and modulus,
there was a significant difference between mice injured at 7 days old then at 21 days old when
examining the differences between 3 and 10 days post injury. Mice injured at 7 days old
demonstrated a change toward improved mechanical parameters while mice injured at 21 days
old demonstrated a change toward decreased mechanical parameters.
Maximum Stress (MPa/MPa)

Percent Relax (%/%)
1.2

3
Maximum Stress (MPa)

#

1.0
0.8
0.6
0.4

*

*
*

2

#
1

0.2
0

3

10
3
Days Post Injury

0

10

*

Modulus (MPa)

*

*
*

1.5

1

0.5

0

3

10
3
Days Post Injury

10
3
Days Post Injury

10

Figure 5.10: Differential responses
between early and late development
were observed in mechanical
parameters. Specifically, a return to
normal mechanics was observed in early
developmental injury (7 days old), not
mechanics are still decreased in late
developmental injury (21 days old). The
horizontal line at 1 indicates no change
from normal development. Error bars
represent standard deviation.
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5.3.3 Collagen Content
Collagen content, as measure by hydroxyproline content, showed no significant
differences across age at injury or time post injury (Figure 5.11).
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When examining the difference between 3 and 10 days post injury, in mice injured at 7
days old compared to those injured at 21 days old, there were no significant differences in
collagen content.

5.3.4 Proteoglycan Expression
Normalized biglycan and decorin contents were significantly increased in AT injured at 21
days old between 3 and 10 days post injury. When comparing across age at injury, at 10 days
post injury, there was a significant increase in normalized biglycan and decorin contents between
AT injured at 7 and 21 days old (Figure 5.12).
When examining the difference between 3 and 10 days post injury, mice injured at 21
days old had a significant increase in both
biglycan and decorin expression when

Collagen per dry weight ((ug/mg)/(ug/mg))
2

7 days old
21 days old

compared to those injured at 7 days old.

1.5

5.3.5 Histological Analysis
1

There was a marked increase in
disorganization, rounded cell shape and cell

0.5

number from 3 days to 10 days post injury in
0
3

10
3
Days Post Injury

AT injured at 21 days (Figure 5.11; Figure

10

5.12). No appreciable differences were

Figure 5.11: Collagen content showed no
significant changes across any group. The
horizontal line at 1 indicates no change from
normal development. Error bars represent
standard deviation.

observed at 3 days post injury or in AT
injured at 7 days old.

5.3.6 Fibril Diameter Parameters
Ultrastructural observations demonstrated circular fibril profiles in all groups (Figure
5.15). For uninjured AT, fibril diameters were initially small and uniform as demonstrated during
early development (Figure 5.16) and the distribution spread throughout growth to include larger
fibrils as expected. When examining the contralateral injured AT, a shift towards smaller fibrils
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was observed, particularly in fibrils approximately 40-60nm in diameter. This shift is most evident
in both ages at 10 days post injury, but prominent in AT injured at 7 days old. These changes
were demonstrated quantitatively by examining the average and standard deviation (Table 5.1).
Specifically, both parameters were significantly decreased at 10 days post injury when compared
to 3 days post injury in AT injured at 7 days old. In AT injured at 21 days old, fibril diameter
average was significantly decreased between 3 and 10 days post injury whereas the standard
deviation trended towards a decrease. When comparing across age at injury, the average
trended towards a decrease at 3 days post injury between AT injured at 7 and 21 days old.
Alternatively, both parameters were significantly increased at 10 days post injury in AT injured at
21 days old when compared to those at 7 days old.
When examining the difference between 3 and 10 days post injury, mice injured at 7 days
old had a significant decrease in both fibril diameter average and standard deviation when
compared to those injured at 21 days old.
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Figure 5.12: Proteoglycan mRNA expression. Increased expression was observed in late
developmental injury, particularly at 10 days post injury. The horizontal line at 1 indicates no
change from normal development. Error bars represent standard deviation.

5.4 Discussion
5.4.1. Interpretation of Results
The goal of this study was to characterize healing during two distinct stages of neonatal
tendon development in a mouse Achilles tendon (AT). Overall, it was demonstrated that AT
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injured at 7 days old had an accelerated healing response when compared to those injured at 21
days old.
When evaluating tendons that were injured during early development (7 days old), there
was an initial decrease (3 days post injury) in mechanical properties which was followed by a
quick return to function after only 10 days. This change in mechanics was accompanied by an
initial increase in cross-sectional area which decreased back to uninjured values during the same
period of time. This is counter to previous studies done in adult tendons that demonstrate little to
no improvement of the impaired mechanics post injury, particularly not during such a short time
post injury [24, 25]. It has previously been shown that during development, the mouse AT
showed an increase in mechanical properties, collagen content, and express biglycan and
decorin[26]. After normalizing for these developmental changes in the current study, no further
changes in any of these parameters were observed at 10 days post injury in early developmental
healing. Tendons during early development already have high cellularity, rounded cell shape and

Figure 5.13: Representative histological images from each experimental group at 20x
magnification. A marked increase in disorganization, rounded cell shape and cell number from
3 days to 10 days post injury in AT injured at 21 days can be seen.
are in the process of producing collagen and proteoglycans in an organized fashion, all of which
are common observations post injury. Therefore, it is possible that during early development, AT
simply continue these processes after injury until the tendon has regained its age appropriate
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mechanical properties. The only parameters that remained altered at 10 days post injury were
fibril diameter average and standard deviation, both of which were decreased. It is possible that
the AT recapitulated the mechanical properties quickly at this stage by increasing the number of
small diameter fibrils. All together, this data indicates that AT injured during early development
may follow an accelerated healing process.
Conversely, when examining AT injured late during development (21 days old) it was
initially observed (3 days post injury) that little to no change from uninjured tendons had
occurred, including cross-sectional area, mechanics, collagen content, collagen organization, fibril
diameter parameters, cellularity, or cell shape. However, when AT injured at 21 days old were
examined at 10 days post injury, they had an increased cross-sectional area, decreased
mechanical properties, increased proteoglycan expression, decreased collagen organization,
decreased fibril diameter size and spread, increased cellularity and an increase in rounded cell
shape. These parameters combined are indicative of a normal adult reparative healing response
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Figure 5.14: Median and interquartile range of histological parameters. AT injured at 21 days
old show marked increase in disorganization, rounded cell shape and cell number whereas
AT injured at 7 days do not. Inj = Injured; Un = Uninjured
where cellular proliferation and extracellular matrix production are delayed for the initial 3 days
post injury[27].
When examining across days post injury, it was observed that AT injured at 7 days old
were significantly larger at 3 days post injury than those injured at 21 days old. Mechanical
properties on the other hand were significantly decreased in 7 days old mice. While there were
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no differences between injured and uninjured AT histologically, AT injured at 7 days old showed
more disorganized collagen, increased cellularity and a more rounded cell shape than those
injured at 21 days old. No changes were seen in collagen content and proteoglycan expression.
Conversely, when examining healing at 10 days post injury, it was observed that no change in
cross-sectional area had occurred between injury at 7 and 21 days old and a decrease in the
mechanical properties of AT injured at 21 days old compared to 7 days old was seen. There was
a significant increase in proteoglycan expression and no change in collagen content, collagen
organization, cellularity or cell shape. While the AT injured at 7 days old were almost back to
normal uninjured values in all parameters measured, the AT injured at 21 days old were in the
middle of the remodeling process.
When examining changes across time post injury through bootstrapping techniques,
larger differences were shown between 3 and 10 days post injury in 7 days old mice than in 21
days old mice, not to mention there were beneficial changes in 7 days old mice. Alternatively,
changes in 21 days old AT showed detrimental effects and were characteristic of the early stages
of remodeling[27]. These results again demonstrate an accelerated healing process in AT injured
at 7 days old while injury at 21 days old is more indicative of a classic healing response.

Figure 5.15: Representative micrographs for each experimental group. Fibril diameters were
circular throughout developmental healing.
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In the current study, a return to normal tendon mechanics after only 10 days post injury
without treatment, in a neonatal mouse AT was demonstrated for the first time. Previous studies
have investigated changes in composition[28], gene expression[13], cell type[29, 30],
structure[31] and mechanical parameters [25] during healing in adult tendons to better
understand the healing process. It is important to understand the natural mechanisms governing
adult healing, because without this understanding, improvements upon normal adult healing
cannot be effectively implemented. However, injured adult tendons do not return to normal
mechanics and therefore, discovering new strategies to improve mechanical properties may be
difficult in an adult healing model.

Alternatively, during fetal healing, tendons heal scarlessly

which is beneficial but are drastically different than adult tendons making application of fetal
processes to an adult environment difficult [9]. Interestingly, in the current study, a fast return to
normal mechanics is present during early neonatal development that is not demonstrated in either
fetal or adult healing. Not only has the current study demonstrated accelerated healing in early
development, but it has also presented these findings in a mouse model. The availability of
genetically modified mice and commercially available assays makes the mouse an ideal model to
study the mechanisms that govern recapitulation of mechanical properties. A greater
understanding of these mechanisms will lead to new techniques to improve adult healing.
One possible mechanism for the return of mechanical parameters after only 10 days
during early neonatal development is that the early neonatal tendon is able to continue normal
developmental processes until the mechanical parameters return to normal. Prior to injury, cells
during early neonatal development are already rounded, in high numbers and producing
appropriate extracellular matrix. Therefore, this natural process may be the dominating
mechanism during early developmental healing that is not present during either fetal development
or maturity.
During normal tendon development, cell number decreases [32], extracellular matrix
production increases and cells become more spindle shaped. The cells are well aligned within
collagen fibers, and cellular processes extend out from the main cell body that are thought to
allow communication between cells. The increased number of cells during development
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Figure 5.16: Histogram of uninjured and injured AT during neonatal development. A shift towards
small diameter fibrils and decreased spread can be seen in AT injured at 10 days post injury in
both ages.
compared to mature tendon indicates this communication is probably vital to the development of
a normal tendon. While not examined in this study, it is hypothesized that strain experienced in
one cell could be sensed at the cell junctions and initiate signaling cascades in response to
mechanical stimuli. In the current study, similar cellular changes continue during early
developmental injury with only slight alterations. During early development, the cells are already
producing matrix, in an organized fashion, to increase mechanical parameters. Injury during this
period may cause a decrease in the stress and strain the cells experience locally, causing them
to produce more matrix until an appropriate mechanical environment is reestablished. However,
in late developmental injury, an increase in cellular number and a return to rounded cell shape
was observed. In this case, it appears the injury may have first initiated a cellular cascade of
factors from broken cellular junctions, which led to cellular proliferation and migration. Once
enough cells were present then extracellular matrix production was resumed. This response is
indicative of a normal adult healing response.
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One of the main differential responses between early and late developmental healing is
the fibril diameter parameters. Normally, fibrils are formed through fibrillogenesis which is a multistep process and each step is independently regulated during tendon development. Collagen
fibrils are initially assembled as immature fibril intermediates. This is followed by linear and
lateral growth of mature fibrils from the preformed intermediates, which initiates around 10 days
old in weight bearing tendons in mice [33, 34]. Proteoglycans have been implicated as important
regulators in this process. Structure function studies indicate complementary roles for decorin and
biglycan in tendons and demonstrate that these fibrillar changes lead to altered mechanics[35].
In the current study, little changes were seen in proteoglycan expression in early developmental
healing and a large, significant increase was seen in late developmental healing. Interestingly,
Table 5.1: Normalized fibril diameter parameters, average
and standard deviation.
Age at
Injury

Days post
Injury

Average
(nm/nm)

Standard
Deviation (nm/nm)

7
3
1.01 ±0.14ad
1.04 ±0.13a
7
10
0.52 ±0.13c
0.41 ±0.14c
a
21
3
0.91 ±0.09
0.97 ±0.12b
21
10
0.83 ±0.10
0.88 ±0.13
a: significantly different than 10 days post injury; b: trend
showing differences from 10 days post injury; c: significnatly
different than injury at 21 days old (at same time point post
injury); d: trend showing differences from injury at 21 days
old (at same time point post injury).

a shift to smaller diameter fibrils in
both early and late developmental
healing was observed, although it
is more pronounced during early
development when the mechanics
had been restored. It is possible
that early developmental injury is
simply accelerated (proteoglycan
expression has already decreased

and more small fibrils have already accumulated) than late injury (still see elevated proteoglycans
and small fibrils are only starting to accumulate). Alternatively, other mechanisms, not examined
in this study, could be affecting fibrillogenesis, mechanics, or their interaction, thereby explaining
the differential effect of small diameter fibrils being associated with both a decrease and increase
in mechanics.
Differences between early and late neonatal healing, in particular fibril diameter
parameters, could also be attributed to differences in collagen degradation and synthesis.
Collagen, in general, has a slow turnover rate but this is altered during injury when
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metalloproteinases are activated. It is unclear if MMP activation is beneficial or detrimental to the
healing process or to what extent. One possibility, in the current study, is that during early
healing, the fibroblasts may continue to produce new collagen and lay it down in an organized
fashion amongst the injured fibers. This could account for the increase in small diameter fibrils
present during early developmental healing; however, these fibrils could also be from MMP
degradation. On the other hand, late developmental healing may require more activation of
MMPs to clear the injured area prior to scar formation. Further studies need to be conducted to
examine the role of MMPs during neonatal healing and whether the presence of small fibrils is
due to de novo collagen synthesis or degraded collagen
Previous studies examining fibril diameter after injury have demonstrated a reduction in
fibril average diameter and spread that does not return to normal even after extended time post
injury [15, 36]. In a sheep model of posterior cruciate ligament auto graft reconstruction, even
after 2 years, there was no evidence of the reestablishment of large diameter fibrils. One
explanation for all these previous studies could simply be that adult fibroblasts are not able to
recapitulate neonatal fibrillogenesis. However, a recent study was able to demonstrate the
initiation of developmental fibrillogensis by adult human tendon fibroblasts when they were
cultured under tension [37]. It was demonstrated that mature tendon fibroblasts have the intrinsic
capacity to behave like cells in the developing tendon and suggests that the environment in
developing and mature tendon determines mechanisms of fibril synthesis, deposition and
alignment [38]. In the current study, a return to normal fibril parameters was not seen. Future
studies that examine longer time points post injury would be beneficial to see if fibril parameters
do indeed return to normal after early developmental injury or whether these are permanently
altered. These observations in conjunction with the current study are promising because they
indicate that if an early developmental neonatal environment is recreated in an adult injury, that
the healing process can be accelerated.
Proteoglycan expression has been associated with many processes including normal
tendon development and fibrosis. During normal adult healing, biglycan levels are elevated and
remain so[13] but decorin expression either does not change [14] or decreases [13]. Interestingly,
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in the current study, differential expression of biglycan and decorin during either early or late
developmental healing was not observed. It appears that during early development, the
proteoglycan expression does not change drastically from what is observed during normal
development. Therefore, it’s possible that despite the presence of an injury the tendon
progresses through normal developmental stages of extracellular matrix deposition. During late
development however, there is an increased expression of both decorin and biglycan. It has
been proposed that an elevated level of biglycan could be attributed to the small fibril diameters
and decreased mechanics post injury. Decorin expression has been associated with scar
formation and fibrosis [39, 40] but alternatively, there is also data suggesting that decorin
decreases scar formation [41]. A previous study that examined proteoglycan expression in adult
mouse patellar tendon showed an increase in only biglycan at 7 days post injury and not
decorin[26]. Therefore, even though the same accelerated healing in late development was not
seen, there are still mechanisms at play in late developmental healing that are different than
those in adult injury. It is possible that if a later time point post injury was investigated a full return
of mechanical parameters may have been demonstrated. Lastly, decorin and biglycan have been
hypothesized to have a role in sequestering and storing growth factors. An increased presence
of proteoglycans may therefore store more cytokines, making them less available to the
fibroblasts. However, current laboratory techniques make differentiating between stored and
active growth factors difficult to determine.
While the role of proteoglycans in fibrillogenesis is well defined, the direct role of
proteoglycans in tensile and viscoelastic mechanical properties is relatively unknown. It has been
hypothesized that proteoglycans have a structure-function role through interconnecting
neighboring fibrils [42-44], transferring forces between them [45, 46]. However, when comparing
two inbred strains of mice, C57Bl/6 mice had a higher chondroitin sulfate/dermatan sulfate
content but also had a lower elastic modulus, indicating that proteoglycans may negatively affect
tendon strength. In addition, two previous studies, one that examined tendons from a decorin
knock out mouse [35] and one that blocked decorin during ligament healing [47], both
demonstrated increased mechanical properties. These results are consistent with those found in
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the current study. On the other hand flexor digitorum longus biglycan knockout tendons had a
significantly lower modulus and maximum stress[35], contrary to results in this study. However,
the overall quantity of biglycan in tendons older than 7 days old is much less than that of decorin;
therefore, the effect of increased decorin may overshadow the effect of biglycan.

5.4.2 Limitation
Type I collagen is the major matrix component in tendon during development and
healing, but type III collagen is also abundant in both of these processes [13]. Since type III
collagen is a major component in scar it has been implicated in playing a role in reduced
mechanics. In the current study, differentiation between type I and type III collagen was not
conducted. It was initially hypothesized that overall collagen content would be increased in early
developmental healing over late developmental healing and would also increase with days post
injury in late developmental healing. However, no changes in collagen content were shown with
any comparison. Since there were no observed changes in overall collagen content it would be
interesting to determine if a differential expression in type I and III collagen occurs. In addition,
changes were not seen in collagen content, but there was a significant increase in cross-sectional
area in AT injured at 7 days old at 3 days post injury. It is however important to note that the area
of tendon analyzed for collagen content corresponded to the grip to grip mechanical testing
without the uninjured struts being removed. It is possible that the presence of this uninjured
tissue may have hidden changes in hydroxyproline content in the injured region. While collagen
was not significant across groups, there was an increase in proteoglycans content above normal
development in these groups. Proteoglycan are negatively charged and therefore thought to bind
water within tendon. Therefore, collagen content was normalized by the dry weight of the tissue
and changes in cross-sectional area were most likely due to the compositional changes
mentioned. Future studies in this injury model will investigate the differential and temporal
expression of types I and III collagen.
Data in the current study was presented as normalized data (injured/uninjured) to
account for changes during development and isolate healing changes. It is possible that the
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decrease in mechanics seen at 10 days post injury during late development could have been
caused by a natural increase in the mechanical properties in the uninjured contralateral tendons.
However, an examination of the raw uninjured data showed only slight changes between 3 and
10 days post injury that would not account for the decreases in mechanical parameters
demonstrated in the injured tendons. Therefore, the decrease in normalized mechanical
parameters demonstrated at 10 days post injury in late development is an actual phenomenon
and not a result of the normalization process. It is also important to note that all standard
deviations in the current study are from the normalized data. Through examination of the raw
mechanical data for uninjured and injured tendons, it was observed that there is larger variation
within the injured groups as would be expected. The standard deviation of the normalized
parameters was subjectively similar to those seen in the injured parameters and therefore, the
standard deviation was most likely not artificially reduced when data was normalized.
In the current study, no analysis of the integration of de novo tendon was conducted. It is
possible that differences in mechanical parameters between early and late developmental healing
were due to the ability of the early developmental tendons to integrate newly produced matrix with
preexisting extracellular matrix. If this were true, the incidence of failure at the wound boundary
in late developmental tendons would be higher; however, failure locations were evenly distributed
across groups and included mainly midsubstance and stain line failure locations with fewer grip
failures.
Previous in vivo studies have provided evidence that the inflammatory response to injury
is altered with age. Most notably, during scarless fetal healing these is a lack of inflammatory
response that many have hypothesized could explain scarless healing [7, 48]. In neonates, the
immune system is not fully mature which leads to differences in the cell subsets in the immune
response between neonatal and adult [49]. This environment may provide an innocuous
environment for the growth and development of neonates. Therefore, one possible explanation
for the results in this study could be due to differences in immune response and inflammation. In
fact, previous work has shown that although healing follows the same trajectory, wounds in
neonates heal faster than those of adults. Fibroblasts are present in greater numbers, collagen
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and elastin are more rapidly produced, and granulation tissue forms more quickly compared to
adults [50]. Future work in this model will include an investigation into the influx of inflammatory
cells and the expression of pro-inflammatory and anti-inflammatory cytokines. This will provide
further insight into the mechanisms behind the accelerated healing observed in early
development.
Another important aspect of healing is nutrient supply or vascularity. Tendons are
hypothesized to have poor healing parameters due to a lack of vascularity. Therefore, increased
vascularity during early developmental healing could have contributed to improved healing. While
histological slides are available to examine vascularity, AT were sectioned through the sagittal
plain which made identification of vasculature difficult and inconsistent across slides. Future
studies could also examine transverse sections for easy identification of vascularture during early
and late developmental healing.
Tendon healing has been studied in many animal models, of which overuse and acute
injuries are the most common. Acute models create a complete or partial transection in the
tendon. While complete transections are more clinically relevant, the need for suture repair
complicates the healing environment. Specifically, when several external factors of surgery were
studied, suture alone reduced viability, extended the zone of regeneration and had the most
adverse effect on tendon [51]. In addition, reruptures from suture pull out are common. Partial
transections in the middle or along the side of the tendon circumvent the need for repair by
leaving intact marginal fibers[52]. The injury used in this study is a central, full thickness, partial
width injury that leaves the lateral struts intact. This is of particular importance in neonatal mice
since the small size and fragile nature of the tendon would likely not hold a suture. A 50% width
injury was used because previous work in a similar injury model in the adult mouse patellar
tendon showed only 8% rupture rate in 50% width injuries and a 50% in vivo rupture rate in large
injuries. In addition, the partial width full thickness injury ensures that differences observed in the
model are due to differences in innate healing of the tendon and not inflammation from the suture.
Despite the advantages in this injury model, there are some disadvantages. Most
notably, the uninjured lateral struts on either side of the injury could stress shield the injured
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tissue in the middle. If tensile stress is experienced uniformly across the tendon, the injured area
will be stress protected. Thus, in vivo stress levels experienced by the injured part of the tendon
could be substantially less than the uninjured portion. This could explain the inability of the
collagen fibrils to regain normal average diameter and spread. However, the inability of fibrils to
regain a large distribution and bimodality [25] is well documented in numerous injury models and
therefore it is unlikely that stress shielding was the main factor in the current study. In addition,
the full thickness, partial width injury necessitated the removal of the uninjured struts on either
side of the injury prior to mechanical testing to ensure only healing tendon was mechanically
tested. While this procedure ensured the mechanical parameters measured were only healing
tissue, it did not allow the measurement of structural mechanical parameters, only material.
In the current study, comparisons were subjectively made to adult tendon healing but no
adult tendons were included in the study design. The objective of the current study was to
examine healing during development and already required 288 mice. The addition of a third age,
which was not part of the study hypotheses, would have added an additional 144 mice to the
experimental design, substantially increasing the size of the experiment and associated costs.
Previous studies have already examined most of the parameters examined in this study in adult
healing, and a current study in our laboratory is currently examining injury in adult mouse AT.
Therefore, based on previous knowledge available, adult mice were not included in the current
study.
Each litter in the current study was initially weaned to 6 pups and care was taken that no
more than one pup from each litter was placed in the same experimental group. By designing the
study in this fashion, a single litter could be considered a specimen where each assay was
represented by one pup in that litter [17]. The main advantage to this approach is that it allows
analysis by multiple regression and decreases variance within a specimen since pups in the
same litter will tend to be more similar than those in different litters (Harlan Sprague Dawley, Inc.;
Indianapolis, Indiana). However, it is possible that differences amongst pups within a litter are
large enough to mask correlations between structure, composition and biomechanics. Despite
this, there is confidence that the changes in development will not be masked by a litter effect. In
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addition, both male and female mice were used in this study. While there is little information on
sex differences at the ages studied, work presented in Chapter 4 and a previous study[53]
demonstrate that there are no sex differences in mechanics, composition and structure at the
ages examined.
In this study changes in collagen organization were demonstrated through three blinded
graders instead of measuring angular deviation through polarized light microscopy. Polarized
light microscopy was attempted in these experimental mice; however, within the wound site of the
AT injured at 7 days old, there was not enough mature collagen for birefringence. Evaluation at
longer time points post injury can be used in future studies to determine quantitative differences
in collagen organization.
When obtaining fibril diameter parameters, spatial variability is always a concern and
therefore sampling presents inherent problems. This is the precise reason why in this study each
AT was sampled not only in the midsubstance of the injury but also along the width. The
sampling pattern utilized in this study was chosen to ensure an objective measure of the fibril
diameters within the wound area of the AT.

5.4.3. Summary
In summary, two different models of healing during neonatal development, early and late,
in a mouse model were characterized. Overall, it was demonstrated that AT injured at 7 days old
(early) had an accelerated healing response when compared to those injured at 21 days old
(late). In particular, during early development, a significant decrease in mechanical parameters
was observed at 3 days post injury along with increased cross-sectional area, no change in
proteoglycans or collagen content or cell shape, number or fiber organization. By 10 days post
injury, the mechanical properties has returned to almost normal levels and the only parameter
that demonstrated a difference from normal were fibril diameter parameters which have become
smaller with a decreased spread. On the other hand, in AT injured at 21 days old (late), little to
no changes were seen at 3 days post injury including mechanical parameters, cross-sectional
area, collagen content, fibril diameter average and cell shape, number and fiber organization. At
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10 days post injury however, a reduction in mechanical properties was observed along with a
significant increase in cross-sectional area, proteoglycans expression, fibril diameter average, cell
number and an increase in rounded cells and disorganized collagen fibers. All together these
observations indicate that healing during development either has unique mechanisms or has an
accelerated healing process. Either way, early developmental healing provides a model system
where mechanical properties were quickly recapitulated and can therefore be used to investigate
new methods for improved adult healing.
Another important aspect of this study is the use of a mouse model. The mouse model
has historically presented logistical complications due to the small size and fragile nature of the
neonatal mouse tendons; however, this study utilizes consistent, reproducible methods to study
neonatal healing in a mouse. A mouse model can be used further to investigate the differential
mechanisms in these processes through genetically modified mice and commercially available
assays.
Lastly, the model presented here was specifically developed to obtain quantitative
measures when possible. Quantitative measures can then be input into rigorous statistical
models to objectively determine which structural and compositional parameters have a significant
effect on the mechanical parameters. This information can then be used to develop new
treatments and strategies for improved adult tendon healing.
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Chapter 6: Investigating structure-function relationships in neonatal Achilles tendon
development and healing in a mouse model using multiple regression models.

6.1 Introduction
6.1.1 Significance
Tendon injuries are a common problem due to their inability to regenerate and the
prolonged presence of scar tissue. While there have been significant advances in surgical
techniques and post operative protocols [1, 2], there is also the potential for biological advances.
Current strategies for identifying areas for improved tendon healing include using scarless fetal
healing as a paradigm and gaining in depth knowledge of the reparative healing process during
adult healing [3, 4]. During fetal healing, tendons are capable of returning to histologically
uninjured states; however, many differences exist between fetal and adult healing, mechanical
load environment and inflammation, which can not be easily altered in the adult injury [4].
Gaining insight into adult healing is important to understand the mechanisms at play during the
reparative process; however, studying adult healing only shows what is presently occurring, not
what needs to occur for improved tendon healing. Chapter 5 in this dissertation characterized
healing during two stages of neonatal development. Interestingly, a return to mechanical
properties only 10 days post injury was observed during early neonatal development. Therefore,
healing during early neonatal development is a new model system through which to study
improved healing in adult tendons and the recapitulation of mechanical properties.

6.1.2 Correlating compositional and structural parameters to mechanics
Tendons are complex tissues whose mechanical behavior depends on their structural
organization and biochemical composition, as well as on their location and function within the
body. It has long been hypothesized that the structure and composition of tendons are a result of
the specific function tendons perform [5]. Tendon is composed mainly of type I collagen which
organizes into aligned fibrils and fibers. It is believed that these aligned fibers bear the main
tensile loads that tendons experience in vivo. Proteoglycans are also present in tendon and,
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while they are a minor constituent, it has been hypothesized that they also play a significant role
in mechanics [6, 7]. Specifically, it is has been documented that proteoglycans play a role in
resisting compression [8] but it has also been hypothesized that they bridge the gap between
neighboring fibers, providing shear resistance within the tendon. Based on these facts and
assumptions, previous studies have used numerous methods to measure compositional and
structural parameters and correlate them to mechanical behavior.
Previous studies have provided insight into the complex interplay of a tendon’s
constituents, which is critical to formalizing structure-function relationships [9-12]. For example,
collagen fibril cross-sectional area fraction explained more than half of the changes in mechanical
properties of mature to aged tendons through linear regression [10]. Interestingly, the addition of
data from younger tendons to this study improved the regression model, thereby supporting the
need for further structure-function analyses of younger, developing tendons. In addition,
chondroitin sulfate and dermatan sulfate, main components of proteoglycans, were significant
predictors of mechanical parameters in a mouse model [11]. While these studies have made
significant contributions to understanding the structure-function relationships in tendon, there are
still areas that should be further investigated. For example, one previous study found significant
correlations between compositional and structural parameters with mechanics, however, the
models only accounted for approximately 50-70% of the variance[11]. Studies using new
experimental techniques or different independent parameters may better predict mechanical
parameters.
While many studies have demonstrated that fibril diameter size is correlated with tendon
mechanics in normal tendons, similar relationships have not been shown in healing tendons. A
study in the healing MCL of rabbits demonstrated that while the injured ligament increased in
mechanical strength to 2/3 the control tendon at 40 weeks, the mean fibril diameter remained
smaller than controls and did not increase over the same time period [13]. An extended study in
the same model showed that the mean fibril diameter did not change up to 104 weeks post injury;
however, it was noted that there was an increased proportion of very small fibrils along with large
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fibrils, creating an increased spread in fibril diameter size [14]. This finding indicates that fibril
diameter spread may be as important as the average to correlate with mechanics.

6.1.3 Multiple regression models
Regression models provide a statistical relationship between a dependent (response)
variable and an independent (predictor) variable. Such a model describes the tendency of the
dependent variable to vary with the independent variable. A multiple regression model allows
evaluation of the relationship between a dependent variable and several independent variables
simultaneously. By regressing independent compositional and structural parameters against
dependent mechanical parameters, the level of contribution of each of the compositional and
structural parameters on mechanical properties can be determined while simultaneously
incorporating the effect of the presence of all the independent parameters. This data will aid in
determining the importance of each of the independent compositional and structural parameters
in the development and recapitulation of mechanical properties in tendon. Therefore, the
objective of this study is to use rigorous statistical models to objectively and quantitatively
compare and contrast not only early and late healing with each other but also with normal
development to determine which parameters are beneficial or detrimental to the development of
mechanical properties. This will be conducted by regressing the independent parameters
collagen, biglycan and decorin content and fibril diameter average and standard deviation against
the dependent mechanical parameters percent relaxation, stress and modulus. It was first
hypothesized that that collagen content would be a significant predictor in all groups. Second, it
was hypothesized that fibril diameter spread will be a significant predictor for maximum stress
and modulus in late development and late stages of healing; however, it will be a stronger
predictor in injury during early development than in injury during late development. Lastly, it was
hypothesized that biglycan and decorin will both be significant predictors of maximum stress and
modulus; however biglycan will predict decreased mechanics and decorin will predict increased
mechanics.
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6.2 Methods and Materials
6.2.1 Data collection
Data collected in Chapter 5 of this dissertation will be used in the regression analysis
presented here. An a priori power analysis to determine the sample size for multiple regression
analysis was calculated based on 5 predictors (total collagen content, fibril diameter mean and
standard deviation, biglycan and decorin content), an alpha set at 0.05, an anticipated R-squared
of 0.8 and a desired statistical power of 0.8. Therefore, calculating the sample size for multiple
regression based on these expectations[15] an n of eleven is needed for each group in this study.
Multiple regression analysis assumes that each dependent variable and the independent
variables are obtained from a single specimen. Therefore, in this study, five distinct and
reproducible injuries are needed, one for each of the following assays: biomechanics (maximum
stress, modulus, and percent relaxation), histology (angular deviation), transmission electron
microscopy (fibril diameter size distribution), biochemistry (total collagen content) and QPCR
(biglycan and decorin mRNA expression). For this study design, it was assumed that a litter of
pups was a single specimen [16]. All litters were weaned to 6 pups to account for experimental
error. Not only does this approach allow analysis by multiple regression, but it also decreases
variance within a specimen since pups in the same litter will tend to be more similar than those in
different litters (Harlan Sprague Dawley, Inc.; Indianapolis, Indiana).
The experimental methods used for this study have been discussed in detail in Chapter
5. Briefly, neonatal mice were unilaterally injured at both 7 and 21 days old and allowed to heal
for 3 or 10 days post injury. Chapter 5 details the methods used to quantify collagen content
through hydroxyproline analysis, biglycan and decorin through mRNA analysis, fibril diameter
mean and standard deviation through TEM analysis and mechanical parameters percent
relaxation, stress and modulus through uniaxial mechanical testing. These measurements were
taken for both the injured and contralateral uninjured Achilles tendon for each mouse. In the
cases where missing values were observed in a specimen, imputation was conducted using the
regression method[17]. Lastly, the data was examined for outliers and each group was found to
have one specimen as an outlier; therefore, each group had a total of 11 specimen.
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6.2.2 Statistical Models
When dealing with large data sets, several experimental groups, multiple variables, and
interactions, it is important to obtain a thorough understanding of how all these parameters relate
to and interact with each other. There are numerous statistical methods that can be employed to
answer specific questions about the interactions and relationships within the data. Pearsons
correlations are an effective statistical test to determine if dependent parameters are linearly
correlated. This is important because one of the underlying assumptions of statistical analyses in
general, is that independent parameters are linearly independent of each other. When dealing
with biologic parameters it is often impossible to obtain independent parameters with no
collinearlity; however, it is still important to understand this correlation when analyzing the data.
A general linear model (GLM) can estimate and test any univariate or multivariate model,
including those for analysis of variance and multiple regression. A GLM is useful because it can
also handle continuous and categorical parameters and complex model designs. A GLM can be
used to determine what significant relationships exist between independent parameters and
experimental groups with the dependent parameters through an analysis of variance. If there are
significant relationships, further analysis can be conducted.
Regression models provide a statistical relationship between a response (dependent)
variable and a predictor (independent) variable. In a study with multiple groups and several
independent variables, multiple different regression models could be analyzed. It is important to
use information obtained from analysis of the entire data set, along with scientific knowledge of
the experimental design and hypotheses, to determine the most appropriate final regression
models. Initially in this study, a multiple linear regression was used to create a model of the
entire data set. However, when the number of independent variables in the regression model is
large, the potential number of interaction terms becomes very large. It is therefore appropriate to
identify, in advance, which independent parameters are more likely to predict the dependent
variables [18]. Upon obtaining which main effects and interactions should be included, the overall
model can be examined. While it is important to understand how the experimental groups affect
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the dependent parameters, the presence of many highly intercorrelated variables may
substantially increase the sampling variation of the regression coefficients, detract from the
model’s descriptive abilities, and not improve, or even worsen the model’s predictive ability [19].
Therefore, these effects, along with the stated hypotheses, need to be taken into account when
formulating the final regression equations.
By analyzing a data set through multiple statistical methods, a clear understanding of the
relationships and interactions between the variables is obtained. In addition, starting a regression
analysis with the entire data set and systematically delineating it into appropriate groups clarifies
the relationships that are present within the data. Below is a detailed summary of the statistical
analyses conducted in this study.

6.2.3 General Linear Model
Summary statistics of all variables were examined and described by mean, median,
standard deviation, minimum and maximum to ensure that assumptions necessary for linear
analysis were met.

A GLM was run to determine if the dependant variables (percent relaxation,

stress and modulus) were significantly related to the independent parameters: continuous
(collagen content (Col), biglycan (Big) and decorin (Dec) content, fibril diameter average (Ave)
and standard deviation (StDev)) and categorical parameters and interactions (age at injury (Age),
days post injury (Days), injured or uninjured (Injury)). For all specimens, the percent relaxation,
stress and modulus was calculated for the injured and uninjured tendon. This resulted in a total of
96 y-values inputted in the GLM for Equation 6.1, where Y1-Y3 were percent relaxation, stress
and modulus respectively.
Equation 6.1:

E{Yi } = β 0 + β 1Col + β 2 Big + β 3 Dec + β 4 Ave + β 5 StDev + β 6 Age + β 7 Days
+ β 8 Injury + β 9 ( Age * Days) + β 10 ( Age * Injury ) + β 11 ( Days * Injury )
+ β 12 ( Age * Days * Injury )
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Upon determining that there are significant effects from the continuous and categorical
parameters on the mechanical properties, an analysis of how the dependent parameters vary with
the independent parameters can be conducted.
6.2.5 Model Refinement
To identify important interactions, the mechanical parameters were regressed against the
continuous and categorical independent parameters, along with the interactions between the
categorical parameters (Equation 6.2). In a regression model, the slope and intercept of the
equation are influenced by the independent parameters by adding interaction terms. For
instance, by including the interaction term age at injury*days post injury (Age*Days) the effect of
days post injury may present different responses in mice injured at 7 days verses those injured at
21. Information obtained in Chapter 5, namely significant difference between groups, provides
support for including these interaction terms in this first regression model.
A backward stepwise regression was used to find the independent parameters that “best”
predicted the dependent parameters. For this method, a simple linear regression model is first fit
for each of the potential independent variables. For each simple linear regression model, a pvalue of 0.1 was used to determine whether or not an independent variable was removed from
the regression equation. A p value of 0.10 was used for this model due to the larger number of
independent variables being regressed against the dependent variables. The X variable with the
largest p-value (p*) is identified and compared to a predetermined value of p to enter. If p* is less
than p then the variable is added to the regression model, and the analysis is repeated for the
additional independent variables. If p* exceeds the p to enter, the stepwise analysis terminates.
After each independent variable is added, the analysis is repeated for all variables with revised
model. p* is calculated for the previously included variables, and compared to a predetermined
value of p to leave. If p* falls above this predetermined value of p, the variable is removed from
the model. The tolerance level was set at 0.01. This regression model was used to determine if
some of the main effects or interactions could be excluded from the regression equation for the
entire model. The reasoning for this is that the equation for the entire model will have very low
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power due to the number of interaction terms. By determining which main effects and
interactions are not significant in this model, the overall model can exclude these effects, thereby
increasing power.
Equation 6.2:

E{Yi } = β 0 + β 1Col + β 2 Big + β 3 Dec + β 4 Ave + β 5 StDev + β 6 Age + β 7 Days
+ β 8 Injury + β 9 ( Age * Days) + β 10 ( Age * Injury ) + β 11 ( Days * Injury )
+ β 12 ( Age * Days * Injury )
Upon determining which main categorical effects and interactions were significant, a
regression analysis for the entire model was performed including only those categorical
parameters. Similar steps were taken as described above. Due to the number of independent
terms in the model, which decreases the power, the p value was set to 0.1 and the tolerance level
was reduced to 0.001. Backwards stepwise linear regression was performed on Equation 6.3.
This analysis gives an overall understanding of how the mechanical parameters vary within the
frame work of the entire study. If there are significant effects of the categorical parameters, then
the data can be broken down into experimental groups for further analysis by multiple
regression[20].

6.2.6 Final Multiple Regression Models
After running the entire model, many significant predictors were found including main categorical
effects and categorical interactions. Since the hypotheses of this study are to analyze how the
mechanical parameters vary with the structural and compositional parameters within each
experimental group, and due to the high number of categorical interaction terms, the data will be
split into experimental groups. Therefore, the final multiple linear regression models will quantify
the relationship between the dependent variables (percent relaxation, stress and modulus) and
the continuous independent variables (collagen content, fibril diameter mean and standard
deviation, biglycan and decorin content) (Equation 6.4) within each experimental group [19]. The
data was delineated into 8 categories based on age at injury (7 and 21 days old), days post injury
(3 and10 days post injury) and injured or uninjured (I, U). This resulted in a total of 11 y-values
139

Equation 6.3:

E{Yi } = β 0 + β 1Col + β 2 Big + β 3 Dec + β 4 Ave + β 5 StDev + β 6 Age + β 7 Injury
+ β 8 ( Age * Days) + β 9 ( Days * Injury ) + β 10 ( Age * Days * Injury ) + β 11 (Col * Age)
+ β 12 ( Big * Age) + β 13 ( Dec * Age) + β 14 ( Ave * Age) + β 15 (StDev * Age)
+ β 16 (Col * Injury ) + β 17 ( Big * Injury ) + β 18 ( Dec * Injury ) + β 19 ( Ave * Injury )
+ β 20 ( StDev * Injury ) + β 21 (Col * Age * Days ) + β 22 ( Big * Age * Days)
+ β 23 ( Dec * Age * Days ) + β 24 ( Ave * Age * Days ) + β 25 (StDev * Age * Days )
+ β 26 (Col * Injury * Days ) + β 27 ( Big * Injury * Days) + β 28 ( Dec * Injury * Days )
+ β 29 ( Ave * Injury * Days ) + β 30 ( StDev * Injury * Days )
+ β 31 (Col * Age * Days * Injury ) + β 32 ( Big * Age * Days * Injury )
+ β 33 ( Dec * Age * Days * Injury ) + β 34 ( Ave * Age * Days * Injury )
+ β 35 ( StDev * Age * Days * Injury )

inputted in the linear regression for equations 6.4, where Y1-Y3 were percent relaxation, stress
and modulus respectively. In this method, a simple linear regression model is first fit for each of
the potential independent variables. For each simple linear regression model, that partial F
statistic (F*) is calculated to determine whether or not the slope is zero. The X variable with the
largest F* is identified and compared to a predetermined value of F to enter. If F* exceeds F then
the variable is added to the regression model, and the analysis is repeated for the additional
independent variables. If F* does not exceed the F to enter, the stepwise analysis terminates.
After each independent variable is added, the analysis is repeated for all variables with revised
model. F* is calculated for the previously included variables, and compared to a predetermined
value of F to leave. If F* falls below this predetermined value of F, the variable is removed from
the model. The tolerance level was set at 0.01. The F to enter was set at 3.3 and F to be removed
was set at 3.2. The criteria for choosing the appropriate range of F to enter and F to remove is
based on the degrees of freedom in the model. For this model, this range for F corresponds to a
2

significance level of 0.1 for a single test. Tolerance is defined as 1-R

k

is the coefficient of

multiple determination the X is regressed over the other included x variables in the model. A
k

tolerance of 0.01 would mean that a variable is excluded if its coefficient of multiple determination
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when it is regressed over the other x-variables exceeds 0.99. Typical values for tolerance level
range between 0.01 and 0.001. This is one measure to prevent entry of variables that are highly
correlated with other x-variables included in the model. Significance was again set at p < 0.1, this
time due to the small sample size (n=11) per regression model and variances within the data.
Equations 6.4

Yi = β 0 + β 1Col + β 2 Big + β 3 Dec + β 4 Ave + β 5 StDev

Durbin Watson (DW) statistic was calculated to identify the existence of correlations
between independent variables. For each equation 6.4 (n=11/group), based on established
guidelines for interpretation of DW statistic , a DW value lower than 1.08 indicated correlation
between the independent variables[21].

6.3 Results
6.3.1 Correlations between the independent parameters
The Pearson correlation coefficients (r) showed some relationships between the
independent variables. Correlations were determined between independent variables within each
group. Correlations were considered strong for r<0.7, moderate for 0.5<r<0.7 and weak for r<0.5
[22]. In the 8 experimental groups examined fibril diameter average was correlated to fibril
diameter standard deviation moderately in 2 groups and strongly in 3 groups. Similarly, decorin
and biglycan were moderately correlated in 3 groups and strongly correlated in 3 groups. Finally,
collagen content and fibril diameter average were moderately correlated in 3 groups (see
Appendix 6.1 for all Pearson correlations).

6.3.2 General Linear Model
A general linear model was conducted on the data for this study to determine how the
dependant variables were related to all the independent variables including the continuous
structural and compositional parameters and the categorical parameters (age at injury, days post
injury and injury). Importantly, this model showed that the interaction terms Days*Age and
Days*Age*Injury both had a significant effect on all the mechanical parameters. In addition, injury
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had a significant effect on stress and modulus. Therefore, this analysis states that the
mechanical parameters are highly dependent on the all three categorical parameters, age at
injury, days post injury and injury. This provides support to further analyze this data through
regression analysis.

6.3.3 Whole Model Analysis - Backward Stepwise Linear Regression Model
To further understand the relationships present in the entire data set, two sets of linear
regression models were developed that included all the data. First, the continuous independent
parameters and categorical main effects and interactions were examined against the dependant
parameters. Equations 6.5-6.7 below show the results of this analysis:
Equation 6.5:

Perc Re lax = 0.44 * StDev + 2.44 * Injury − 4.5 * ( Age * Days ) + 1.27 * ( Days * Injury )
+ 2.75 * ( Age * Days * Injury )
Equation 6.6:

Perc Re lax = 0.44 * StDev + 2.44 * Injury − 4.5 * ( Age * Days ) + 1.27 * ( Days * Injury )
+ 2.75 * ( Age * Days * Injury )
Equation 6.7:

Modulus = −1.00 * Ave − 22.87 * Age + 27.22 * Injury − 16.71 * ( Age * Days )
+ 8.78 * ( Age * Days * Injury )
From this analysis it can see that days post injury (Days) and the interaction term
Injury*Age do not contribute to the overall prediction of the mechanical parameters. Therefore,
when developing a linear regression model that includes all the interactions, these parameters
can be excluded. This method helps to increase the overall power of the entire regression
analysis.
Now that a clearer idea of which parameters are predictive has been determined, a full
model with all the interactions was conducted (Equation 6.3) where Y1-Y3 are percent relaxation,
stress and modulus respectively.

142

Results of this analysis showed not only predictive effects from the main parameters but
also from many of the interactions, including interactions with Age, Days and Injury (See
Appendix 6.2). Due to the complexity of interpreting these equations and the stated hypotheses
of the study, the data will be separated into experimental groups (age, days, injury). A clearer
understanding of how the structural and compositional parameters affect the mechanics, without
the confounding effects of the age, days and injury, will therefore be obtained.

6.3.4 Grouped Analysis – Backward Stepwise Linear Regression Analysis
For this analysis, data was grouped according to age at injury (7, 10 days old), days post
injury (3, 10 days post injury) and whether or not the tendon was injured or uninjured. This
resulted in 8 categories with 3 regression equations for each (percent relaxation, stress and
modulus) for a total of 24 equations (Figure 6.1). See Appendix 6.3 for a summary of the
complete results of all 24 equations. Presented here are the results of the significant models.
(Equations 6.8-6.20). None of the models presented below had a Durban-Watson score lower
than 1.08.

6.4 Discussion
6.4.1 Interpretation of Results
This study employed a neonatal healing model in a mouse to study the structure-function
relationships in tendon development and healing. A unilateral injury was created in developing
neonatal Achilles tendons at two ages (7 and 21 days old) and held out to two time points post
injury (3 and 10 days post injury). The uninjured and injured Achilles tendons were then assayed
for mechanical parameters (percent relaxation, stress and modulus), compositional parameters
(collagen, biglycan and decorin content) and structural parameters (fibril diameter average and
standard deviation). The compositional and structural parameters measured were then used as
independent variables in multiple regression models to predict mechanical properties, the
dependent variables. Briefly, proteoglycans were shown to be significant predictors of modulus
during early developmental healing but not during late developmental healing or normal
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Eq. # Linear Regression Equation
Model p Model R2
PercRe lax7,3,U = 18.4 − 0.12 *Col + 0.77* Ave
8
0.04
0.57
Perc
Re
lax
=
70
.
80
−
28
.
14
*
Dec
9
0.07
0.30
7 ,10 ,U
Perc Re lax 21, 3,U = 78.00 − 0.06 * Col
10
0.01
0.50
Stress 21,3 ,U = 47.81 − 0.38 * Ave
11
0.01
0.50
Modulus 21, 3 ,U = 478.26 − 255.52 * Big − 8.76 * Ave4 + 16.62 * StDev
12
0.08
0.60
Perc Re lax 21,10,U = 136.14 − 0.03 * Col − 60.84 * Big − 0.57 * Ave
13
0.05
0.65
Modulus 21,10 ,U = −39.94 + 3.66 * Ave4 − 6.75 * StDev
14
0.03
0.59
Perc Re lax 7 , 3, I = 54.14 − 1.05 * Ave + 2.75 * StDev
15
0.05
0.50
Modulus
=
14
.
65
−
4
.
62
*
Big
+
3
.
00
*
Dec
16
0.06
0.50
7,3,I
Perc Re lax 7 ,10, I = 40.54 + 1.25 * StDev
17
0.01
0.57
Mod 7 ,10 , I = 31.7 + 102.2 * Big − 66.35 * Dec
18
0.00
0.77
Stress 21,3 , I = 29.10 − 0.23 * Ave
19
0.06
0.34
Modulus
=
370
.
5
−
3
.
19
*
Ave
20
0.04
0.39
21, 3, I
development. Multiple independent parameters predicted percent relaxation during normal

development, however, only biglycan and fibril diameter parameters predicted percent relaxation
during early developmental healing. Last, multiple differential predictors were observed between
early development and early developmental healing, however, no differential predictors were
observed between late development and late developmental healing.
To date, the viscoelastic parameter stress relaxation has not been regressed against
compositional and structural parameters in tendon. Proteoglycans and water, along with the
inherent viscoelasticity of the collagen itself, are thought to be primarily responsible for
viscoelastic behavior [23, 24]. In the current study, collagen content is a predictor of percent
relaxation in three of the four uninjured developmental equations. In addition, both proteoglycans
are predictors in one equation each while fibril diameter average is a predictor in two.
Throughout development collagen content increases and small, discontinuous fibril intermediates
are longitudinally fused to form continuous fibrils and laterally fused to produce larger diameter
fibrils [25]. It has been proposed that small, uniform fibrils contribute to viscoelastic parameters
due to possible discontinuity thereby allowing sliding between the fibrils. The presence of
collagen and fibril diameter average as predictors for percent relaxation throughout development
supports this hypothesis. Proteoglycans are negatively charged, hold water in the tendon and
therefore, are hypothesized to have an effect on viscoelastic parameters [26], which is also
supported in this study. Surprisingly, only fibril diameter average and standard deviation are
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significant predictor of percent relaxation during healing. This may be due to increased
discontinuity of fibrils in the injured tendon. Future studies will further investigate the differential
mechanisms behind viscoelastic parameters during normal development and developmental
healing.
When examining the elastic parameter modulus during early develop and healing,
significant predictors, decorin and biglycan, were demonstrated only in healing tendon, with no
significant predictors for uninjured development. It has been previously hypothesized that
collagen bears the main load in elastic tensile mechanics; however, these results are not
surprising as chondroitin sulfate and dermatan sulfate have previously been demonstrated to
significantly predict elastic mechanical parameters in a mouse model[11]. It is important to point
out that in Chapter 5 the same experimental group demonstrated an accelerated healing
response with a return of mechanical function. This could therefore indicate that increased
proteoglycan expression is beneficial during healing. Further investigation into the role of the
proteoglycans in this model could lead to new treatments for improved healing in adult injury.
Interestingly, no changes were seen in any group for maximum stress. During
development, tendon fibroblasts must ensure that the tendon is growing and functionally strong
enough to accommodate an increasing body size. It is hypothesized that the mechanical
parameters most important for function are toe region and linear region parameter, for example,
modulus. In particular, during development, tendons rarely experience stresses that would cause
tendon rupture (maximum stress). Therefore, it is possible that in the healing tendon, resources
were allocated to regaining function (modulus) over failure properties (maximum stress).
In Chapter 5, an accelerated healing response was observed during early development
that was not seen in late developmental. Interestingly, 4 out of the 6 possible early
developmental healing equations had significant predictors and only 2 out of the 6 had significant
predictors during late developmental healing. In addition, the predictors in late developmental
healing were also present in normal development in comparable groups, indicating that these
predictors may simply be an effect of developmental growth and not healing. One possible
explanation for these observations is that the healing response during late development is slower;
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therefore, the parameters that were measured may not have had enough time to affect the
mechanics. In addition, there may be other factors, not measured in the current study, that better
predict healing during late development.
In this study, specific compositional and structural parameters were chosen that were
hypothesized to predict mechanical parameters during development. Collagen content was
chosen as it is the main constituent of tendon; however, it may have been more beneficial to
analyze type I, III, V, XII and XIV collagens throughout development and healing as they each are
shown to have an effect on fibril growth. In particular, type III and type V collagen are associated
with early stages of tendon development and injury [27, 28]. On the other hand, as stated in
Chapter 3, type XII and XIV collagens play a role in fibrillogenesis during development and type
XIV collagen has a differential effect on mechanical parameters during development and maturity.
It was important in this study to obtain quantitative information on each compositional measure
from an individual neonatal tendon; therefore, it was unfortunately technically not possible to
separate each collagen type in this study. Elastin is also a major component of tendon which is
believed to affect mechanical parameters and increases during development. It also however is
present in relatively small quantities and would have been difficult to measure quantitatively in
individual tendons. In addition to collagen, the proteoglycans decorin and biglycan were
examined in the current study. Decorin and biglycan were chosen because they are the most
abundant proteoglycans in tendon and are thought to be differentially regulated. In addition, they
play a role in fibrillogenesis and possibly mechanical development. Other proteoglycans are
thought to have similar roles including lumican and fibromodulin. Knockout mice studies have
shown altered fibrillogenesis in these mice which also led to altered mechanics during
development. While each proteoglycan present in tendon may play a role in mechanical
development and injury, decorin and biglycan were chosen based on abundance and the
possibility of obtaining protein content (mRNA content was obtained in this study, this limitation
was discussed in Chapter 4). Lastly, collagen cross-links have been extensively studied in softtissue development and are thought to prevent fiber sliding. A previous study correlated an
increase in collage cross-links with tensile mechanical strength in cartilage [29]. However,
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current methods for measuring cross-links can depend on the concentration of the cross-links and
may therefore be inaccurate.
Tendon is a hierarchical structure and there is much debate as to which hierarchical level
contributes the most to tendon mechanics. At the smallest structural level, bonds which are
reversible between fibrils and fibril associated molecules, are thought to be integral in the
mechanical integrity of a tissue. Some of these fibril associated molecules include decorin and
biglycan, which lends further support to including them in this study. It has long been
hypothesized that fibril diameter is an important mechanical predictor since fibril diameter
increases throughout development concurrently with mechanics. Some studies have shown
correlations between fibril diameter parameters and mechanics, but fibril diameter average was
not able to account for most changes in mechanics post injury in the current study. At the next
level, some studies have suggested that fiber sliding is one of the main causes of stressrelaxation in tendon [30]. Lastly, others have argued that examining a whole fascicle provides a
“homogonous” section of tendons to be studied. In the current study, fibril diameter parameters
were chosen based on past correlations during development and the hypothesis that fibril
diameter spread would be an important predictor during healing. Fiber organization was
examined during normal development but could not be examined during healing due to lack of
mature fibers. It would have been advantageous to examine fiber sliding during stress-relaxation
and ramp to failure in the current study, but extensive preparation and manipulation for this
measurement may have altered the mechanical parameters of the neonatal Achilles tendon.
Lastly, in order to maintain appropriate power for the regression analysis, the number of
independent parameters had to remain low (5). Therefore, for the reasons stated above, total
collagen content, biglycan and decorin expression, and fibril diameter average and standard
deviation were chosen for this study.
Multiple statistical analyses were conducted in this study to gain a thorough
understanding of the data and to determine the appropriate final linear regression model to
analyze. Before a multiple linear regression could be conducted, it had to first be determined if
the categorical experimental parameters (age at injury, days post injury and injured or uninjured)
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were related to the dependent mechanical parameters. A GLM was run to determine this
relationship. It was demonstrated that interactions between the categorical parameters were
indeed significantly related to the mechanical parameters. Second, with this knowledge, a
backward stepwise linear regression was conducted on the entire data set to help refine the
model. A reduced form of the model was run to determine which categorical parameters were
significant predictors of the mechanical parameters without the confounding effects of every
possible interaction. The reduced regression model of all the data demonstrated that the
categorical parameters days post injury (Days) and the interaction term (age at injury)*(injury)
(Age*Injury) were not significant predictors. Third, a backward stepwise regression model was
run which included all continuous parameters, all categorical and all interactions (excluding Days
and Age*Injury). This analysis demonstrated multiple, significant predictor variables, many of
which included categorical parameters. Along with the hypotheses of the study, this analysis
provided support for running individual regression analyses based on experimental groups.
An analysis of the compositional and structural independent variables measured in this
study revealed some multicollinearity between independent parameters. In particular, fibril
diameter average and standard deviation, decorin and biglycan, and collagen content and fibril
diameter all showed correlations in some of the groups analyzed. These correlations are
observationally supported by previous studies that have examined compositional and structural
properties of tendon. For instance, as tendons develop, both the fibril diameter average and
standard deviation (spread) increase with age [25]. In addition, biglycan and decorin are thought
to have differential effects on collagen fibrillogenesis and be differentially regulated with respect
to each other [6, 7, 26]. Lastly, it is not surprising that collagen content and fibril diameter
average showed correlations in some groups because increased collagen production and
increased fibril diameter average occur during similar stages of development [25, 31, 32]. When
predictor variables are highly correlated, the regression coefficients tend to have large sampling
variability. Imprecise information may be presented about the true regression coefficients in
these models; however, definite statistical relations may still exist between the independent and
dependent parameters. The Durbin–Watson statistic is a test statistic used to detect the presence
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of autocorrelation in the residuals from a regression analysis. In other words, it tests for the lack
of randomness in least squares residuals. No correlations were seen between the independent
variables for any of the significant models, therefore the error terms were indeed random.

6.4.2 Limitations
Stepwise linear regressions are used to automatically determine the “best” subset of
independent variables that would significantly predict the dependent variables. The forward
stepwise regression procedure is probably the most widely used of the automatic search
methods. However, in the current study, the backwards stepwise regression was employed. The
main difference between the two procedures is that in a forward regression, parameters that have
a significant effect are added to the model. In backwards regression, all the parameters are
initially in the model and subsequently removed if they do not have a significant effect. For small
and moderate numbers of variables in the pool of potential independent variables, some
statisticians argue for backward stepwise search over forward. This argument is based primarily
on situations where it is a first step to look at each X variable in the regression function adjusted
for all the other X variables in the pool [19]. While no significant differences should be observed
between the two methods, the backward stepwise was used in the current study based on the
argument above.
The coefficient of determination (R2) for the significant equations ranged from 0.3 to 0.77.
A low R2 indicates that a very small portion of the variability in the mechanical parameter is
attributable to these independent parameters. It is likely that the inclusion of factors not
2

considered in this model would result in an improvement in some of the R values. Such
additional factors could include additional compositional parameters such as type XII and XIV
collagens, additional structural parameters, such as fibril area fraction, or biologic parameters
such as the number of inflammatory cells present. In addition, a nested study design may have
been possible based on the fact that each individual mouse is only present within each
“specimen.” However, based on the study design and hypotheses, a specimen was defined as 5
individual mice (from the same litter). Therefore, the factors for this study were age at injury and
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days post injury with individual “specimen” randomly assigned to each group. This study design
dictated that a crossed design across factors, and not nested within specimen, was most
appropriate for the hypotheses.
The existence of correlations between independent variables causes complexities in
interpreting the results. For instance, the effect of individual factors cannot be separated out.
However, since this correlation is not an experimental artifact, but rather the result of the complex
environment experienced by the tendon, manual removal of any factor was not conducted. In
addition, the regression analysis manages such correlations by removing strongly correlated
variables in the backward elimination step, leaving only the strongest predictor variables in the
model. However, it should be noted that correlations between the dependent variables potentially
allows one variable to mask the contribution of another. The hypotheses of this study were to
determine which independent parameters had a significant effect on the dependent parameters;
therefore, despite collinearity, the conclusions presented here remain valid.
In this study, 13 out of the potential 24 equations were found to have significant
predictors. Most of the regression equations that did not demonstrate any significant predictors
were due to high influence in the data set. A specimen is considered to be influential if its
exclusion causes major changes in the fitted regression function. One possible explanation for
the high incident of influence could be the small sample size used in the final grouped analyses.
While an a prior power analysis test was conducted, a general rule of thumb for sample size in
regression analysis is an n of 10 per independent parameter. Therefore, the current study could
have consisted of 50 specimens per group. As a reminder, one specimen actually consisted of 6
neonatal mice, with 4 experimental groups (uninjured and injured samples came from the same
specimen); therefore, 1,200 neonatal mice would have been required under these criteria.
Interestingly, 13 out of 24 equations were still found to have significant predictors. However, an
increase in sample size would likely produce more significant results and should be taken into
consideration in future studies.

6.4.3 Summary
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In summary, 8 different experimental groups (age at injury, days post injury and injured or
uninjured) were analyzed in backward stepwise linear regression to determine how the
independent parameters (collagen, biglycan and decorin content, and fibril diameter average and
standard deviation) predicted the dependent parameters (percent relaxation, stress and
modulus). 13 out of the 24 possible equations were demonstrated to have significant predictors.
Specifically, percent relaxation was found to have collagen content, fibril diameter average and
decorin content as significant predictors during normal development; whereas, only fibril diameter
average and standard deviation predicted percent relaxation during healing. In addition, during
early development, biglycan and decorin are significant predictors of modulus during healing but
no significant predictors for modulus were demonstrated during normal development. The
differences between early normal development and developmental healing should be further
examined due to the fact that early developmental healing demonstrated an accelerated healing
response with a recapitulation of normal mechanical properties. Understanding the exact
mechanisms of action behind these predictor variables could provide new therapeutic treatments
for the improvement of mechanical properties during adult healing.
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Chapter 7: Summary, Limitations and Future Directions

7.1 Overall Conclusions
The previous chapters describe different methods in which development can be used as
a new paradigm through which to improve adult healing. Through the course of the work, factors
that were differentially regulated during development and healing were more closely examined in
knock-out mouse models, a new model of neonatal tendon development in a mouse Achilles
tendon was established as well as a new model of healing during two stages of neonatal
development in a mouse Achilles tendon. A brief summary of the background and significance
motivating this work, a brief summary of the findings, as well as limitations and future directions
are provided below.

7.1.1 Background and Significance
Tendon injuries are a large problem clinically due to their inability to regain normal
function. During the repair response to injury, structural and compositional changes occur, but a
mechanically inferior tendon is produced. An injured tendon which is mechanically inferior, has
compromised function and reruptures after treatment is commonly observed clinically.
Conversely, during neonatal development, tendons undergo a well orchestrated process whereby
extensive structural and compositional changes occur in synchrony to produce a normal
tendon[1, 2]. As a result, the process of development has been postulated as a potential
paradigm through which improved adult tendon healing may occur.
Chapter 1 outlined general knowledge of tendon composition, structure, mechanical
properties, healing process and the current issues still plaguing tendon healing clinically.
Tendons are composed mainly of aligned, type I collagen and transfer tensile stress from the
muscle to the bone. Minor constituents are also present (minor collagens and proteoglycans) that
are thought to play a role in fibrillogenesis during development and possibly mechanics. Some of
the new treatments to help tendons heal include new surgical and rehabilitation protocols, growth
factor and cytokine application, gene therapy, and tendon grafts with cells. Interestingly, fetal
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tendons have the ability to heal without scar, but have fundamentally differences from adult
healing that are difficult to alter in the adult wound [3]. Due to the differential healing response
between fetal and adult tendons, it has been proposed that healing parameters may change
throughout fetal and neonatal development into adulthood. During neonatal development,
tendons have significant compositional and structural changes including an increase in collagen
content, temporal expression of minor constituents and an increase in both the fibril diameter
average and spread. However, little information is available on the mechanical development and
healing parameters during neonatal development. With this in mind, it is the goal of this
dissertation to characterize neonatal development and healing, identify parameters that are
important to mechanical properties during development and healing and see how these
parameters affect healing.

7.1.2 CD44 Deficiency Improves Healing Tendon Mechanics and Increases Matrix and Cytokine
Expression in a Mouse Patellar Tendon Injury Model
In Chapter 2, the role of CD44 in adult healing was investigated. CD44 is a cellular
receptor for hyaluronic acid (HA). During fetal healing CD44 expression is depressed and HA
has a prolonged expression; however, during adult healing CD44 is highly expressed and HA is
also expressed but for only a short period of time. Due to this differential response between fetal
and adult healing, it was hypothesized that a lack of CD44 would have an effect on adult healing.
Based on previous studies that investigated a decrease in CD44 during healing, it was
hypothesized that a lack of CD44 would have a detrimental effect on adult healing. To test this
hypothesis, a CD44 knockout (KO) mouse model was used in conjunction with a patellar tendon
injury model. In general, the cross-sectional areas of the KO tendons were reduced at 3 and 6
weeks post injury when compared to wild type (WT) controls. In contrast to the hypothesis,
mechanical stress, strain energy density and failure strain were increased when compared to WT.
Histologically, when comparing across time post injury, the KO tendons approached uninjured
fiber organization whereas WT did not at 6 weeks post injury. Lastly, gene expression data
indicated that matrix components and cytokines that are beneficial to superior healing were up
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regulated in KO tendons. This study indicates that limiting the role of CD44 may improve healing
parameters in adult tendon injury.

7.1.3. Temporal and Tissue Specific Dysfunction in the Absence of Type XIV Collagen in a
Mouse Model
In Chapter 3, the role of type XIV collagen in tendon mechanics was evaluated during
both development and maturity in soft tissues, specifically tendon and skin. Type XIV collagen is
a fibril associated collagen that is present during development in tendon and throughout life in
skin. It is a minor constituent that has a role in the lateral fusion phase of fibrillogenesis. It was
hypothesized that the significant role type XIV collagen plays in the regulation of fibrillogenesis
would lead to alterations in the mechanics of developing soft tissues. To test this hypothesis, a
new method to mechanically test small, fragile neonatal tendons was developed. As
hypothesized, skin in the mature KO mice had a reduced stress and modulus. A decrease was
also seen in almost all mechanical parameters of neonatal flexor digitorum longus tendons with
no change in cross-sectional area; however, there was no change in mechanics in the mature
tendons. In addition, heterozygous tendons (Col14-/+) had mechanical properties intermediate to
those of the WT and KO tendons, implying that type XIV collagen has a dose dependent effect on
the mechanics of neonatal developing tendon. Changes in collagen structure from altered
fibrillogenesis during development may account for the changes seen in tendon neonatal
development but not maturity. Overall, the data suggested a tissue-specific and age specific role
of type XIV collagen in the structure-function relationships of connective tissues.

7.1.4 Mechanical, Compositional and Structural Properties of the Neonatal Mouse Achilles
Tendon
It has been proposed that understanding the similarities and differences between
neonatal development and healing could lead to new treatments in adult healing; however, a
greater understanding of neonatal development must first be obtained. In Chapter 4, a mouse
model of neonatal development was created to investigate compositional, structural and
157

mechanical changes throughout development. Achilles tendons from mice at 4, 7, 10, 14, 21 and
28 days old were examined. In general, it was found that collagen content increased, biglycan
expression decreased, decorin content was unaltered, fibril diameter mean and spread increased,
cross-sectional area and mechanical parameters increased. Not only does this chapter provide
fundamental knowledge about neonatal development, but it provides that information using a
mouse model. A mouse model is important because of the potential use of genetically altered
mice and commercially available assays that will help answer more mechanistic questions in
future studies

7.1.5 Recapitulation of the Achilles Tendon Mechanical Strength during Neonatal Development:
A Study of Differential Healing During Two Stages of Development in a Mouse Model
As previously stated, understanding the differences between development and healing
could lead to improved healing in adults. In addition, it has been proposed that healing
parameters change throughout development. A thorough understanding of healing during
development could lead to new models for improved tendon function during healing. In Chapter
5, two different stages of healing during neonatal development were investigated. Data from
Chapter 4 demonstrated that at 7 and 21 days old neonatal Achilles tendons were distinctly
different in their composition, structure and mechanics; therefore, these two stages were chosen
to study healing. An in vivo surgical model of neonatal healing was created by introduction of a
full thickness, partial width (~50%) biopsy injury in the Achilles tendon. Healing parameters were
then observed at 3 and 10 days post injury. In general, it was observed that during early
development (7 days old) compositional and mechanical parameters had returned to normal
values although the fibril diameter mean and spread remained lower (small fibrils, narrow spread)
than normal. During late development (21 days old), there was little to no change in most
parameters at 3 days post injury and then drastic changes at 10 days post injury, most of which
were associated with adult reparative healing (increased collagen and proteoglycans content,
increased cross-sectional area, decreased mechanical properties). In addition, mechanical
properties were higher in early development when compared to late (when comparing parameters
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normalized for development) and during early development, mechanical properties improved over
time but not during late development (when comparing parameters normalized for development).
Overall, Chapter 5 demonstrated an accelerated healing response during early development that
was not present during late development.

7.1.6 Investigating Structure-Function Relationships in Achilles Tendon Neonatal Development
and Healing during Neonatal Development in a Mouse Model using Multiple Regression Models
In Chapter 6 a linear regression statistical model was utilized to quantitatively and
objectively compare and contrast normal developmental tendons with healing developmental
tendons. In Chapter 5, compositional, structural and mechanical changes were quantified for
both uninjured and injured tendons through a unilateral injury in the mouse Achilles tendon. This
data was then used in statistical analyses. First, a general linear model was used to determine
how the compositional, structural and experimental groups (age at injury, days post injury and
injured or uninjured) related to the mechanical parameters. Second, a backward, stepwise linear
regression model was examined for the entire data set. A model regressing the compositional,
structural, and experimental groups and only the interactions between the experimental groups
was initially conducted. After excluding non-significant experimental groups a backward,
stepwise linear regression model of the entire data set, including all other main effects and
interactions, was run for each mechanical parameter. This analysis provided statistical support to
regress the mechanical parameters against only the compositional and structural parameters
within experimental groups. Out of 24 possible equations (3 mechanical parameters for each of 8
groups), 13 were found to have significant predictors. In general, proteoglycans were shown to
be significant predictors of modulus during early developmental healing but not during late
developmental healing or normal development. Multiple independent parameters predicted
percent relaxation during normal development, however, only biglycan and fibril diameter
parameters predicted percent relaxation during early developmental healing. Last, multiple
differential predictors were observed between early development and early developmental
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healing, however, no differential predictors were observed between late development and late
developmental healing.

7.2 Limitations and Future Directions
The body of work described in this dissertation has expanded our knowledge of neonatal
tendon development and healing through a greater understanding of the specific roles of CD44 in
healing and type XIV collagen in development, a characterization of neonatal development and
healing during development and a structure-function analysis of development and healing during
development. Within this work, a new mouse model of neonatal tendon development and healing
during neonatal development was created. In addition, a new method to mechanically test small,
fragile tendons and a new surgical model were developed. This dissertation has uncovered
fundamental knowledge on neonatal development and healing and answered questions regarding
the role of different tendon parameters during development and healing. In addition, it has
provided new model systems through which additional questions can be proposed and answered.
The following sections describe limitations in the current studies and potential avenues for future
work loosely organized around the previous Chapters 2-6.

7.2.1 CD44 in Adult Healing
As with all studies, the study of the role of CD44 during healing had its limitations. First,
mRNA expression may not completely mirror the protein levels since there is post-transcriptional
regulation of protein synthesis. However, these findings are consistent with those reported by
other investigators [4]. Second, only male mice were examined. It was recently demonstrated
that collagen synthesis in human females is significantly less than in males [5]; therefore, the
results of this study may not be translatable to female mice. However, since a change in type I
collagen expression was not shown, the overall conclusions are likely still applicable to both
sexes. Third, all the uninjured control tendons were harvested at 12 weeks of age, even though
they were compared to injured mice as up to 18 weeks of age. Somerville et al [6] demonstrated
that most material and mechanical properties of cortical bone had reached their maximum value
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around 3 months of age. Therefore, it is unlikely that an additional 6 weeks would have
significantly affected results on the material properties of the tendons due to growth. Fourth, as
with all knockout studies, there is a possibility of compensation by other molecules. The most
likely candidate is RHAMM, another HA receptor. While RHAMM expression was not examined
directly, signaling or the inflammatory response, which is connected to RHAMM expression.
Nevertheless, expression of IL1β, a main down stream effecter of RHAMM, was not increased in
this study; therefore, it is unlikely that RHAMM signaling increased in this study.
The present study was a good first step in determining CD44’s role in tendon healing and
mechanical properties; however, the mechanism of action was not uncovered in this study. If the
mechanisms are determined, then clinical applications involving CD44 could be undertaken to
help improve adult tendon healing. Outlined below are steps that could be taken in future studies
to meet these objectives.
First, a better understanding of possible compensatory mechanisms would provide
further insight into this model system. While the gene analysis conducted in this study pin
pointed the cytokines and matrix molecules that were deemed important from previous research,
other components of normal and healing tendon may also be altered. Previous studies have
examined the phenotypes of CD44 KO mice and found some differences in inflammatory cell
recruitment [7, 8]. However, an overall view of the differential expression of mRNA has not been
conducted. Microarray provides a broad understanding of the changes in mRNA expression,
thereby providing more complete knowledge of possible altered mechanisms. Therefore, an
analysis of mRNA expression in WT and CD44 KO adult mice should be conducted. Upon
obtaining baseline expression values and differences, an additional microarray study examining
differences in expression shortly after injury (1, 3 and 7 days post injury) would help explain the
differential healing response demonstrated in the current study. The value of a microarray study
is that a broad range of targets were examined; therefore, molecules that were not initially
hypothesized to play a role in healing in the absence of CD44 can be identified for further study.
After determining overall expression in the normal KO and the KO during healing, further
investigation into differentially regulated molecules can be conducted. First, altered expression
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needs to be confirmed by PCR and second, if possible, protein levels should be determined.
Upon determining that these molecules are indeed differentially regulated, a greater
understanding of the mechanisms can be determined.
The present study demonstrated a beneficial effect of limiting the expression of CD44,
but, as stated, it did not provide the mechanism behind this effect. When CD44 and HA interact
on the cell surface, a cascade of events is initiated intracellularly. The work in this study could
indicate that these intracellular events are detrimental to healing; however, it is possible that there
are still beneficial mechanisms from the interactions of CD44 and HA. Support for this hypothesis
is based on the fact that high molecular weight HA has been shown to have beneficial effects on
tendon healing (fetal healing) whereas low molecular weight HA has detrimental effects (adult
healing) [9]. The differential response between these two interactions is still not well understood.
Therefore, a closer examination of the intracellular signaling processes that occur during fetal
healing and normal adult healing may help elucidate and differentiate these mechanisms. CD44
has been implicated to in the initiation of the ERK [10], Rac [11] and p38 [12] intracellular
pathways. Specific cell signaling differences have already been observed in vitro with age [13]
and between high and low molecular weight HA [11]. One method to determine how different
intracellular signaling pathways are mediating the healing process is through inhibition of an
upstream target. Specifically, the inhibitors SB 203580 (p38) and U0126 (ERK) can be applied to
an injury in vivo. In addition, these inhibitors can be applied singularly and in combination. These
inhibitors act by preventing the phosphorylation of p38 and ERK which occurs after injury. One
complication of this method is that phosphorylated and unphosphorylated p38 and ERK need to
be detected in injury, without inhibitors and with inhibitors, respectively. Unfortunately, due to the
p38/ERK’s intracellular location and the small number of cells present in tendon, this is a
technically difficult assay, particularly in a mouse model where the tendons provide limited
starting material. Therefore, future studies should examine these mechanisms in a larger animal
model, either a rat or potentially even a rabbit. Lastly, a thorough investigation into which form of
HA is present in each of the age groups examined is necessary to elucidate the differential effect
of HA on the intracellular processes in vivo. With information obtained from this experiment, a
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deeper understanding of the exact mechanisms behind improved healing in the absence of CD44
and its intracellular signals will be obtained and may therefore be applied clinically.
The present work is very encouraging because it demonstrates the ability to alter the
mechanical, organizational and genetic response to injury through the removal of a single
molecule. This is particularly important clinically because synergistic effects with other treatments
can be avoided. One method that could potentially block CD44’s actions clinically that is showing
promise is the application of siRNA and shRNA (small interfering plasmid and lentiviral RNA) [14].
These small RNA molecules are targeted to knock down expression of a specific gene of interest
and have been used extensively in vitro [4], in animal models [15] and even clinically [16]. The
main advantage of this research tool is that the possibility of developmental compensation is
circumvented by applying the siRNA locally and only after injury. Multiple methods for delivery are
being investigated including nanoparticles, viral and extracellular matrix. In addition, this
technology is already in clinical trials and has shown efficient targeting and internalization. Of all
the potential delivery methods, the most promising for the field of tendon regeneration is the
ability to deliver siRNA through matrix components [17]; therefore, CD44 siRNA could be added
to a tendon graft to improve tendon healing.
Before siRNA can be applied clinically, an in vivo animal model must first be conducted in
a clinically relevant model. Therefore, a first step would be to augment a rotator cuff tear in a rat
supraspinatus model with an siRNA treated tendon graft and observe the mechanical parameters
at 4 and 8 weeks post injury compared to repair without augmentation. In addition to mechanical
parameters, fibril organization and mRNA expression of IL-1β, TGFβ, decorin, biglycan, types I
and III collagen should all be examined so the results can be comparable to those found in the
CD44 KO study. In addition, assays to confirm uptake of the siRNA into tendon fibroblasts need
to be conducted prior to the start of this study to ensure transfection efficiency. Upon completion
of this study, assuming beneficial healing parameters were observed, future studies in a larger
animal and then clinical trials can be undertaken.

7.2.2 The Role of Type XIV Collagen in Development
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To investigate the role of type XIV collagen during development a Col14a1 knockout (KO)
mouse was utilized. As mentioned above in the CD44 study, compensatory mechanisms may
have accounted for the discrepancy between neonatal and mature tendons. Other molecules in
the KO tendon may have compensated by maturity or the discrepancy could simply mean type
XIV collagen plays a more significant role in mechanical development. The main candidates for
compensation were the four proteoglycans, decorin, biglycan, lumican, fibromodulin, and type XII
collagen. Type XII collagen is also a FACIT collagen and is more widely expressed throughout
development, maturation and aging than type XIV collagen in most connective tissues [18-20].
The four proteoglycans have previously been shown to play multiple roles during fibrillogenesis,
making them candidates for compensation. Neither type XII collagen or the four proteoglycans
were shown to be upregulated in the current study; therefore, it can be hypothesized that the
discrepancy seen between neonatal development and maturity in the Col14a1-/- tendon is due to
type XIV collagen.
A greater understanding of how type XII and XIV collagen affect fibrillogenesis and
mechanical properties is needed. The current study indicates that the absence of type XIV
collagen decreases the mechanical parameters during development of tendon; therefore, type
XIV collagen’s presence may be beneficial during development and healing. If subsequent
studies find data to support this hypothesis, type XIV collagen can be incorporated into tendon
grafts for clinical applications. However, numerous studies need to be conducted before tissue
engineering work can begin. First, a study parallel to the one conducted in this dissertation needs
to be conducted on the type XII and compound type XII/XIV KO mice. Specifically, the
mechanical properties, fibril diameter average and spread, along with the expression of biglycan,
decorin, fibromodulin and lumican should be studies in developing, juvenile and mature Achilles
tendons (7, 21 and 42 days old). The study should incorporate a multiple regression statistical
analysis that will systematically demonstrate which compositional and structural parameters affect
the mechanics and whether the FACIT collagens have a differential effect. Therefore, the
statistical model should regress the mechanical parameters against the presence of the FACIT
collagens, compositional and structural parameters. This design will demonstrate how the FACIT
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collagens are affecting mechanics in three stages of development, whether the change in fibril
properties are a main effect and whether there are significant compensations by the
proteoglycans in the knockout mice.
Type XIV collagen plays a role in the lateral fusion of fibrils during fibrillogenesis. In
particular, in the absence of type XIV collagen, an increase in fibril diameter was observed along
with a decrease in mechanical parameters. In a pilot study presented in Chapter 3, type XIV
collagen expression was present in elevated levels one week post injury in adult tendon and adult
healing tendon has been shown to have decreased fibril diameters. Similarly, in Chapter 5 of this
dissertation, during early neonatal development, a decrease in fibril diameter average was
observed along with a return of mechanical properties. These three observations lead to the
hypothesis that the presence of type XIV collagen, post injury could be preventing the lateral
fusion of fibrils; however, small diameter fibrils may be beneficial to the recapitulation of
mechanical strength during development but detrimental during adult healing. This differential
response could be due to the presence or absence of type XIV collagen or other minor
constituents during development or healing. Therefore, gaining an understanding of how the
FACIT collagens affect both fibril diameter and the mechanical parameters would give invaluable
information considering the apparently contrasting observations. Specifically, the unilateral injury
model presented in Chapter 5 should be implemented in mice at 7, 21 and 60 days old and
examined at 7, 14 and 28 days post injury. Fibril diameter average, spread and modality,
collagen content (both type I and III) measured by either ELISA or western blot, decorin and
biglycan protein expression by western blot, fiber organization measured through polarized light
microscopy, type XII and XIV collagen content measure by western blot and mechanical
parameters from stress relaxation and ramp to failure tensile tests should all be investigated. The
proposed ages were chosen due to the differential effect of type XIV collagen’s absence between
7 and 60 days old mice during normal development and due to the differential healing response
between 7 and 21 days old mice. The time points post injury were chosen so fiber organization,
progression of possible fibril diameter growth and accumulation of minor matrix molecules can be
observed. Similar to Chapter 5, the uninjured contralateral Achilles tendon should be used to
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control for developmental changes and comparisons should be made across age at injury and
days post injury. Due to the older ages proposed in this study, only male mice will be examined
so sex is not a confounding factor. In addition, regression analysis is not being proposed for the
data in this study due to the large number of independent parameters (and therefore large sample
size required for regression); therefore, litters do not need to be weaned to 6 pups and Achilles
tendons can be pooled to obtain measurements of matrix constituents (biglycan, decorin, type I,
III, XII and XIV collagen). This study will provide a deeper understanding of how type XII and
XIV collagen affect fibrillogenesis and the development of mechanical properties at different
stages of development and healing. Not only will this study characterize type XII and XIV
collagen during development, but also will further characterize the developmental healing models
presented in Chapter 5.
While the study presented above is too extensive to incorporate a multiple regression
model as noted, simple linear regressions can be conducted comparing mechanical parameters
to compositional and structural parameters in groups that showed improved healing. If fibril
diameter parameters are found to correlate with mechanics, the fibril diameter average and
standard deviation can also be regressed with the matrix components. This analysis will lend
insight into which proteoglycans and collagens may play a role in fibrillogenesis. While simple
linear regression does not determine which parameters are the “best” predictors within the frame
work of all possible predictors, it does give an objective, quantitative relationship between
measured parameters.

7.2.3. Neonatal Tendon Development and Developmental Healing
In this dissertation, the neonatal Achilles tendon mechanical development and
healing during development in a mouse model were studied for the first time. These fundamental
studies were however, not without limitations. Both male and female mice were used in this study
due to study design restraints of needing litters of at least 6 pups. While it is currently unknown if
there are sex differences at the ages examined, previous studies showed little to no effect of sex
on tendon mechanics and composition in one month old mice or rats [21-23]. It is important to
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note that effects due to sex were seen at older ages, after the onset of puberty, in some studies.
While there is still a possibility of sex differences even in pre-pubescent mice, Chapter 4
demonstrated little to no effects of sex on mechanical properties. Compositional and structural
parameters were not evaluated for sex differences due to the low number of total specimens per
group; however, based on previous studies, it is assumed that there is no effect due to sex.
In addition, in the current study, comparisons were subjectively made to adult tendon
healing but no adult tendons were included in the present study design. The objective of the
current study was to examine healing during development and already required 288 mice. The
addition of a third age, which was not part of the study hypotheses, would have added an
additional 144 mice to the experimental design, substantially and unnecessarily increasing the
size of the experiment. Previous studies have already examined most of the parameters
examined in this study in adult healing, and a current study in our laboratory is examining injury in
adult mouse AT. Therefore, based on previous knowledge available, adult mice were not
included in the current study.
In this dissertation, total collagen content was measured even though there was most
likely a differential response between type I and III collagen during healing. It is possible that the
presence of type III collagen during healing prevents the progression of fibril diameter growth.
Future studies should determine the amount of type III collagen during developmental healing to
determine its role in scar formation and the recapitulation of mechanical properties. Specifically,
the future study detailed in section 7.2.2 includes measuring type I and III collagen by either
ELISA or western blot analysis. Examining type III collagen, along with the other matrix
components during several stages of healing will help to draw conclusions as to which
parameters are differentially regulated and may be beneficial to mechanical properties.
The relative expression of biglycan and decorin were measured through mRNA
expression in this study. It would have been advantageous to measure the actual protein content
of these proteoglycans during development. The ability to collect quantitative measures from
individual tendons lends itself towards using experimental parameters in rigorous statistical
regression models. Therefore, this criterion was used when selecting compositional and
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structural parameters to measure. Unfortunately, protein measures could not be obtained for
individual tendons due to the size of neonatal Achilles tendon and limited quantity of biglycan and
decorin in an individual tendon, in addition to a lack of a biglycan ELISA. Previous studies that
have detected these proteins through western blot pooled 6-12 neonatal tendons together to
obtain enough protein. Therefore, this analysis was not used due the necessity of obtaining
individual measures for each tendon for the regression analysis. A pilot study was attempted to
correlate mRNA expression of decorin and biglycan to protein expression with pooled tendon
during development; however, as detailed in Chapter 4, the results of this study were
inconclusive. Future studies should include quantitative measures of actual protein content when
the appropriate assays become available or when Achilles tendons can be pooled. Again, the
study presented in section 7.2.2 takes these additional assays into account.
One advantage to conducting the current study in a mouse model is the availability of
numerous genetically modified mice and commercially available assays and techniques that are
not available in other animal models. The current study provides fundamental knowledge of
normal tendon development from which other, more elaborate, mechanistic studies can be built.
For instance, by comparing changes in normal development with those in a knockout mouse, the
role of that molecule in the development of mechanical strength can be further understood. An
example, using type XII and compound type XII/XIV collagen KO mice, was provided in section
7.2.2. In addition, more in depth biological studies can be conducted to determine what cell
signaling processes are at play during development and how they affect mechanical strength. An
example in the CD44 KO mouse using cell signaling inhibitors was given in section 7.2.1. With
the number of genetically modified mice (knockout and conditional knockout) and assays
available, the number of questions that can now be answered about tendon development are
abundant. Understanding, on a deeper level, how tendons naturally develop mechanical strength
and how healing during early development is accelerated will lead to new strategies to improve
tendon healing.
Previous in vivo studies have provided evidence that the inflammatory response to injury
is altered with age. Most notably, during scarless fetal healing, there is a lack of inflammatory
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response that many have hypothesized could explain scarless healing [26, 27]. In addition, when
comparing skin wounds in mature (6 months old) to aged (30 months old) mice, an early influx of
neutrophils was apparent in the wounds of the aged compared to the younger controls [28]. One
possible explanation for the differences observed in this study could therefore be differences in
inflammation. Future work in this model should include an investigation into the influx of
inflammatory cells and the expression of pro-inflammatory and anti-inflammatory growth factors
(IL-1B, TGFB1, TGFB3, PDGF, IL-4, IL-6, IL-10) during early and late development by both
mRNA expression and immunohistochemistry. mRNA expression will help obtain a quantitative
measure while the immunohistochemistry will confirm the location and protein presence of each
factor. In addition, the number of inflammatory cells should be determined. Flow cytometry is
the most useful tool to determine cellular markers and therefore different cell types; however, due
to the small size of mouse tendons and the small number of cells within tendon, this technique is
most likely not feasible. Instead, immunological staining of cell markers can be conducted and
cell types can be visually counted. Upon determining which inflammatory markers and cell types
are differentially regulated between early and late developmental healing, a study should be
conducted to replicate the early developmental healing environment in an adult injury. This will
provide further insight into the mechanisms behind the accelerated healing observed in early
development and attempt to improve adult healing by recapitulating that environment.
Despite the advantages in this injury model, there are some disadvantages. Most
notably, the uninjured lateral struts on either side of the injury could stress shield the injured
tissue in the middle. Thus, in vivo stress levels experienced by the injured part of the tendon
could be substantially less than the uninjured portion. This could explain the inability of the
collagen fibrils to regain normal mean diameter and spread. However, the inability of fibrils to
regain a large distribution and bimodality [29] is well documented in numerous injury models and
therefore it is unlikely that stress shielding was the main factor in the current study. The current
study also demonstrated a return of mechanical strength during early development in the middle
portion of the tendon, indicating that it is indeed responding to mechanical load.
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The full thickness, partial width injury necessitated the removal of the uninjured struts on
either side of the injury prior to mechanical testing to ensure only healing tendon was
mechanically tested. While this procedure ensured the mechanical parameters measured were
only healing tissue, it did not allow the measurement of structural mechanical parameters, only
material. The excisional injury used in this model was chosen based on reproducibility and
consistency of the injury. In addition, there was a concern of possibly creating too minimal a
healing response at younger ages with an incisional injury where changes might not be
observable. An excisional injury provided a more substantial defect to help ensure an observable
healing response. An excisional model is appropriate for this study because this study was not
intended to have a direct clinical translation, but rather to be a model for studying the basic
biology during developmental healing. It would however be beneficial to examine if an incisional
injury demonstrates the same healing properties as the excisional injury presented in this study.
Specifically, a small study comparing full thickness, partial width excisional and incisional
unilateral injuries should be conducted on mice at 7 and 21 days of age. The parameters
examined should include mechanical properties, proteoglycans expression and fibril diameter
average. These parameters were chosen based on large difference observed in Chapter 5. This
study may help develop a more clinically relevant model of tendon injury during development.
In this study, changes in collagen organization were demonstrated through three blinded
graders instead of measuring angular deviation through polarized light microscopy. Polarized
light microscopy was attempted in these experimental animals; however, within the wound site of
the AT injured at 7 days old, there was not enough mature collagen for birefringence. Evaluation
at longer time points post injury proposed in the study in section 7.2.2 can be used to determine
quantitative differences in collagen organization.
Little is currently know about the mechanisms behind fibrillogenesis post injury and even
less is known about it during developmental healing. When qualitatively examining the entire
width of the injured tendons in this dissertation under electron microscopy, many cellular
processes were observed at the borders and within the injury. Understanding the cellular
changes within a tendon and across groups may provide substantial knowledge on the
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recapitulation of mechanical strength, particularly since the current study demonstrated prolonged
changes in fibril diameter properties in the presence of a return to mechanical strength. A
detailed study on these processes and how they change from the periphery of the tendon through
the center of the injury could help gain insight into fibrillogenesis during developmental healing.
In addition, comparing and contrasting, not only within a tendon but also across groups, could
lead to the recognition of unique cellular processes observed during early and late neonatatal
developmental healing.

7.2.5 Regression Analysis of Healing During Development
Stepwise linear regressions are used to automatically determine the “best” subset of
independent variables that would significantly predict the dependent variables. The forward
stepwise regression procedure is probably the most widely used of the automatic search
methods. However, in the current study, the backwards stepwise regression was employed. The
main difference between the two procedures is that in a forward regression, parameters that have
a significant effect are added to the model. In backwards regression, all the parameters are
initially in the model and subsequently removed if they do not have a significant effect. For small
and moderate numbers of variables in the pool of potential independent variables, some
statisticians argue for backward stepwise search over forward. This argument is based primarily
on situations where it is a first step to look at each X variable in the regression function adjusted
for all the other X variables in the pool [30]. While no significant differences should be observed
between the two methods, the backward stepwise was used in the current study based on the
argument above.
The coefficient of determination (R2) for the significant equations ranged from 0.3 to 0.77.
2

A low R indicates that a very small portion of the variability in the mechanical parameter is
attributable to these independent parameters. It is likely that the inclusion of factors not
2

considered in this model would result in an improvement in some of the R values. Such
additional factors could include additional compositional parameters such as type XII and XIV
collagens, additional structural parameters, such as fibril area fraction, or biologic parameters
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such as the number of inflammatory cells present. Section 7.2.2 detailed a study that utilizes the
collagen XII and compound XII/XIV mouse models to determine how composition, structure and
the presence of the FACIT collagen affect mechanical parameters.
The existence of correlations between independent variables causes complexities in
interpreting the results. For instance, the effect of individual factors cannot be entirely separated
out. However, since this correlation is not an experimental artifact, but rather the result of the
complex environment experienced by the tendon, manual removal of any factor was not
conducted. In addition, the regression analysis manages such correlations by removing strongly
correlated variables in the backward elimination step, leaving only the strongest predictor
variables in the model. However, it should be noted that correlations between the dependent
variables potentially allows one variable to mask the contribution of another. The hypotheses of
this study were to determine which independent parameters had a significant effect on the
dependent parameters; therefore, despite collinearity, the conclusions presented here remain
valid.

7.3 Final Conclusion
Development has long been considered a potential paradigm through which the
improvement of adult healing could be studied. Through extensive work from other researchers,
much has been learned about development including the stages of fibrillogenesis, compositional
changes including proteoglycans and minor collagens, structural changes including fibril diameter
parameter and a few studies have examined mechanical development. Most studies that
examined mechanical development started the study at approximately one month of age in a
mouse. One study was able to capture the mechanical development throughout neonatal
development in a chick model. While these studies have expanded our knowledge greatly, a
deeper understanding of the mechanisms behind the development of mechanical strength was
left unknown due to limitations in the animal models used.
Healing has previously been shown to have different parameters at different stages of
life. In particular, fetal healing occurs scarlessly whereas adult healing occurs with extensive scar
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formation and reduced mechanical function. Extensive work has been done in both these healing
models in an attempt to understand the normal processes and then improve upon them.
However, neither of these model systems has demonstrated a return of normal mechanics.
Healing parameters have been hypothesized to heal throughout development but this hypothesis
was previously untested. The dissertation presented here first identified two molecules that had a
differential expression either during development (type XIV collagen) or healing (CD44) and
examined their role during development and healing respectively. Then, a mouse model of
normal tendon development was created that allowed the quantitative measure of compositional,
structural and mechanical properties. Further expansion of that model included the development
of a tendon injury model at two stages of neonatal development. Through the injury model, an
accelerated healing response was observed during early neonatal healing that was not seen
during late neonatal healing. Lastly, a statistical regression model was developed to objectively
and quantitatively determine which structural and compositional parameters were significant
predictors of both normal development and healing during development.
As a result of the research presented here, a mouse model of neonatal development and
healing during neonatal development are available for future studies into the mechanisms behind
these processes. In addition, a model of accelerated healing where mechanical strength is
recapitulated in a short period of time without treatment is presented for the first time. Lastly, the
statistical regression data can be used to obtain parameters that are important for improved adult
healing and implemented in clinical treatments and tissue engineered grafts. This work has laid
the ground work for many future mechanistic studies to be conducted on the development of
mechanical strength during both development and healing.
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APPENDIX: RESULTS OF REGRESSION MODEL REFINEMENT
Appendix 6.1: Pearons Correlations for all independent parameters calculated within each experimental
group. Group = age at injury, days post injur, (I)njured or (U)ninjured
Group – 7,3,U

Group – 7,3,I

Group – 7,10,U

Group – 7,10,I

Group – 21,3,U

Group – 21,3,I

Group – 21,10,U

Group – 21,10,I
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Appendix 6.2: Results of significant predictors from the backward, stepwise regression
analysis of the entire data set for percent relaxation, stress and modulus.
Percent Relaxation

Stress
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Modulus

179

180

2

Group - 21,10,U
Percent Relaxation
Stress
Modulus

Group - 21,3,U
Percent Relaxation
Stress
Modulus

Group - 7,10,U
Percent Relaxation
Stress
Modulus

Group - 7,3,U
Percent Relaxation
Stress
Modulus

Model p Model R
0.05
0.65
0.03
0.59

2

Model p Model R
0.01
0.5
0.009
0.5
0.08
0.6

2

Model p Model R
0.07
0.3
-
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0.57
-
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Ave StDev
-0.38
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Group - 21,10,I
Percent Relaxation
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Modulus
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Percent Relaxation
Stress
Modulus

Group - 7,10,I
Percent Relaxation
Stress
Modulus
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Percent Relaxation
Stress
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Model p
-

Model p
0.06
0.04
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0.003
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0.05
0.06

2

Model R
-

2
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0.39
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Appendix 6.3: P-value, R and regression coefficients for all grouped regression equations. Group = age at injury, days post injury, (I)njured or (U)ninjured.

